CONSOLIDATED SCHEDULE OF INVESTMENTS

v3.23.1

CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands, $ in Thousands		Mar. 31, 2023 USD ($) shares		Dec. 31, 2022 USD ($) shares		Dec. 31, 2022 GBP (£) shares
Investment Holdings [Line Items]
Investment, Basis Spread, Variable Rate		8.00%		7.50%		7.50%
Investment cost		$ 3,150,846		$ 3,005,696
Investments at Fair Value		$ 3,130,178		$ 2,963,955
Investment, Identifier [Axis]: Investments in Cash & Cash Equivalents (1.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(1.00%)
Investment cost	[2]	$ 15,000
Investments at Fair Value		15,000
Investment, Identifier [Axis]: Cash & Cash Equivalents and GS Financial Square Government Fund, Cash & Cash Equivalents
Investment Holdings [Line Items]
Investment cost	[2]	15,000
Investments at Fair Value		$ 15,000
Investment, Identifier [Axis]: Debt Investments (198.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	198.04%
Investment cost	[2]	$ 2,971,498
Investments at Fair Value		$ 2,968,651
Investment, Identifier [Axis]: Debt Investments (199.47%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			199.47%		199.47%
Investment cost	[4]			$ 2,818,060
Investments at Fair Value				$ 2,795,444
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.17%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(2.17%)
Investment cost	[2]	$ 32,527
Investments at Fair Value		$ 32,527
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.31%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.31%		2.31%
Investment cost	[4]			$ 32,339
Investments at Fair Value				$ 32,339
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-06	[5],[6],[7]	2026-06	[8]	2026-06	[8]
Investments Maturity Month and Year		2026-06	[5],[6],[7]	2026-06	[8]	2026-06	[8]
Investment, Basis Spread, Variable Rate		3.00%	[5],[6],[7],[9]	3.00%	[8],[10]	3.00%	[8],[10]
Investment, Interest Rate, Floor		6.50%	[5],[6],[7],[9]	6.50%	[8],[10]	6.50%	[8],[10]
Investment, Interest Rate, Paid in Kind		1.00%	[5],[6],[7],[9]	1.00%	[8],[10]	1.00%	[8],[10]
Principal Amount		$ 5,011	[5],[6],[7]	$ 5,000	[8]
Investment cost		4,987	[2],[5],[6],[7]	4,951	[4],[8]
Investments at Fair Value		$ 4,987	[5],[6],[7]	$ 4,951	[8]
Investment Exit Fee		5.95%	[5],[6],[7],[9]	5.95%	[8],[10]	5.95%	[8],[10]
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-01	[7]	2027-01	[8]	2027-01	[8]
Investments Maturity Month and Year		2027-01	[7]	2027-01	[8]	2027-01	[8]
Investment, Basis Spread, Variable Rate		2.15%	[7],[9]	2.15%	[8],[10]	2.15%	[8],[10]
Investment, Interest Rate, Floor		9.15%	[7],[9]	9.15%	[8],[10]	9.15%	[8],[10]
Principal Amount		$ 28,000	[7]	$ 28,000	[8]
Investment cost		27,540	[2],[7]	27,388	[4],[8]
Investments at Fair Value		$ 27,540	[7]	$ 27,388	[8]
Investment Exit Fee		11.21%	[7],[9]	11.21%	[8],[10]	11.21%	[8],[10]
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.14%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(7.14%)
Investment cost	[2]	$ 104,071
Investments at Fair Value		$ 107,083
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.26%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			7.26%		7.26%
Investment cost	[4]			$ 99,167
Investments at Fair Value				$ 101,734
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-07	[5],[7],[11]	2026-07	[8],[12],[13]	2026-07	[8],[12],[13]
Investments Maturity Month and Year		2026-07	[5],[7],[11]	2026-07	[8],[12],[13]	2026-07	[8],[12],[13]
Investment, Basis Spread, Variable Rate		3.25%	[5],[7],[9],[11]	3.25%	[8],[10],[12],[13]	3.25%	[8],[10],[12],[13]
Investment, Interest Rate, Floor		6.75%	[5],[7],[9],[11]	6.75%	[8],[10],[12],[13]	6.75%	[8],[10],[12],[13]
Investment, Interest Rate, Paid in Kind		1.05%	[5],[7],[9],[11]	1.05%	[8],[10],[12],[13]	1.05%	[8],[10],[12],[13]
Principal Amount		$ 15,036	[5],[7],[11]	$ 5,023	[8],[12],[13]
Investment cost		14,842	[2],[5],[7],[11]	4,969	[4],[8],[12],[13]
Investments at Fair Value		$ 15,377	[5],[7],[11]	$ 5,053	[8],[12],[13]
Investment Exit Fee		3.55%	[5],[7],[9],[11]	3.55%	[8],[10],[12],[13]	3.55%	[8],[10],[12],[13]
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31%
Investment Holdings [Line Items]
Maturity Date	[8],[14],[15]			2025-02		2025-02
Investments Maturity Month and Year	[8],[14],[15]			2025-02		2025-02
Investment, Basis Spread, Variable Rate	[8],[10],[14],[15]			9.31%		9.31%
Investment, Interest Rate, Floor	[8],[10],[14],[15]			10.31%		10.31%
Principal Amount	[8],[14],[15]			$ 8,910
Investment cost	[4],[8],[14],[15]			8,768
Investments at Fair Value	[8],[14],[15]			$ 8,748
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.72%, Floor rate 10.62%
Investment Holdings [Line Items]
Maturity Date	[7],[16],[17]	2025-02
Investments Maturity Month and Year	[7],[16],[17]	2025-02
Investment, Basis Spread, Variable Rate	[7],[9],[16],[17]	9.72%
Investment, Interest Rate, Floor	[7],[9],[16],[17]	10.62%
Principal Amount	[7],[16],[17]	$ 3,292
Investment cost	[2],[7],[16],[17]	3,247
Investments at Fair Value	[7],[16],[17]	$ 3,256
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-06	[5],[6],[16],[18],[19]	2024-06	[13],[14],[20],[21],[22]	2024-06	[13],[14],[20],[21],[22]
Investments Maturity Month and Year		2024-06	[5],[6],[16],[18],[19]	2024-06	[13],[14],[20],[21],[22]	2024-06	[13],[14],[20],[21],[22]
Investment, Basis Spread, Variable Rate		4.90%	[5],[6],[9],[16],[18],[19]	4.90%	[10],[13],[14],[20],[21],[22]	4.90%	[10],[13],[14],[20],[21],[22]
Investment, Interest Rate, Floor		8.15%	[5],[6],[9],[16],[18],[19]	8.15%	[10],[13],[14],[20],[21],[22]	8.15%	[10],[13],[14],[20],[21],[22]
Investment, Interest Rate, Paid in Kind		1.25%	[5],[6],[9],[16],[18],[19]	1.25%	[10],[13],[14],[20],[21],[22]	1.25%	[10],[13],[14],[20],[21],[22]
Principal Amount		$ 84,846	[5],[6],[16],[18],[19]	$ 84,581	[13],[14],[20],[21],[22]
Investment cost		85,982	[2],[5],[6],[16],[18],[19]	85,430	[4],[13],[14],[20],[21],[22]
Investments at Fair Value		$ 88,450	[5],[6],[16],[18],[19]	$ 87,933	[13],[14],[20],[21],[22]
Investment Exit Fee		3.25%	[5],[6],[9],[16],[18],[19]	3.25%	[10],[13],[14],[20],[21],[22]	3.25%	[10],[13],[14],[20],[21],[22]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.59%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			30.59%		30.59%
Investment cost	[4]			$ 444,703
Investments at Fair Value				$ 428,750
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.89%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(30.89%)
Investment cost	[2]	$ 479,170
Investments at Fair Value		$ 463,084
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 8.29% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-04	[7],[18]	2026-04	[8],[21]	2026-04	[8],[21]
Investments Maturity Month and Year		2026-04	[7],[18]	2026-04	[8],[21]	2026-04	[8],[21]
Investment, Basis Spread, Variable Rate		5.50%	[7],[9],[18]	5.50%	[8],[10],[21]	5.50%	[8],[10],[21]
Investment, Interest Rate, Floor		8.75%	[7],[9],[18]	8.70%	[8],[10],[21]	8.70%	[8],[10],[21]
Principal Amount		$ 40,790	[7],[18]	$ 40,790	[8],[21]
Investment cost		42,034	[2],[7],[18]	41,856	[4],[8],[21]
Investments at Fair Value		$ 42,902	[7],[18]	$ 42,426	[8],[21]
Investment Exit Fee		8.29%	[7],[9],[18]	8.29%	[8],[10],[21]	8.29%	[8],[10],[21]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-12	[5],[7],[23],[24]	2024-12	[13],[25],[26]	2024-12	[13],[25],[26]
Investments Maturity Month and Year		2024-12	[5],[7],[23],[24]	2024-12	[13],[25],[26]	2024-12	[13],[25],[26]
Investment, Basis Spread, Variable Rate		4.70%	[5],[7],[9],[23],[24]	4.70%	[10],[13],[25],[26]	4.70%	[10],[13],[25],[26]
Investment, Interest Rate, Floor		7.95%	[5],[7],[9],[23],[24]	7.95%	[10],[13],[25],[26]	7.95%	[10],[13],[25],[26]
Investment, Interest Rate, Paid in Kind		1.45%	[5],[7],[9],[23],[24]	1.45%	[10],[13],[25],[26]	1.45%	[10],[13],[25],[26]
Principal Amount		$ 19,166	[5],[7],[23],[24]			£ 18,890	[13],[25],[26]
Investment cost		26,212	[2],[5],[7],[23],[24]	$ 26,024	[4],[13],[25],[26]
Investments at Fair Value		$ 23,888	[5],[7],[23],[24]	$ 22,971	[13],[25],[26]
Investment Exit Fee		4.95%	[5],[7],[9],[23],[24]	4.95%	[10],[13],[25],[26]	4.95%	[10],[13],[25],[26]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Collective Health, Inc.Senior Secured, Maturity Date September 2023, Prime + 4.75%, Floor rate 12.50%
Investment Holdings [Line Items]
Maturity Date		2023-09
Investments Maturity Month and Year		2023-09
Investment, Basis Spread, Variable Rate	[9]	4.75%
Investment, Interest Rate, Floor	[9]	12.50%
Principal Amount		$ 4,000
Investment cost	[2]	3,964
Investments at Fair Value		$ 3,964
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50%
Investment Holdings [Line Items]
Maturity Date		2028-05	[5],[27]	2028-05	[13],[28]	2028-05	[13],[28]
Investments Maturity Month and Year		2028-05	[5],[27]	2028-05	[13],[28]	2028-05	[13],[28]
Investment, Interest Rate, Paid in Kind		5.50%	[5],[9],[27]	5.50%	[10],[13],[28]	5.50%	[10],[13],[28]
Principal Amount		$ 22,154	[5],[27]	$ 21,853	[13],[28]
Investment cost		22,154	[2],[5],[27]	21,853	[4],[13],[28]
Investments at Fair Value		$ 21,536	[5],[27]	$ 20,356	[13],[28]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-02	[23],[24]	2025-02	[25],[26]	2025-02	[25],[26]
Investments Maturity Month and Year		2025-02	[23],[24]	2025-02	[25],[26]	2025-02	[25],[26]
Investment, Basis Spread, Variable Rate		8.86%	[9],[23],[24]	8.86%	[10],[25],[26]	8.86%	[10],[25],[26]
Investment, Interest Rate, Floor		9.75%	[9],[23],[24]	9.75%	[10],[25],[26]	9.75%	[10],[25],[26]
Principal Amount		$ 14,000	[23],[24]	$ 14,000	[25],[26]
Investment cost		13,910	[2],[23],[24]	13,853	[4],[25],[26]
Investments at Fair Value		$ 14,002	[23],[24]	$ 13,904	[25],[26]
Investment Exit Fee		3.00%	[9],[23],[24]	3.00%	[10],[25],[26]	3.00%	[10],[25],[26]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[7]	2027-02
Investments Maturity Month and Year	[7]	2027-02
Investment, Basis Spread, Variable Rate	[7],[9]	2.75%
Investment, Interest Rate, Floor	[7],[9]	8.75%
Principal Amount	[7]	$ 17,000
Investment cost	[2],[7]	16,617
Investments at Fair Value	[7]	$ 16,617
Investment Exit Fee	[7],[9]	5.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-12	[29]	2026-12	[30]	2026-12	[30]
Investments Maturity Month and Year		2026-12	[29]	2026-12	[30]	2026-12	[30]
Investment, Basis Spread, Variable Rate		4.40%	[9],[29]	4.40%	[10],[30]	4.40%	[10],[30]
Investment, Interest Rate, Floor		10.65%	[9],[29]	10.65%	[10],[30]	10.65%	[10],[30]
Principal Amount		$ 15,000	[29]	$ 15,000	[30]
Investment cost		14,778	[2],[29]	14,739	[4],[30]
Investments at Fair Value		$ 14,778	[29]	$ 14,739	[30]
Investment Exit Fee		2.95%	[9],[29]	2.95%	[10],[30]	2.95%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Investment Holdings [Line Items]
Maturity Date		2026-12	[5],[6],[7],[29]	2026-12	[8],[13],[20],[30]	2026-12	[8],[13],[20],[30]
Investments Maturity Month and Year		2026-12	[5],[6],[7],[29]	2026-12	[8],[13],[20],[30]	2026-12	[8],[13],[20],[30]
Investment, Basis Spread, Variable Rate		5.50%	[5],[6],[7],[9],[29]	5.50%	[8],[10],[13],[20],[30]	5.50%	[8],[10],[13],[20],[30]
Investment, Interest Rate, Floor		6.50%	[5],[6],[7],[9],[29]	6.50%	[8],[10],[13],[20],[30]	6.50%	[8],[10],[13],[20],[30]
Investment, Interest Rate, Paid in Kind		4.00%	[5],[6],[7],[9],[29]	4.00%	[8],[10],[13],[20],[30]	4.00%	[8],[10],[13],[20],[30]
Principal Amount		$ 28,009	[5],[6],[7],[29]	$ 27,730	[8],[13],[20],[30]
Investment cost		27,576	[2],[5],[6],[7],[29]	27,265	[4],[8],[13],[20],[30]
Investments at Fair Value		$ 27,657	[5],[6],[7],[29]	$ 27,256	[8],[13],[20],[30]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Investment Holdings [Line Items]
Maturity Date		2024-03	[5],[29]	2024-03	[13],[30]	2024-03	[13],[30]
Investments Maturity Month and Year		2024-03	[5],[29]	2024-03	[13],[30]	2024-03	[13],[30]
Investment, Basis Spread, Variable Rate		5.50%	[5],[9],[29]	5.50%	[10],[13],[30]	5.50%	[10],[13],[30]
Investment, Interest Rate, Floor		8.75%	[5],[9],[29]	8.75%	[10],[13],[30]	8.75%	[10],[13],[30]
Investment, Interest Rate, Paid in Kind		2.25%	[5],[9],[29]	2.25%	[10],[13],[30]	2.25%	[10],[13],[30]
Principal Amount		$ 16,593	[5],[29]	$ 16,500	[13],[30]
Investment cost		16,475	[2],[5],[29]	16,328	[4],[13],[30]
Investments at Fair Value		$ 16,475	[5],[29]	$ 16,496	[13],[30]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50%
Investment Holdings [Line Items]
Maturity Date		2023-06	[5],[6],[18],[19]	2023-06	[13],[20],[21],[22]	2023-06	[13],[20],[21],[22]
Investments Maturity Month and Year		2023-06	[5],[6],[18],[19]	2023-06	[13],[20],[21],[22]	2023-06	[13],[20],[21],[22]
Investment, Basis Spread, Variable Rate		5.00%	[5],[6],[9],[18],[19]	5.00%	[10],[13],[20],[21],[22]	5.00%	[10],[13],[20],[21],[22]
Investment, Interest Rate, Floor		10.50%	[5],[6],[9],[18],[19]	10.50%	[10],[13],[20],[21],[22]	10.50%	[10],[13],[20],[21],[22]
Investment, Interest Rate, Paid in Kind		0.50%	[5],[6],[9],[18],[19]	0.50%	[10],[13],[20],[21],[22]	0.50%	[10],[13],[20],[21],[22]
Principal Amount		$ 60,992	[5],[6],[18],[19]	$ 60,915	[13],[20],[21],[22]
Investment cost		60,911	[2],[5],[6],[18],[19]	60,721	[4],[13],[20],[21],[22]
Investments at Fair Value		$ 61,072	[5],[6],[18],[19]	$ 60,721	[13],[20],[21],[22]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%
Investment Holdings [Line Items]
Maturity Date		2026-05	[5],[16],[19]	2026-05	[13],[14],[22]	2026-05	[13],[14],[22]
Investments Maturity Month and Year		2026-05	[5],[16],[19]	2026-05	[13],[14],[22]	2026-05	[13],[14],[22]
Investment, Basis Spread, Variable Rate		7.00%	[5],[9],[16],[19]	7.00%	[10],[13],[14],[22]	7.00%	[10],[13],[14],[22]
Investment, Interest Rate, Floor		10.50%	[5],[9],[16],[19]	10.50%	[10],[13],[14],[22]	10.50%	[10],[13],[14],[22]
Investment, Interest Rate, Paid in Kind		0.50%	[5],[9],[16],[19]	0.50%	[10],[13],[14],[22]	0.50%	[10],[13],[14],[22]
Principal Amount		$ 25,103	[5],[16],[19]	$ 25,071	[13],[14],[22]
Investment cost		24,954	[2],[5],[16],[19]	24,912	[4],[13],[14],[22]
Investments at Fair Value		$ 25,885	[5],[16],[19]	$ 25,823	[13],[14],[22]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-11	[5],[6]	2026-11	[13],[20]	2026-11	[13],[20]
Investments Maturity Month and Year		2026-11	[5],[6]	2026-11	[13],[20]	2026-11	[13],[20]
Investment, Basis Spread, Variable Rate		2.75%	[5],[6],[9]	2.75%	[10],[13],[20]	2.75%	[10],[13],[20]
Investment, Interest Rate, Floor		9.25%	[5],[6],[9]	9.25%	[10],[13],[20]	9.25%	[10],[13],[20]
Investment, Interest Rate, Paid in Kind		1.75%	[5],[6],[9]	1.75%	[10],[13],[20]	1.75%	[10],[13],[20]
Principal Amount		$ 9,047	[5],[6]	$ 9,007	[13],[20]
Investment cost		8,984	[2],[5],[6]	8,918	[4],[13],[20]
Investments at Fair Value		$ 9,002	[5],[6]	$ 8,870	[13],[20]
Investment Exit Fee		3.00%	[5],[6],[9]	3.00%	[10],[13],[20]	3.00%	[10],[13],[20]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00%
Investment Holdings [Line Items]
Maturity Date		2024-07	[5],[31],[32]	2024-07	[13],[33],[34]	2024-07	[13],[33],[34]
Investments Maturity Month and Year		2024-07	[5],[31],[32]	2024-07	[13],[33],[34]	2024-07	[13],[33],[34]
Investment, Interest Rate, Paid in Kind		5.00%	[5],[9],[31],[32]	5.00%	[10],[13],[33],[34]	5.00%	[10],[13],[33],[34]
Principal Amount		$ 23,703	[5],[31],[32]	$ 10,680	[13],[33],[34]
Investment cost		$ 13,263	[2],[5],[31],[32]	240	[4],[13],[33],[34]
Investments at Fair Value	[13],[33],[34]			$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00%
Investment Holdings [Line Items]
Maturity Date	[13],[33],[34]			2024-07		2024-07
Investments Maturity Month and Year	[13],[33],[34]			2024-07		2024-07
Investment, Interest Rate, Paid in Kind	[10],[13],[33],[34]			5.00%		5.00%
Principal Amount	[13],[33],[34]			$ 13,023
Investment cost	[4],[13],[33],[34]			13,023
Investments at Fair Value	[13],[33],[34]			$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%
Investment Holdings [Line Items]
Maturity Date		2024-07	[31]	2024-07	[13],[33],[34]	2024-07	[13],[33],[34]
Investments Maturity Month and Year		2024-07	[31]	2024-07	[13],[33],[34]	2024-07	[13],[33],[34]
Investment, Interest Rate, Paid in Cash		8.25%	[9],[31]	8.25%	[10],[13],[33],[34]	8.25%	[10],[13],[33],[34]
Principal Amount		$ 8,250	[31]	$ 8,250	[13],[33],[34]
Investment cost		8,250	[2],[31]	8,250	[4],[13],[33],[34]
Investments at Fair Value		$ 7,774	[31]	$ 8,042	[13],[33],[34]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-04	[5],[7],[18]	2026-04	[8],[13],[21]	2026-04	[8],[13],[21]
Investments Maturity Month and Year		2026-04	[5],[7],[18]	2026-04	[8],[13],[21]	2026-04	[8],[13],[21]
Investment, Basis Spread, Variable Rate		4.95%	[5],[7],[9],[18]	4.95%	[8],[10],[13],[21]	4.95%	[8],[10],[13],[21]
Investment, Interest Rate, Floor		8.20%	[5],[7],[9],[18]	8.20%	[8],[10],[13],[21]	8.20%	[8],[10],[13],[21]
Investment, Interest Rate, Paid in Kind		1.50%	[5],[7],[9],[18]	1.50%	[8],[10],[13],[21]	1.50%	[8],[10],[13],[21]
Principal Amount		$ 10,141	[5],[7],[18]	$ 10,103	[8],[13],[21]
Investment cost		10,114	[2],[5],[7],[18]	10,050	[4],[8],[13],[21]
Investments at Fair Value		$ 10,304	[5],[7],[18]	$ 10,167	[8],[13],[21]
Investment Exit Fee		3.95%	[5],[7],[9],[18]	3.95%	[8],[10],[13],[21]	3.95%	[8],[10],[13],[21]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-09	[5],[18]	2024-09	[13],[21]	2024-09	[13],[21]
Investments Maturity Month and Year		2024-09	[5],[18]	2024-09	[13],[21]	2024-09	[13],[21]
Investment, Basis Spread, Variable Rate		4.50%	[5],[9],[18]	4.50%	[10],[13],[21]	4.50%	[10],[13],[21]
Investment, Interest Rate, Floor		7.75%	[5],[9],[18]	7.75%	[10],[13],[21]	7.75%	[10],[13],[21]
Investment, Interest Rate, Paid in Kind		2.00%	[5],[9],[18]	2.00%	[10],[13],[21]	2.00%	[10],[13],[21]
Principal Amount		$ 52,197	[5],[18]	$ 51,937	[13],[21]
Investment cost		52,678	[2],[5],[18]	52,265	[4],[13],[21]
Investments at Fair Value		$ 50,982	[5],[18]	$ 52,976	[13],[21]
Investment Exit Fee		3.00%	[5],[9],[18]	3.00%	[10],[13],[21]	3.00%	[10],[13],[21]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-03	[5],[6]	2025-03	[13],[20]	2025-03	[13],[20]
Investments Maturity Month and Year		2025-03	[5],[6]	2025-03	[13],[20]	2025-03	[13],[20]
Investment, Basis Spread, Variable Rate		4.00%	[5],[6],[9]	4.00%	[10],[13],[20]	4.00%	[10],[13],[20]
Investment, Interest Rate, Floor		7.25%	[5],[6],[9]	7.25%	[10],[13],[20]	7.25%	[10],[13],[20]
Investment, Interest Rate, Paid in Kind		1.25%	[5],[6],[9]	1.25%	[10],[13],[20]	1.25%	[10],[13],[20]
Principal Amount		$ 5,058	[5],[6]	$ 5,043	[13],[20]
Investment cost		5,042	[2],[5],[6]	5,000	[4],[13],[20]
Investments at Fair Value		$ 5,108	[5],[6]	$ 5,042	[13],[20]
Investment Exit Fee		4.50%	[5],[6],[9]	4.50%	[10],[13],[20]	4.50%	[10],[13],[20]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-03	[5]	2025-03	[13]	2025-03	[13]
Investments Maturity Month and Year		2025-03	[5]	2025-03	[13]	2025-03	[13]
Investment, Basis Spread, Variable Rate		4.70%	[5],[9]	4.70%	[10],[13]	4.70%	[10],[13]
Investment, Interest Rate, Floor		7.95%	[5],[9]	7.95%	[10],[13]	7.95%	[10],[13]
Investment, Interest Rate, Paid in Kind		1.50%	[5],[9]	1.50%	[10],[13]	1.50%	[10],[13]
Principal Amount		$ 5,052	[5]	$ 5,033	[13]
Investment cost		5,043	[2],[5]	4,988	[4],[13]
Investments at Fair Value		$ 5,185	[5]	$ 5,124	[13]
Investment Exit Fee		4.50%	[5],[9]	4.50%	[10],[13]	4.50%	[10],[13]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Vida Health, Inc., Senior Secured, Maturity Date March 2026, Prime + -3.25%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[7]	2026-03
Investments Maturity Month and Year	[7]	2026-03
Investment, Basis Spread, Variable Rate	[7],[9]	(3.25%)
Investment, Interest Rate, Floor	[7],[9]	9.20%
Investment, Interest Rate, Cap	[7],[9]	10.20%
Principal Amount	[7]	$ 11,822
Investment cost	[2],[7]	11,683
Investments at Fair Value	[7]	$ 11,447
Investment Exit Fee	[7],[9]	4.95%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[12],[14],[21],[22],[25],[26]			2025-02		2025-02
Investments Maturity Month and Year	[12],[14],[21],[22],[25],[26]			2025-02		2025-02
Investment, Basis Spread, Variable Rate	[10],[12],[14],[21],[22],[25],[26]			9.25%		9.25%
Investment, Interest Rate, Floor	[10],[12],[14],[21],[22],[25],[26]			10.25%		10.25%
Principal Amount	[12],[14],[21],[22],[25],[26]			$ 94,500
Investment cost	[4],[12],[14],[21],[22],[25],[26]			94,418
Investments at Fair Value	[12],[14],[21],[22],[25],[26]			$ 93,837
Investment Exit Fee	[10],[12],[14],[21],[22],[25],[26]			3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.20% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[11],[16],[18],[19],[23],[24]	2025-02
Investments Maturity Month and Year	[11],[16],[18],[19],[23],[24]	2025-02
Investment, Basis Spread, Variable Rate	[9],[11],[16],[18],[19],[23],[24]	9.25%
Investment, Interest Rate, Floor	[9],[11],[16],[18],[19],[23],[24]	10.25%
Principal Amount	[11],[16],[18],[19],[23],[24]	$ 94,500
Investment cost	[2],[11],[16],[18],[19],[23],[24]	94,528
Investments at Fair Value	[11],[16],[18],[19],[23],[24]	$ 94,506
Investment Exit Fee	[9],[11],[16],[18],[19],[23],[24]	3.20%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, SeatGeek, Inc.
Investment Holdings [Line Items]
Principal Amount		$ 86,095		$ 85,986
Investment cost		85,865	[2]	85,633	[4]
Investments at Fair Value		86,957		86,544
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Tectura Corporation
Investment Holdings [Line Items]
Principal Amount		31,953		31,953
Investment cost		21,513	[2]	21,513	[4]
Investments at Fair Value		7,774		8,042
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Veem, Inc.
Investment Holdings [Line Items]
Principal Amount		10,110		10,076
Investment cost		10,085	[2]	9,988	[4]
Investments at Fair Value		$ 10,293		$ 10,166
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.40%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.40%		2.40%
Investment cost	[4]			$ 36,567
Investments at Fair Value				$ 33,700
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.10%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(3.10%)
Investment cost	[2]	$ 46,425
Investments at Fair Value		$ 46,425
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%
Investment Holdings [Line Items]
Maturity Date		2026-09	[31]	2026-09	[33]	2026-09	[33]
Investments Maturity Month and Year		2026-09	[31]	2026-09	[33]	2026-09	[33]
Investment, Interest Rate, Paid in Cash		11.50%	[9],[31]	11.50%	[10],[33]	11.50%	[10],[33]
Principal Amount		$ 25,000	[31]	$ 10,000	[33]
Investment cost		24,589	[2],[31]	9,852	[4],[33]
Investments at Fair Value		$ 24,589	[31]	$ 8,898	[33]
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50%
Investment Holdings [Line Items]
Maturity Date	[33]			2026-09		2026-09
Investments Maturity Month and Year	[33]			2026-09		2026-09
Investment, Interest Rate, Paid in Cash	[10],[33]			14.50%		14.50%
Principal Amount	[33]			$ 15,000
Investment cost	[4],[33]			14,715
Investments at Fair Value	[33]			$ 12,802
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%
Investment Holdings [Line Items]
Maturity Date		2025-06	[31]	2025-06	[33]	2025-06	[33]
Investments Maturity Month and Year		2025-06	[31]	2025-06	[33]	2025-06	[33]
Investment, Interest Rate, Paid in Cash		5.00%	[9],[31]	5.00%	[10],[33]	5.00%	[10],[33]
Principal Amount		$ 12,000	[31]	$ 12,000	[33]
Investment cost		12,000	[2],[31]	12,000	[4],[33]
Investments at Fair Value		$ 12,000	[31]	12,000	[33]
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50%
Investment Holdings [Line Items]
Maturity Date	[5],[7],[11]	2028-02
Investments Maturity Month and Year	[5],[7],[11]	2028-02
Investment, Basis Spread, Variable Rate	[5],[7],[9],[11]	(1.50%)
Investment, Interest Rate, Floor	[5],[7],[9],[11]	4.75%
Investment, Interest Rate, Paid in Kind	[5],[7],[9],[11]	5.50%
Principal Amount	[5],[7],[11]	$ 10,040
Investment cost	[2],[5],[7],[11]	9,836
Investments at Fair Value	[5],[7],[11]	$ 9,836
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured
Investment Holdings [Line Items]
Principal Amount				25,000
Investment cost	[4]			24,567
Investments at Fair Value				$ 21,700
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.49%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	78.49%
Investment cost	[2]	$ 1,172,536
Investments at Fair Value		$ 1,176,627
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.59%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			78.59%		78.59%
Investment cost	[4]			$ 1,107,352
Investments at Fair Value				$ 1,101,430
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-08	[7],[23],[24]	2026-08	[25],[26]	2026-08	[25],[26]
Investments Maturity Month and Year		2026-08	[7],[23],[24]	2026-08	[25],[26]	2026-08	[25],[26]
Investment, Basis Spread, Variable Rate		4.55%	[7],[9],[23],[24]	4.55%	[10],[25],[26]	4.55%	[10],[25],[26]
Investment, Interest Rate, Floor		8.55%	[7],[9],[23],[24]	8.55%	[10],[25],[26]	8.55%	[10],[25],[26]
Principal Amount		$ 10,500	[7],[23],[24]	$ 10,500	[25],[26]
Investment cost		10,559	[2],[7],[23],[24]	10,513	[4],[25],[26]
Investments at Fair Value		$ 10,570	[7],[23],[24]	$ 10,513	[25],[26]
Investment Exit Fee		6.95%	[7],[9],[23],[24]	6.95%	[10],[25],[26]	6.95%	[10],[25],[26]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-01	[6],[7],[23]	2027-01	[8],[20],[25]	2027-01	[8],[20],[25]
Investments Maturity Month and Year		2027-01	[6],[7],[23]	2027-01	[8],[20],[25]	2027-01	[8],[20],[25]
Investment, Basis Spread, Variable Rate		3.65%	[6],[7],[9],[23]	3.65%	[8],[10],[20],[25]	3.65%	[8],[10],[20],[25]
Investment, Interest Rate, Floor		7.65%	[6],[7],[9],[23]	7.65%	[8],[10],[20],[25]	7.65%	[8],[10],[20],[25]
Principal Amount		$ 12,500	[6],[7],[23]	$ 5,000	[8],[20],[25]
Investment cost		12,321	[2],[6],[7],[23]	4,986	[4],[8],[20],[25]
Investments at Fair Value		$ 12,734	[6],[7],[23]	$ 5,039	[8],[20],[25]
Investment Exit Fee		5.85%	[6],[7],[9],[23]	5.85%	[8],[10],[20],[25]	5.85%	[8],[10],[20],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-10	[16]	2024-10	[14]	2024-10	[14]
Investments Maturity Month and Year		2024-10	[16]	2024-10	[14]	2024-10	[14]
Investment, Basis Spread, Variable Rate		3.10%	[9],[16]	3.10%	[10],[14]	3.10%	[10],[14]
Investment, Interest Rate, Floor		8.60%	[9],[16]	8.60%	[10],[14]	8.60%	[10],[14]
Principal Amount		$ 15,000	[16]	$ 15,000	[14]
Investment cost		15,961	[2],[16]	15,879	[4],[14]
Investments at Fair Value		$ 16,111	[16]	$ 15,974	[14]
Investment Exit Fee		8.90%	[9],[16]	8.90%	[10],[14]	8.90%	[10],[14]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[20]			2026-09		2026-09
Investments Maturity Month and Year	[8],[20]			2026-09		2026-09
Investment, Basis Spread, Variable Rate	[8],[10],[20]			3.65%		3.65%
Investment, Interest Rate, Floor	[8],[10],[20]			8.40%		8.40%
Investment, Interest Rate, Cap	[8],[10],[20]			10.90%		10.90%
Principal Amount	[8],[20]			$ 15,000
Investment cost	[4],[8],[20]			14,920
Investments at Fair Value	[8],[20]			$ 14,920
Investment Exit Fee	[8],[10],[20]			10.60%		10.60%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 9.09% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[6],[7]	2026-09
Investments Maturity Month and Year	[6],[7]	2026-09
Investment, Basis Spread, Variable Rate	[6],[7],[9]	3.65%
Investment, Interest Rate, Floor	[6],[7],[9]	8.40%
Investment, Interest Rate, Cap	[6],[7],[9]	10.90%
Principal Amount	[6],[7]	$ 17,500
Investment cost	[2],[6],[7]	17,455
Investments at Fair Value	[6],[7]	$ 17,323
Investment Exit Fee	[6],[7],[9]	9.09%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-01	[29]	2027-01	[30]	2027-01	[30]
Investments Maturity Month and Year		2027-01	[29]	2027-01	[30]	2027-01	[30]
Investment, Basis Spread, Variable Rate		2.50%	[9],[29]	2.50%	[10],[30]	2.50%	[10],[30]
Investment, Interest Rate, Floor		9.50%	[9],[29]	9.50%	[10],[30]	9.50%	[10],[30]
Investment, Interest Rate, Cap		10.75%	[9],[29]	10.75%	[10],[30]	10.75%	[10],[30]
Principal Amount		$ 24,000	[29]	$ 24,000	[30]
Investment cost		23,771	[2],[29]	23,663	[4],[30]
Investments at Fair Value		$ 23,771	[29]	$ 23,663	[30]
Investment Exit Fee		5.85%	[9],[29]	5.85%	[10],[30]	5.85%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[14],[30]			2024-09		2024-09
Investments Maturity Month and Year	[14],[30]			2024-09		2024-09
Investment, Basis Spread, Variable Rate	[10],[14],[30]			6.40%		6.40%
Investment, Interest Rate, Floor	[10],[14],[30]			9.65%		9.65%
Investment, Interest Rate, Cap	[10],[14],[30]			15.00%		15.00%
Principal Amount	[14],[30]			$ 40,000
Investment cost	[4],[14],[30]			41,644
Investments at Fair Value	[14],[30]			$ 43,183
Investment Exit Fee	[10],[14],[30]			6.95%		6.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.93% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[7],[16],[18],[19],[23]	2028-01
Investments Maturity Month and Year	[7],[16],[18],[19],[23]	2028-01
Investment, Basis Spread, Variable Rate	[7],[9],[16],[18],[19],[23]	2.20%
Investment, Interest Rate, Floor	[7],[9],[16],[18],[19],[23]	9.95%
Investment, Interest Rate, Cap	[7],[9],[16],[18],[19],[23]	10.70%
Principal Amount	[7],[16],[18],[19],[23]	$ 121,600
Investment cost	[2],[7],[16],[18],[19],[23]	121,143
Investments at Fair Value	[7],[16],[18],[19],[23]	$ 121,464
Investment Exit Fee	[7],[9],[16],[18],[19],[23]	5.93%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[14],[21],[22],[25]			2026-10		2026-10
Investments Maturity Month and Year	[8],[14],[21],[22],[25]			2026-10		2026-10
Investment, Basis Spread, Variable Rate	[8],[10],[14],[21],[22],[25]			5.70%		5.70%
Investment, Interest Rate, Floor	[8],[10],[14],[21],[22],[25]			8.95%		8.95%
Investment, Interest Rate, Cap	[8],[10],[14],[21],[22],[25]			10.70%		10.70%
Principal Amount	[8],[14],[21],[22],[25]			$ 81,725
Investment cost	[4],[8],[14],[21],[22],[25]			81,631
Investments at Fair Value	[8],[14],[21],[22],[25]			$ 78,074
Investment Exit Fee	[8],[10],[14],[21],[22],[25]			5.31%		5.31%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-07	[16],[18],[23],[24]	2025-07	[14],[21],[25],[26]	2025-07	[14],[21],[25],[26]
Investments Maturity Month and Year		2025-07	[16],[18],[23],[24]	2025-07	[14],[21],[25],[26]	2025-07	[14],[21],[25],[26]
Investment, Basis Spread, Variable Rate		4.55%	[9],[16],[18],[23],[24]	4.55%	[10],[14],[21],[25],[26]	4.55%	[10],[14],[21],[25],[26]
Investment, Interest Rate, Floor		8.05%	[9],[16],[18],[23],[24]	8.05%	[10],[14],[21],[25],[26]	8.05%	[10],[14],[21],[25],[26]
Investment, Interest Rate, Cap		9.05%	[9],[16],[18],[23],[24]	9.05%	[10],[14],[21],[25],[26]	9.05%	[10],[14],[21],[25],[26]
Principal Amount		$ 11,500	[16],[18],[23],[24]	$ 11,500	[14],[21],[25],[26]
Investment cost		11,788	[2],[16],[18],[23],[24]	11,757	[4],[14],[21],[25],[26]
Investments at Fair Value		$ 11,519	[16],[18],[23],[24]	$ 11,435	[14],[21],[25],[26]
Investment Exit Fee		5.00%	[9],[16],[18],[23],[24]	5.00%	[10],[14],[21],[25],[26]	5.00%	[10],[14],[21],[25],[26]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-09	[16],[23],[24]	2025-09	[14],[25],[26]	2025-09	[14],[25],[26]
Investments Maturity Month and Year		2025-09	[16],[23],[24]	2025-09	[14],[25],[26]	2025-09	[14],[25],[26]
Investment, Basis Spread, Variable Rate		5.70%	[9],[16],[23],[24]	5.70%	[10],[14],[25],[26]	5.70%	[10],[14],[25],[26]
Investment, Interest Rate, Floor		8.95%	[9],[16],[23],[24]	8.95%	[10],[14],[25],[26]	8.95%	[10],[14],[25],[26]
Principal Amount		$ 8,749	[16],[23],[24]	$ 9,000	[14],[25],[26]
Investment cost		8,971	[2],[16],[23],[24]	9,174	[4],[14],[25],[26]
Investments at Fair Value		$ 8,904	[16],[23],[24]	$ 9,052	[14],[25],[26]
Investment Exit Fee		6.55%	[9],[16],[23],[24]	6.55%	[10],[14],[25],[26]	6.55%	[10],[14],[25],[26]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-11	[5],[6],[18]	2026-11	[13],[20],[21]	2026-11	[13],[20],[21]
Investments Maturity Month and Year		2026-11	[5],[6],[18]	2026-11	[13],[20],[21]	2026-11	[13],[20],[21]
Investment, Interest Rate, Paid in Cash		9.00%	[5],[6],[9],[18]	9.00%	[10],[13],[20],[21]	9.00%	[10],[13],[20],[21]
Interest rate	[10],[13],[20],[21]			2.00%		2.00%
Principal Amount		$ 37,598	[5],[6],[18]	$ 37,312	[13],[20],[21]
Investment cost		37,380	[2],[5],[6],[18]	37,039	[4],[13],[20],[21]
Investments at Fair Value		$ 33,695	[5],[6],[18]	$ 33,344	[13],[20],[21]
Investment Exit Fee	[5],[6],[9],[18]	2.00%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-06	[6],[29]	2026-06	[20],[30]	2026-06	[20],[30]
Investments Maturity Month and Year		2026-06	[6],[29]	2026-06	[20],[30]	2026-06	[20],[30]
Investment, Basis Spread, Variable Rate		5.70%	[6],[9],[29]	5.70%	[10],[20],[30]	5.70%	[10],[20],[30]
Investment, Interest Rate, Floor		8.95%	[6],[9],[29]	8.95%	[10],[20],[30]	8.95%	[10],[20],[30]
Principal Amount		$ 30,000	[6],[29]	$ 30,000	[20],[30]
Investment cost		29,947	[2],[6],[29]	29,841	[4],[20],[30]
Investments at Fair Value		$ 30,380	[6],[29]	$ 30,097	[20],[30]
Investment Exit Fee		3.75%	[6],[9],[29]	3.75%	[10],[20],[30]	3.75%	[10],[20],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-04	[16]	2024-04	[14]	2024-04	[14]
Investments Maturity Month and Year		2024-04	[16]	2024-04	[14]	2024-04	[14]
Investment, Basis Spread, Variable Rate		6.30%	[9],[16]	6.30%	[10],[14]	6.30%	[10],[14]
Investment, Interest Rate, Floor		9.55%	[9],[16]	9.55%	[10],[14]	9.55%	[10],[14]
Principal Amount		$ 10,000	[16]	$ 10,000	[14]
Investment cost		10,275	[2],[16]	10,235	[4],[14]
Investments at Fair Value		$ 10,498	[16]	$ 10,292	[14]
Investment Exit Fee		3.95%	[9],[16]	3.95%	[10],[14]	3.95%	[10],[14]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-10	[16]	2025-10	[14]	2025-10	[14]
Investments Maturity Month and Year		2025-10	[16]	2025-10	[14]	2025-10	[14]
Investment, Basis Spread, Variable Rate		5.00%	[9],[16]	5.00%	[10],[14]	5.00%	[10],[14]
Investment, Interest Rate, Floor		8.25%	[9],[16]	8.25%	[10],[14]	8.25%	[10],[14]
Principal Amount		$ 17,500	[16]	$ 25,000	[14]
Investment cost		18,337	[2],[16]	25,759	[4],[14]
Investments at Fair Value		$ 16,343	[16]	$ 25,177	[14]
Investment Exit Fee		5.50%	[9],[16]	5.50%	[10],[14]	5.50%	[10],[14]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-09	[6],[19]	2026-09	[20],[22]	2026-09	[20],[22]
Investments Maturity Month and Year		2026-09	[6],[19]	2026-09	[20],[22]	2026-09	[20],[22]
Investment, Basis Spread, Variable Rate		5.70%	[6],[9],[19]	5.70%	[10],[20],[22]	5.70%	[10],[20],[22]
Investment, Interest Rate, Floor		8.95%	[6],[9],[19]	8.95%	[10],[20],[22]	8.95%	[10],[20],[22]
Principal Amount		$ 132,675	[6],[19]	$ 132,675	[20],[22]
Investment cost		134,041	[2],[6],[19]	133,557	[4],[20],[22]
Investments at Fair Value		$ 136,593	[6],[19]	$ 135,619	[20],[22]
Investment Exit Fee		7.75%	[6],[9],[19]	7.75%	[10],[20],[22]	7.75%	[10],[20],[22]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-04	[29]	2025-04	[30]	2025-04	[30]
Investments Maturity Month and Year		2025-04	[29]	2025-04	[30]	2025-04	[30]
Investment, Basis Spread, Variable Rate		6.25%	[9],[29]	6.25%	[10],[30]	6.25%	[10],[30]
Investment, Interest Rate, Floor		9.50%	[9],[29]	9.50%	[10],[30]	9.50%	[10],[30]
Principal Amount		$ 5,000	[29]	$ 12,500	[30]
Investment cost		5,621	[2],[29]	12,753	[4],[30]
Investments at Fair Value		$ 5,542	[29]	$ 12,535	[30]
Investment Exit Fee		6.55%	[9],[29]	6.55%	[10],[30]	6.55%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date				2026-11		2026-11
Investments Maturity Month and Year				2026-11		2026-11
Investment, Basis Spread, Variable Rate	[10]			4.05%		4.05%
Investment, Interest Rate, Floor	[10]			7.55%		7.55%
Investment, Interest Rate, Cap	[10]			8.80%		8.80%
Principal Amount				$ 15,000
Investment cost	[4]			15,012
Investments at Fair Value				$ 13,940
Investment Exit Fee	[10]			5.50%		5.50%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-11	[7],[16],[18],[29]	2026-11	[8],[14],[21],[30]	2026-11	[8],[14],[21],[30]
Investments Maturity Month and Year		2026-11	[7],[16],[18],[29]	2026-11	[8],[14],[21],[30]	2026-11	[8],[14],[21],[30]
Investment, Basis Spread, Variable Rate		5.90%	[7],[9],[16],[18],[29]	5.90%	[8],[10],[14],[21],[30]	5.90%	[8],[10],[14],[21],[30]
Investment, Interest Rate, Floor		9.15%	[7],[9],[16],[18],[29]	9.15%	[8],[10],[14],[21],[30]	9.15%	[8],[10],[14],[21],[30]
Principal Amount		$ 58,125	[7],[16],[18],[29]	$ 58,125	[8],[14],[21],[30]
Investment cost		58,872	[2],[7],[16],[18],[29]	58,674	[4],[8],[14],[21],[30]
Investments at Fair Value		$ 58,817	[7],[16],[18],[29]	$ 58,407	[8],[14],[21],[30]
Investment Exit Fee		9.86%	[7],[9],[16],[18],[29]	9.86%	[8],[10],[14],[21],[30]	9.86%	[8],[10],[14],[21],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[6],[18],[23]	2025-04
Investments Maturity Month and Year	[6],[18],[23]	2025-04
Investment, Basis Spread, Variable Rate	[6],[9],[18],[23]	5.75%
Investment, Interest Rate, Floor	[6],[9],[18],[23]	9.00%
Principal Amount	[6],[18],[23]	$ 18,500
Investment cost	[2],[6],[18],[23]	19,176
Investments at Fair Value	[6],[18],[23]	$ 19,379
Investment Exit Fee	[6],[9],[18],[23]	6.55%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[20],[21],[25]			2024-10		2024-10
Investments Maturity Month and Year	[20],[21],[25]			2024-10		2024-10
Investment, Basis Spread, Variable Rate	[10],[20],[21],[25]			5.75%		5.75%
Investment, Interest Rate, Floor	[10],[20],[21],[25]			9.00%		9.00%
Principal Amount	[20],[21],[25]			$ 18,500
Investment cost	[4],[20],[21],[25]			19,109
Investments at Fair Value	[20],[21],[25]			$ 19,174
Investment Exit Fee	[10],[20],[21],[25]			6.55%		6.55%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-07	[5],[6],[7]	2027-07	[8],[13]	2027-07	[8],[13]
Investments Maturity Month and Year		2027-07	[5],[6],[7]	2027-07	[8],[13]	2027-07	[8],[13]
Investment, Basis Spread, Variable Rate		3.15%	[5],[6],[7],[9]	3.15%	[8],[10],[13]	3.15%	[8],[10],[13]
Investment, Interest Rate, Floor		7.15%	[5],[6],[7],[9]	7.15%	[8],[10],[13]	7.15%	[8],[10],[13]
Investment, Interest Rate, Cap		8.65%	[5],[6],[7],[9]	8.65%	[8],[10],[13]	8.65%	[8],[10],[13]
Investment, Interest Rate, Paid in Kind		2.00%	[5],[6],[7],[9]	2.00%	[8],[10],[13]	2.00%	[8],[10],[13]
Principal Amount		$ 22,689	[5],[6],[7]	$ 15,113	[8],[13]
Investment cost		22,693	[2],[5],[6],[7]	15,109	[4],[8],[13]
Investments at Fair Value		$ 21,942	[5],[6],[7]	$ 15,109	[8],[13]
Investment Exit Fee		5.75%	[5],[6],[7],[9]	5.75%	[8],[10],[13]	5.75%	[8],[10],[13]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-05	[6],[29]	2025-05	[20],[30]	2025-05	[20],[30]
Investments Maturity Month and Year		2025-05	[6],[29]	2025-05	[20],[30]	2025-05	[20],[30]
Investment, Basis Spread, Variable Rate		5.40%	[6],[9],[29]	5.40%	[10],[20],[30]	5.40%	[10],[20],[30]
Investment, Interest Rate, Floor		8.65%	[6],[9],[29]	8.65%	[10],[20],[30]	8.65%	[10],[20],[30]
Principal Amount		$ 17,000	[6],[29]	$ 17,000	[20],[30]
Investment cost		17,381	[2],[6],[29]	17,313	[4],[20],[30]
Investments at Fair Value		$ 17,369	[6],[29]	$ 17,265	[20],[30]
Investment Exit Fee		4.95%	[6],[9],[29]	4.95%	[10],[20],[30]	4.95%	[10],[20],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-05	[5],[7],[29]	2027-05	[8],[13],[30]	2027-05	[8],[13],[30]
Investments Maturity Month and Year		2027-05	[5],[7],[29]	2027-05	[8],[13],[30]	2027-05	[8],[13],[30]
Investment, Basis Spread, Variable Rate		1.05%	[5],[7],[9],[29]	1.05%	[8],[10],[13],[30]	1.05%	[8],[10],[13],[30]
Investment, Interest Rate, Floor		4.55%	[5],[7],[9],[29]	4.55%	[8],[10],[13],[30]	4.55%	[8],[10],[13],[30]
Investment, Interest Rate, Cap		6.05%	[5],[7],[9],[29]	6.05%	[8],[10],[13],[30]	6.05%	[8],[10],[13],[30]
Investment, Interest Rate, Paid in Kind		2.85%	[5],[7],[9],[29]	2.85%	[8],[10],[13],[30]	2.85%	[8],[10],[13],[30]
Principal Amount		$ 12,150	[5],[7],[29]	$ 12,072	[8],[13],[30]
Investment cost		12,167	[2],[5],[7],[29]	12,043	[4],[8],[13],[30]
Investments at Fair Value		$ 11,462	[5],[7],[29]	$ 11,333	[8],[13],[30]
Investment Exit Fee		7.15%	[5],[7],[9],[29]	7.15%	[8],[10],[13],[30]	7.15%	[8],[10],[13],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-08	[7],[18],[23]	2027-08	[21],[25]	2027-08	[21],[25]
Investments Maturity Month and Year		2027-08	[7],[18],[23]	2027-08	[21],[25]	2027-08	[21],[25]
Investment, Basis Spread, Variable Rate		4.00%	[7],[9],[18],[23]	4.00%	[10],[21],[25]	4.00%	[10],[21],[25]
Investment, Interest Rate, Floor		8.75%	[7],[9],[18],[23]	8.75%	[10],[21],[25]	8.75%	[10],[21],[25]
Investment, Interest Rate, Cap		10.25%	[7],[9],[18],[23]	10.25%	[10],[21],[25]	10.25%	[10],[21],[25]
Principal Amount		$ 49,500	[7],[18],[23]	$ 49,500	[21],[25]
Investment cost		49,211	[2],[7],[18],[23]	49,090	[4],[21],[25]
Investments at Fair Value		$ 48,495	[7],[18],[23]	$ 49,090	[21],[25]
Investment Exit Fee		4.25%	[7],[9],[18],[23]	4.25%	[10],[21],[25]	4.25%	[10],[21],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-11	[7],[23],[29]	2027-11	[8],[25],[30]	2027-11	[8],[25],[30]
Investments Maturity Month and Year		2027-11	[7],[23],[29]	2027-11	[8],[25],[30]	2027-11	[8],[25],[30]
Investment, Basis Spread, Variable Rate		2.40%	[7],[9],[23],[29]	2.40%	[8],[10],[25],[30]	2.40%	[8],[10],[25],[30]
Investment, Interest Rate, Floor		8.65%	[7],[9],[23],[29]	8.65%	[8],[10],[25],[30]	8.65%	[8],[10],[25],[30]
Principal Amount		$ 5,500	[7],[23],[29]	$ 5,500	[8],[25],[30]
Investment cost		5,468	[2],[7],[23],[29]	5,448	[4],[8],[25],[30]
Investments at Fair Value		$ 5,468	[7],[23],[29]	$ 5,448	[8],[25],[30]
Investment Exit Fee		15.13%	[7],[9],[23],[29]	15.13%	[8],[10],[25],[30]	15.13%	[8],[10],[25],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-07	[29]	2025-07	[30]	2025-07	[30]
Investments Maturity Month and Year		2025-07	[29]	2025-07	[30]	2025-07	[30]
Investment, Basis Spread, Variable Rate		6.10%	[9],[29]	6.10%	[10],[30]	6.10%	[10],[30]
Investment, Interest Rate, Floor		9.35%	[9],[29]	9.35%	[10],[30]	9.35%	[10],[30]
Principal Amount		$ 7,544	[29]	$ 8,000	[30]
Investment cost		7,699	[2],[29]	8,120	[4],[30]
Investments at Fair Value		$ 7,701	[29]	$ 8,085	[30]
Investment Exit Fee		4.95%	[9],[29]	4.95%	[10],[30]	4.95%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[7],[23]	2026-05
Investments Maturity Month and Year	[7],[23]	2026-05
Investment, Basis Spread, Variable Rate	[7],[9],[23]	2.45%
Investment, Interest Rate, Floor	[7],[9],[23]	8.25%
Principal Amount	[7],[23]	$ 57,800
Investment cost	[2],[7],[23]	57,574
Investments at Fair Value	[7],[23]	$ 57,885
Investment Exit Fee	[7],[9],[23]	5.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[25]			2026-05		2026-05
Investments Maturity Month and Year	[8],[25]			2026-05		2026-05
Investment, Basis Spread, Variable Rate	[8],[10],[25]			3.95%		3.95%
Investment, Interest Rate, Floor	[8],[10],[25]			7.45%		7.45%
Principal Amount	[8],[25]			$ 34,000
Investment cost	[4],[8],[25]			33,945
Investments at Fair Value	[8],[25]			$ 33,987
Investment Exit Fee	[8],[10],[25]			5.35%		5.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[20],[25],[26]			2023-06		2023-06
Investments Maturity Month and Year	[20],[25],[26]			2023-06		2023-06
Investment, Basis Spread, Variable Rate	[10],[20],[25],[26]			4.30%		4.30%
Investment, Interest Rate, Floor	[10],[20],[25],[26]			9.80%		9.80%
Principal Amount	[20],[25],[26]			$ 2,079
Investment cost	[4],[20],[25],[26]			2,734
Investments at Fair Value	[20],[25],[26]			$ 2,804
Investment Exit Fee	[10],[20],[25],[26]			9.95%		9.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-10	[5],[7],[18],[19],[23],[29],[35]	2026-10	[8],[13],[21],[22],[25],[30],[36]	2026-10	[8],[13],[21],[22],[25],[30],[36]
Investments Maturity Month and Year		2026-10	[5],[7],[18],[19],[23],[29],[35]	2026-10	[8],[13],[21],[22],[25],[30],[36]	2026-10	[8],[13],[21],[22],[25],[30],[36]
Investment, Basis Spread, Variable Rate		2.25%	[5],[7],[9],[18],[19],[23],[29],[35]	2.25%	[8],[10],[13],[21],[22],[25],[30],[36]	2.25%	[8],[10],[13],[21],[22],[25],[30],[36]
Investment, Interest Rate, Floor		5.50%	[5],[7],[9],[18],[19],[23],[29],[35]	5.50%	[8],[10],[13],[21],[22],[25],[30],[36]	5.50%	[8],[10],[13],[21],[22],[25],[30],[36]
Investment, Interest Rate, Paid in Kind		3.35%	[5],[7],[9],[18],[19],[23],[29],[35]	3.35%	[8],[10],[13],[21],[22],[25],[30],[36]	3.35%	[8],[10],[13],[21],[22],[25],[30],[36]
Principal Amount		$ 95,494	[5],[7],[18],[19],[23],[29],[35]	$ 94,737	[8],[13],[21],[22],[25],[30],[36]
Investment cost		96,111	[2],[5],[7],[18],[19],[23],[29],[35]	95,032	[4],[8],[13],[21],[22],[25],[30],[36]
Investments at Fair Value		$ 95,310	[5],[7],[18],[19],[23],[29],[35]	$ 93,916	[8],[13],[21],[22],[25],[30],[36]
Investment Exit Fee		7.50%	[5],[7],[9],[18],[19],[23],[29],[35]	7.50%	[8],[10],[13],[21],[22],[25],[30],[36]	7.50%	[8],[10],[13],[21],[22],[25],[30],[36]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.20%, Floor rate 8.20%, 6.60% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-09
Investments Maturity Month and Year		2027-09
Investment, Basis Spread, Variable Rate	[9]	2.20%
Investment, Interest Rate, Floor	[9]	8.20%
Principal Amount		$ 65,000
Investment cost	[2]	64,186
Investments at Fair Value		$ 70,594
Investment Exit Fee	[9]	6.60%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8]			2027-09		2027-09
Investments Maturity Month and Year	[8]			2027-09		2027-09
Investment, Basis Spread, Variable Rate	[8],[10]			2.70%		2.70%
Investment, Interest Rate, Floor	[8],[10]			8.20%		8.20%
Principal Amount	[8]			$ 25,000
Investment cost	[4],[8]			24,670
Investments at Fair Value	[8]			$ 24,670
Investment Exit Fee	[8],[10]			6.60%		6.60%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-01	[29]	2026-01	[30]	2026-01	[30]
Investments Maturity Month and Year		2026-01	[29]	2026-01	[30]	2026-01	[30]
Investment, Basis Spread, Variable Rate		4.25%	[9],[29]	4.25%	[10],[30]	4.25%	[10],[30]
Investment, Interest Rate, Floor		7.50%	[9],[29]	7.50%	[10],[30]	7.50%	[10],[30]
Principal Amount		$ 5,000	[29]	$ 5,000	[30]
Investment cost		4,979	[2],[29]	4,957	[4],[30]
Investments at Fair Value		$ 5,001	[29]	$ 4,946	[30]
Investment Exit Fee		3.80%	[9],[29]	3.80%	[10],[30]	3.80%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-10	[5],[7],[23]	2027-10	[8],[13],[25]	2027-10	[8],[13],[25]
Investments Maturity Month and Year		2027-10	[5],[7],[23]	2027-10	[8],[13],[25]	2027-10	[8],[13],[25]
Investment, Basis Spread, Variable Rate		1.75%	[5],[7],[9],[23]	1.75%	[8],[10],[13],[25]	1.75%	[8],[10],[13],[25]
Investment, Interest Rate, Floor		7.25%	[5],[7],[9],[23]	7.25%	[8],[10],[13],[25]	7.25%	[8],[10],[13],[25]
Investment, Interest Rate, Cap		9.00%	[5],[7],[9],[23]	9.00%	[8],[10],[13],[25]	9.00%	[8],[10],[13],[25]
Investment, Interest Rate, Paid in Kind		1.50%	[5],[7],[9],[23]	1.50%	[8],[10],[13],[25]	1.50%	[8],[10],[13],[25]
Principal Amount		$ 20,832	[5],[7],[23]	$ 20,754	[8],[13],[25]
Investment cost		20,781	[2],[5],[7],[23]	20,656	[4],[8],[13],[25]
Investments at Fair Value		$ 20,781	[5],[7],[23]	$ 20,656	[8],[13],[25]
Investment Exit Fee		4.95%	[5],[7],[9],[23]	4.95%	[8],[10],[13],[25]	4.95%	[8],[10],[13],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-03	[6],[18]	2025-03	[20],[21]	2025-03	[20],[21]
Investments Maturity Month and Year		2025-03	[6],[18]	2025-03	[20],[21]	2025-03	[20],[21]
Investment, Basis Spread, Variable Rate		5.80%	[6],[9],[18]	5.80%	[10],[20],[21]	5.80%	[10],[20],[21]
Investment, Interest Rate, Floor		9.05%	[6],[9],[18]	9.05%	[10],[20],[21]	9.05%	[10],[20],[21]
Principal Amount		$ 18,667	[6],[18]	$ 18,667	[20],[21]
Investment cost		18,758	[2],[6],[18]	18,675	[4],[20],[21]
Investments at Fair Value		$ 19,544	[6],[18]	$ 18,698	[20],[21]
Investment Exit Fee		3.95%	[6],[9],[18]	3.95%	[10],[20],[21]	3.95%	[10],[20],[21]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-10	[6],[18]	2024-10	[20],[21]	2024-10	[20],[21]
Investments Maturity Month and Year		2024-10	[6],[18]	2024-10	[20],[21]	2024-10	[20],[21]
Investment, Basis Spread, Variable Rate		6.40%	[6],[9],[18]	6.40%	[10],[20],[21]	6.40%	[10],[20],[21]
Investment, Interest Rate, Floor		9.65%	[6],[9],[18]	9.65%	[10],[20],[21]	9.65%	[10],[20],[21]
Principal Amount		$ 37,500	[6],[18]	$ 37,500	[20],[21]
Investment cost		38,768	[2],[6],[18]	38,638	[4],[20],[21]
Investments at Fair Value		$ 38,982	[6],[18]	$ 38,816	[20],[21]
Investment Exit Fee		4.98%	[6],[9],[18]	4.98%	[10],[20],[21]	4.98%	[10],[20],[21]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[5],[7],[16],[18],[23]	2026-01
Investments Maturity Month and Year	[5],[7],[16],[18],[23]	2026-01
Investment, Basis Spread, Variable Rate	[5],[7],[9],[16],[18],[23]	1.20%
Investment, Interest Rate, Floor	[5],[7],[9],[16],[18],[23]	8.95%
Investment, Interest Rate, Paid in Kind	[5],[7],[9],[16],[18],[23]	2.25%
Principal Amount	[5],[7],[16],[18],[23]	$ 64,648
Investment cost	[2],[5],[7],[16],[18],[23]	64,368
Investments at Fair Value	[5],[7],[16],[18],[23]	$ 64,374
Investment Exit Fee	[5],[7],[9],[16],[18],[23]	5.69%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[13],[14],[21],[25]			2026-01		2026-01
Investments Maturity Month and Year	[13],[14],[21],[25]			2026-01		2026-01
Investment, Basis Spread, Variable Rate	[10],[13],[14],[21],[25]			2.15%		2.15%
Investment, Interest Rate, Floor	[10],[13],[14],[21],[25]			5.40%		5.40%
Investment, Interest Rate, Paid in Kind	[10],[13],[14],[21],[25]			3.45%		3.45%
Principal Amount	[13],[14],[21],[25]			$ 47,983
Investment cost	[4],[13],[14],[21],[25]			47,889
Investments at Fair Value	[13],[14],[21],[25]			$ 48,649
Investment Exit Fee	[10],[13],[14],[21],[25]			5.95%		5.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[6],[7],[23]	2027-02
Investments Maturity Month and Year	[6],[7],[23]	2027-02
Investment, Basis Spread, Variable Rate	[6],[7],[9],[23]	4.45%
Investment, Interest Rate, Floor	[6],[7],[9],[23]	8.45%
Investment, Interest Rate, Cap	[6],[7],[9],[23]	11.45%
Principal Amount	[6],[7],[23]	$ 10,313
Investment cost	[2],[6],[7],[23]	10,346
Investments at Fair Value	[6],[7],[23]	$ 10,397
Investment Exit Fee	[6],[7],[9],[23]	4.75%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[20],[25]			2027-02		2027-02
Investments Maturity Month and Year	[8],[20],[25]			2027-02		2027-02
Investment, Basis Spread, Variable Rate	[8],[10],[20],[25]			5.20%		5.20%
Investment, Interest Rate, Floor	[8],[10],[20],[25]			8.45%		8.45%
Principal Amount	[8],[20],[25]			$ 8,250
Investment cost	[4],[8],[20],[25]			8,274
Investments at Fair Value	[8],[20],[25]			$ 8,423
Investment Exit Fee	[8],[10],[20],[25]			4.75%		4.75%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-08	[6]	2024-08	[20]	2024-08	[20]
Investments Maturity Month and Year		2024-08	[6]	2024-08	[20]	2024-08	[20]
Investment, Basis Spread, Variable Rate		6.10%	[6],[9]	6.10%	[10],[20]	6.10%	[10],[20]
Investment, Interest Rate, Floor		9.35%	[6],[9]	9.35%	[10],[20]	9.35%	[10],[20]
Principal Amount		$ 20,000	[6]	$ 20,000	[20]
Investment cost		21,165	[2],[6]	21,079	[4],[20]
Investments at Fair Value		$ 21,136	[6]	$ 20,967	[20]
Investment Exit Fee		6.25%	[6],[9]	6.25%	[10],[20]	6.25%	[10],[20]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-05	[6],[16]	2024-05	[14],[20]	2024-05	[14],[20]
Investments Maturity Month and Year		2024-05	[6],[16]	2024-05	[14],[20]	2024-05	[14],[20]
Investment, Basis Spread, Variable Rate		6.45%	[6],[9],[16]	6.45%	[10],[14],[20]	6.45%	[10],[14],[20]
Investment, Interest Rate, Floor		9.70%	[6],[9],[16]	9.70%	[10],[14],[20]	9.70%	[10],[14],[20]
Principal Amount		$ 6,708	[6],[16]	$ 8,146	[14],[20]
Investment cost		7,021	[2],[6],[16]	8,416	[4],[14],[20]
Investments at Fair Value		$ 7,030	[6],[16]	$ 8,410	[14],[20]
Investment Exit Fee		3.85%	[6],[9],[16]	3.85%	[10],[14],[20]	3.85%	[10],[14],[20]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[20],[25]			2026-10		2026-10
Investments Maturity Month and Year	[8],[20],[25]			2026-10		2026-10
Investment, Basis Spread, Variable Rate	[8],[10],[20],[25]			4.20%		4.20%
Investment, Interest Rate, Floor	[8],[10],[20],[25]			7.45%		7.45%
Investment, Interest Rate, Cap	[8],[10],[20],[25]			8.95%		8.95%
Principal Amount	[8],[20],[25]			$ 2,000
Investment cost	[4],[8],[20],[25]			2,012
Investments at Fair Value	[8],[20],[25]			$ 1,934
Investment Exit Fee	[8],[10],[20],[25]			4.76%		4.76%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[6],[7],[23]	2026-10
Investments Maturity Month and Year	[6],[7],[23]	2026-10
Investment, Basis Spread, Variable Rate	[6],[7],[9],[23]	4.20%
Investment, Interest Rate, Floor	[6],[7],[9],[23]	7.45%
Investment, Interest Rate, Cap	[6],[7],[9],[23]	8.95%
Principal Amount	[6],[7],[23]	$ 2,000
Investment cost	[2],[6],[7],[23]	2,019
Investments at Fair Value	[6],[7],[23]	$ 1,943
Investment Exit Fee	[6],[7],[9],[23]	6.00%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.15%, Floor rate 10.15%, 6.35% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[6],[16],[18]	2026-04
Investments Maturity Month and Year	[6],[16],[18]	2026-04
Investment, Basis Spread, Variable Rate	[6],[9],[16],[18]	3.15%
Investment, Interest Rate, Floor	[6],[9],[16],[18]	10.15%
Principal Amount	[6],[16],[18]	$ 32,500
Investment cost	[2],[6],[16],[18]	32,445
Investments at Fair Value	[6],[16],[18]	$ 32,445
Investment Exit Fee	[6],[9],[16],[18]	6.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[14],[20],[21]			2024-07		2024-07
Investments Maturity Month and Year	[14],[20],[21]			2024-07		2024-07
Investment, Basis Spread, Variable Rate	[10],[14],[20],[21]			3.75%		3.75%
Investment, Interest Rate, Floor	[10],[14],[20],[21]			8.75%		8.75%
Principal Amount	[14],[20],[21]			$ 32,500
Investment cost	[4],[14],[20],[21]			33,705
Investments at Fair Value	[14],[20],[21]			$ 33,700
Investment Exit Fee	[10],[14],[20],[21]			8.80%		8.80%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-07	[6],[18],[23],[24]	2025-07	[20],[21],[25],[26]	2025-07	[20],[21],[25],[26]
Investments Maturity Month and Year		2025-07	[6],[18],[23],[24]	2025-07	[20],[21],[25],[26]	2025-07	[20],[21],[25],[26]
Investment, Basis Spread, Variable Rate		5.00%	[6],[9],[18],[23],[24]	5.00%	[10],[20],[21],[25],[26]	5.00%	[10],[20],[21],[25],[26]
Investment, Interest Rate, Floor		8.25%	[6],[9],[18],[23],[24]	8.25%	[10],[20],[21],[25],[26]	8.25%	[10],[20],[21],[25],[26]
Principal Amount		$ 11,000	[6],[18],[23],[24]	$ 11,000	[20],[21],[25],[26]
Investment cost		11,150	[2],[6],[18],[23],[24]	11,072	[4],[20],[21],[25],[26]
Investments at Fair Value		$ 11,115	[6],[18],[23],[24]	$ 11,067	[20],[21],[25],[26]
Investment Exit Fee		6.35%	[6],[9],[18],[23],[24]	6.35%	[10],[20],[21],[25],[26]	6.35%	[10],[20],[21],[25],[26]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[14],[21],[22],[25],[26]			2025-12		2025-12
Investments Maturity Month and Year	[14],[21],[22],[25],[26]			2025-12		2025-12
Investment, Basis Spread, Variable Rate	[10],[14],[21],[22],[25],[26]			4.70%		4.70%
Investment, Interest Rate, Floor	[10],[14],[21],[22],[25],[26]			7.95%		7.95%
Principal Amount	[14],[21],[22],[25],[26]			$ 70,000
Investment cost	[4],[14],[21],[22],[25],[26]			72,329
Investments at Fair Value	[14],[21],[22],[25],[26]			$ 73,019
Investment Exit Fee	[10],[14],[21],[22],[25],[26]			7.28%		7.28%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 8.03% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[16],[18],[23],[24]	2025-12
Investments Maturity Month and Year	[16],[18],[23],[24]	2025-12
Investment, Basis Spread, Variable Rate	[9],[16],[18],[23],[24]	4.70%
Investment, Interest Rate, Floor	[9],[16],[18],[23],[24]	7.95%
Principal Amount	[16],[18],[23],[24]	$ 70,000
Investment cost	[2],[16],[18],[23],[24]	72,628
Investments at Fair Value	[16],[18],[23],[24]	$ 74,010
Investment Exit Fee	[9],[16],[18],[23],[24]	8.03%
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.27%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	1.27%
Investment cost	[2]	$ 18,213
Investments at Fair Value		$ 19,081
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.34%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			1.34%		1.34%
Investment cost	[4]			$ 18,171
Investments at Fair Value				$ 18,723
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-06	[7],[11]	2026-06	[12]	2026-06	[12]
Investments Maturity Month and Year		2026-06	[7],[11]	2026-06	[12]	2026-06	[12]
Investment, Basis Spread, Variable Rate		4.50%	[7],[9],[11]	4.50%	[10],[12]	4.50%	[10],[12]
Investment, Interest Rate, Floor		8.00%	[7],[9],[11]	8.00%	[10],[12]	8.00%	[10],[12]
Principal Amount		$ 18,281	[7],[11]	$ 18,281	[12]
Investment cost		18,213	[2],[7],[11]	18,171	[4],[12]
Investments at Fair Value		$ 19,081	[7],[11]	$ 18,723	[12]
Investment Exit Fee		1.00%	[7],[9],[11]	1.00%	[10],[12]	1.00%	[10],[12]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.98%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			13.98%		13.98%
Investment cost	[4]			$ 196,342
Investments at Fair Value				$ 195,855
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (14.10%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	14.10%
Investment cost	[2]	$ 208,331
Investments at Fair Value		$ 211,331
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-08	[29]	2025-08	[30]	2025-08	[30]
Investments Maturity Month and Year		2025-08	[29]	2025-08	[30]	2025-08	[30]
Investment, Basis Spread, Variable Rate		5.70%	[9],[29]	5.70%	[10],[30]	5.70%	[10],[30]
Investment, Interest Rate, Floor		8.95%	[9],[29]	8.95%	[10],[30]	8.95%	[10],[30]
Principal Amount		$ 11,652	[29]	$ 12,000	[30]
Investment cost		11,883	[2],[29]	12,162	[4],[30]
Investments at Fair Value		$ 11,615	[29]	$ 12,053	[30]
Investment Exit Fee		5.95%	[9],[29]	5.95%	[10],[30]	5.95%	[10],[30]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Investment Holdings [Line Items]
Maturity Date	[13],[14],[20]			2026-11		2026-11
Investments Maturity Month and Year	[13],[14],[20]			2026-11		2026-11
Investment, Basis Spread, Variable Rate		5.00%	[5],[6],[9],[16]	5.00%	[10],[13],[14],[20]	5.00%	[10],[13],[14],[20]
Investment, Interest Rate, Floor	[10],[13],[14],[20]			6.00%		6.00%
Investment, Interest Rate, Paid in Kind		4.45%	[5],[6],[9],[16]	4.45%	[10],[13],[14],[20]	4.45%	[10],[13],[14],[20]
Principal Amount		$ 52,055	[5],[6],[16]	$ 51,480	[13],[14],[20]
Investment cost		51,415	[2],[5],[6],[16]	50,813	[4],[13],[14],[20]
Investments at Fair Value		$ 50,547	[5],[6],[16]	$ 49,732	[13],[14],[20]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 3-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Investment Holdings [Line Items]
Maturity Date	[5],[6],[16]	2026-11
Investments Maturity Month and Year	[5],[6],[16]	2026-11
Investment, Interest Rate, Floor	[5],[6],[9],[16]	6.00%
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-03	[6],[11],[16]	2025-03	[12],[14],[20]	2025-03	[12],[14],[20]
Investments Maturity Month and Year		2025-03	[6],[11],[16]	2025-03	[12],[14],[20]	2025-03	[12],[14],[20]
Investment, Basis Spread, Variable Rate		5.60%	[6],[9],[11],[16]	5.60%	[10],[12],[14],[20]	5.60%	[10],[12],[14],[20]
Investment, Interest Rate, Floor		8.85%	[6],[9],[11],[16]	8.85%	[10],[12],[14],[20]	8.85%	[10],[12],[14],[20]
Principal Amount		$ 46,125	[6],[11],[16]	$ 46,125	[12],[14],[20]
Investment cost		46,702	[2],[6],[11],[16]	46,552	[4],[12],[14],[20]
Investments at Fair Value		$ 47,052	[6],[11],[16]	$ 46,548	[12],[14],[20]
Investment Exit Fee		4.61%	[6],[9],[11],[16]	4.61%	[10],[12],[14],[20]	4.61%	[10],[12],[14],[20]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%
Investment Holdings [Line Items]
Maturity Date		2026-02	[5],[16],[18]	2026-02	[13],[21]	2026-02	[13],[21]
Investments Maturity Month and Year		2026-02	[5],[16],[18]	2026-02	[13],[21]	2026-02	[13],[21]
Investment, Basis Spread, Variable Rate		6.25%	[5],[9],[16],[18]	6.25%	[10],[13],[21]	6.25%	[10],[13],[21]
Investment, Interest Rate, Floor		9.50%	[5],[9],[16],[18]	9.50%	[10],[13],[21]	9.50%	[10],[13],[21]
Investment, Interest Rate, Paid in Kind		1.55%	[5],[9],[16],[18]	1.55%	[10],[13],[21]	1.55%	[10],[13],[21]
Principal Amount		$ 53,795	[5],[16],[18]	$ 53,587	[13],[21]
Investment cost		53,407	[2],[5],[16],[18]	53,164	[4],[13],[21]
Investments at Fair Value		$ 53,963	[5],[16],[18]	$ 53,871	[13],[21]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-10	[5],[7],[23]	2027-10	[8],[13],[25]	2027-10	[8],[13],[25]
Investments Maturity Month and Year		2027-10	[5],[7],[23]	2027-10	[8],[13],[25]	2027-10	[8],[13],[25]
Investment, Basis Spread, Variable Rate		2.45%	[5],[7],[9],[23]	2.45%	[8],[10],[13],[25]	2.45%	[8],[10],[13],[25]
Investment, Interest Rate, Floor		7.95%	[5],[7],[9],[23]	7.95%	[8],[10],[13],[25]	7.95%	[8],[10],[13],[25]
Investment, Interest Rate, Cap		9.45%	[5],[7],[9],[23]	9.45%	[8],[10],[13],[25]	9.45%	[8],[10],[13],[25]
Investment, Interest Rate, Paid in Kind		1.00%	[5],[7],[9],[23]	1.00%	[8],[10],[13],[25]	1.00%	[8],[10],[13],[25]
Principal Amount		$ 45,143	[5],[7],[23]	$ 33,808	[8],[13],[25]
Investment cost		44,924	[2],[5],[7],[23]	33,651	[4],[8],[13],[25]
Investments at Fair Value		$ 48,154	[5],[7],[23]	$ 33,651	[8],[13],[25]
Investment Exit Fee		4.95%	[5],[7],[9],[23]	4.95%	[8],[10],[13],[25]	4.95%	[8],[10],[13],[25]
Investment, Identifier [Axis]: Debt Investments Information Services (3.71%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	3.71%
Investment cost	[2]	$ 55,015
Investments at Fair Value		$ 55,583
Investment, Identifier [Axis]: Debt Investments Information Services (3.72%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			3.72%		3.72%
Investment cost	[4]			$ 52,619
Investments at Fair Value				$ 52,075
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-11	[5],[11],[29]	2025-11	[12],[13],[30]	2025-11	[12],[13],[30]
Investments Maturity Month and Year		2025-11	[5],[11],[29]	2025-11	[12],[13],[30]	2025-11	[12],[13],[30]
Investment, Basis Spread, Variable Rate		5.00%	[5],[9],[11],[29]	5.00%	[10],[12],[13],[30]	5.00%	[10],[12],[13],[30]
Investment, Interest Rate, Floor		8.25%	[5],[9],[11],[29]	8.25%	[10],[12],[13],[30]	8.25%	[10],[12],[13],[30]
Investment, Interest Rate, Paid in Kind		1.10%	[5],[9],[11],[29]	1.10%	[10],[12],[13],[30]	1.10%	[10],[12],[13],[30]
Principal Amount		$ 20,305	[5],[11],[29]	$ 20,250	[12],[13],[30]
Investment cost		20,663	[2],[5],[11],[29]	20,506	[4],[12],[13],[30]
Investments at Fair Value		$ 20,822	[5],[11],[29]	$ 20,574	[12],[13],[30]
Investment Exit Fee		7.00%	[5],[9],[11],[29]	7.00%	[10],[12],[13],[30]	7.00%	[10],[12],[13],[30]
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-06	[7],[23],[24]	2025-06	[8],[25],[26]	2025-06	[8],[25],[26]
Investments Maturity Month and Year		2025-06	[7],[23],[24]	2025-06	[8],[25],[26]	2025-06	[8],[25],[26]
Investment, Basis Spread, Variable Rate		5.50%	[7],[9],[23],[24]	5.50%	[8],[10],[25],[26]	5.50%	[8],[10],[25],[26]
Investment, Interest Rate, Floor		9.00%	[7],[9],[23],[24]	9.00%	[8],[10],[25],[26]	9.00%	[8],[10],[25],[26]
Investment, Interest Rate, Cap		12.00%	[7],[9],[23],[24]	12.00%	[8],[10],[25],[26]	12.00%	[8],[10],[25],[26]
Principal Amount		$ 3,000	[7],[23],[24]	$ 750	[8],[25],[26]
Investment cost		2,956	[2],[7],[23],[24]	742	[4],[8],[25],[26]
Investments at Fair Value		$ 2,956	[7],[23],[24]	$ 738	[8],[25],[26]
Investment Exit Fee		3.45%	[7],[9],[23],[24]	3.45%	[8],[10],[25],[26]	3.45%	[8],[10],[25],[26]
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2026-09		2026-09
Investments Maturity Month and Year	[8],[15]			2026-09		2026-09
Investment, Basis Spread, Variable Rate	[8],[10],[15]			9.08%		9.08%
Investment, Interest Rate, Floor	[8],[10],[15]			10.08%		10.08%
Principal Amount	[8],[15]			$ 31,875
Investment cost	[4],[8],[15]			31,371
Investments at Fair Value	[8],[15]			$ 30,763
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.14%, Floor rate 10.04%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2026-09
Investments Maturity Month and Year	[7],[17]	2026-09
Investment, Basis Spread, Variable Rate	[7],[9],[17]	9.14%
Investment, Interest Rate, Floor	[7],[9],[17]	10.04%
Principal Amount	[7],[17]	$ 31,875
Investment cost	[2],[7],[17]	31,396
Investments at Fair Value	[7],[17]	$ 31,805
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.99%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.99%		2.99%
Investment cost	[4]			$ 41,568
Investments at Fair Value				$ 41,953
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (3.06%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	3.06%
Investment cost	[2]	$ 44,797
Investments at Fair Value		$ 45,884
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-04	[6]	2025-04	[20]	2025-04	[20]
Investments Maturity Month and Year		2025-04	[6]	2025-04	[20]	2025-04	[20]
Investment, Basis Spread, Variable Rate		4.00%	[6],[9]	4.00%	[10],[20]	4.00%	[10],[20]
Investment, Interest Rate, Floor		9.50%	[6],[9]	9.50%	[10],[20]	9.50%	[10],[20]
Principal Amount		$ 11,050	[6]	$ 11,050	[20]
Investment cost		10,951	[2],[6]	10,832	[4],[20]
Investments at Fair Value		$ 11,045	[6]	$ 10,832	[20]
Investment Exit Fee		5.00%	[6],[9]	5.00%	[10],[20]	5.00%	[10],[20]
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-03	[5]	2026-03	[8],[13]	2026-03	[8],[13]
Investments Maturity Month and Year		2026-03	[5]	2026-03	[8],[13]	2026-03	[8],[13]
Investment, Basis Spread, Variable Rate		4.35%	[5],[9]	4.35%	[8],[10],[13]	4.35%	[8],[10],[13]
Investment, Interest Rate, Floor		7.60%	[5],[9]	7.60%	[8],[10],[13]	7.60%	[8],[10],[13]
Investment, Interest Rate, Paid in Kind		1.25%	[5],[9]	1.25%	[8],[10],[13]	1.25%	[8],[10],[13]
Principal Amount		$ 20,191	[5]	$ 17,137	[8],[13]
Investment cost		19,808	[2],[5]	16,766	[4],[8],[13]
Investments at Fair Value		$ 20,330	[5]	$ 16,917	[8],[13]
Investment Exit Fee		4.50%	[5],[9]	4.50%	[8],[10],[13]	4.50%	[8],[10],[13]
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-05	[6],[23]	2026-05	[20],[25]	2026-05	[20],[25]
Investments Maturity Month and Year		2026-05	[6],[23]	2026-05	[20],[25]	2026-05	[20],[25]
Investment, Basis Spread, Variable Rate		6.15%	[6],[9],[23]	6.15%	[10],[20],[25]	6.15%	[10],[20],[25]
Investment, Interest Rate, Floor		9.40%	[6],[9],[23]	9.40%	[10],[20],[25]	9.40%	[10],[20],[25]
Principal Amount		$ 14,000	[6],[23]	$ 14,000	[20],[25]
Investment cost		14,038	[2],[6],[23]	13,970	[4],[20],[25]
Investments at Fair Value		$ 14,509	[6],[23]	$ 14,204	[20],[25]
Investment Exit Fee		7.45%	[6],[9],[23]	7.45%	[10],[20],[25]	7.45%	[10],[20],[25]
Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.66%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.66%
Investment cost	[2]	$ 9,892
Investments at Fair Value		9,892
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc.
Investment Holdings [Line Items]
Principal Amount		10,001
Investment cost	[2]	9,892
Investments at Fair Value		$ 9,892
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 2.98% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[11]	2025-12
Investments Maturity Month and Year	[11]	2025-12
Investment, Basis Spread, Variable Rate	[9],[11]	3.50%
Investment, Interest Rate, Floor	[9],[11]	9.00%
Principal Amount	[11]	$ 1,667
Investment cost	[2],[11]	1,646
Investments at Fair Value	[11]	$ 1,646
Investment Exit Fee	[9],[11]	2.98%
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 2.67% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[11]	2025-09
Investments Maturity Month and Year	[11]	2025-09
Investment, Basis Spread, Variable Rate	[9],[11]	3.50%
Investment, Interest Rate, Floor	[9],[11]	9.00%
Principal Amount	[11]	$ 1,667
Investment cost	[2],[11]	1,652
Investments at Fair Value	[11]	$ 1,652
Investment Exit Fee	[9],[11]	2.67%
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 3.67% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[11]	2026-09
Investments Maturity Month and Year	[11]	2026-09
Investment, Basis Spread, Variable Rate	[9],[11]	3.50%
Investment, Interest Rate, Floor	[9],[11]	9.00%
Principal Amount	[11]	$ 6,667
Investment cost	[2],[11]	6,594
Investments at Fair Value	[11]	$ 6,594
Investment Exit Fee	[9],[11]	3.67%
Investment, Identifier [Axis]: Debt Investments Semiconductors (1.51%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			1.51%		1.51%
Investment cost	[4]			$ 19,639
Investments at Fair Value				$ 21,192
Investment, Identifier [Axis]: Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[12],[30]			2024-12		2024-12
Investments Maturity Month and Year	[12],[30]			2024-12		2024-12
Investment, Basis Spread, Variable Rate	[10],[12],[30]			5.00%		5.00%
Investment, Interest Rate, Floor	[10],[12],[30]			8.25%		8.25%
Principal Amount	[12],[30]			$ 20,000
Investment cost	[4],[12],[30]			19,639
Investments at Fair Value	[12],[30]			$ 21,192
Investment Exit Fee	[10],[12],[30]			4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Software (52.97%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	52.97%
Investment cost	[2]	$ 793,185
Investments at Fair Value		$ 793,978
Investment, Identifier [Axis]: Debt Investments Software (54.28%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			54.28%		54.28%
Investment cost	[4]			$ 762,371
Investments at Fair Value				760,679
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC
Investment Holdings [Line Items]
Principal Amount				13,176
Investment cost	[4]			13,035
Investments at Fair Value				$ 12,998
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57%
Investment Holdings [Line Items]
Maturity Date	[15]			2025-02		2025-02
Investments Maturity Month and Year	[15]			2025-02		2025-02
Investment, Basis Spread, Variable Rate	[10],[15]			6.57%		6.57%
Investment, Interest Rate, Floor	[10],[15]			7.57%		7.57%
Principal Amount	[15]			$ 2,750
Investment cost	[4],[15]			2,744
Investments at Fair Value	[15]			$ 2,681
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.27%, Floor rate 10.27%
Investment Holdings [Line Items]
Maturity Date	[7],[16],[17]	2025-02
Investments Maturity Month and Year	[7],[16],[17]	2025-02
Investment, Basis Spread, Variable Rate	[7],[9],[16],[17]	9.27%
Investment, Interest Rate, Floor	[7],[9],[16],[17]	10.27%
Principal Amount	[7],[16],[17]	$ 13,205
Investment cost	[2],[7],[16],[17]	13,078
Investments at Fair Value	[7],[16],[17]	$ 13,140
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28%
Investment Holdings [Line Items]
Maturity Date	[14],[15]			2025-02		2025-02
Investments Maturity Month and Year	[14],[15]			2025-02		2025-02
Investment, Basis Spread, Variable Rate	[10],[14],[15]			9.28%		9.28%
Investment, Interest Rate, Floor	[10],[14],[15]			10.28%		10.28%
Principal Amount	[14],[15]			$ 10,426
Investment cost	[4],[14],[15]			10,291
Investments at Fair Value	[14],[15]			$ 10,317
Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%
Investment Holdings [Line Items]
Maturity Date		2026-10	[7],[17],[18]	2026-10	[8],[15],[21]	2026-10	[8],[15],[21]
Investments Maturity Month and Year		2026-10	[7],[17],[18]	2026-10	[8],[15],[21]	2026-10	[8],[15],[21]
Investment, Basis Spread, Variable Rate		9.00%	[7],[9],[17],[18]	9.00%	[8],[10],[15],[21]	9.00%	[8],[10],[15],[21]
Investment, Interest Rate, Floor		10.00%	[7],[9],[17],[18]	10.00%	[8],[10],[15],[21]	10.00%	[8],[10],[15],[21]
Principal Amount		$ 9,283	[7],[17],[18]	$ 9,306	[8],[15],[21]
Investment cost		9,075	[2],[7],[17],[18]	9,088	[4],[8],[15],[21]
Investments at Fair Value		$ 8,975	[7],[17],[18]	$ 8,977	[8],[15],[21]
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2028-05		2028-05
Investments Maturity Month and Year	[8],[15]			2028-05		2028-05
Investment, Basis Spread, Variable Rate	[8],[10],[15]			7.89%		7.89%
Investment, Interest Rate, Floor	[8],[10],[15]			8.89%		8.89%
Principal Amount	[8],[15]			$ 20,463
Investment cost	[4],[8],[15]			19,999
Investments at Fair Value	[8],[15]			$ 20,123
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%
Investment Holdings [Line Items]
Maturity Date	[6],[7],[17]	2028-05
Investments Maturity Month and Year	[6],[7],[17]	2028-05
Investment, Basis Spread, Variable Rate	[6],[7],[9],[17]	8.14%
Investment, Interest Rate, Floor	[6],[7],[9],[17]	9.14%
Principal Amount	[6],[7],[17]	$ 20,908
Investment cost	[2],[6],[7],[17]	20,459
Investments at Fair Value	[6],[7],[17]	$ 20,975
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00%
Investment Holdings [Line Items]
Maturity Date	[8],[20]			2027-02		2027-02
Investments Maturity Month and Year	[8],[20]			2027-02		2027-02
Investment, Basis Spread, Variable Rate	[8],[10],[20]			8.99%		8.99%
Investment, Interest Rate, Floor	[8],[10],[20]			10.00%		10.00%
Principal Amount	[8],[20]			$ 8,500
Investment cost	[4],[8],[20]			8,292
Investments at Fair Value	[8],[20]			$ 8,176
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 9.99%
Investment Holdings [Line Items]
Maturity Date	[6],[7]	2027-02
Investments Maturity Month and Year	[6],[7]	2027-02
Investment, Basis Spread, Variable Rate	[6],[7],[9]	8.99%
Investment, Interest Rate, Floor	[6],[7],[9]	9.99%
Principal Amount	[6],[7]	$ 8,500
Investment cost	[2],[6],[7]	8,302
Investments at Fair Value	[6],[7]	$ 8,270
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-09	[7],[11],[16]	2027-09	[8],[12],[14]	2027-09	[8],[12],[14]
Investments Maturity Month and Year		2027-09	[7],[11],[16]	2027-09	[8],[12],[14]	2027-09	[8],[12],[14]
Investment, Basis Spread, Variable Rate		4.25%	[7],[9],[11],[16]	4.25%	[8],[10],[12],[14]	4.25%	[8],[10],[12],[14]
Investment, Interest Rate, Floor		9.00%	[7],[9],[11],[16]	9.00%	[8],[10],[12],[14]	9.00%	[8],[10],[12],[14]
Principal Amount		$ 19,600	[7],[11],[16]	$ 19,600	[8],[12],[14]
Investment cost		19,127	[2],[7],[11],[16]	19,059	[4],[8],[12],[14]
Investments at Fair Value		$ 19,653	[7],[11],[16]	$ 19,059	[8],[12],[14]
Investment Exit Fee		2.50%	[7],[9],[11],[16]	2.50%	[8],[10],[12],[14]	2.50%	[8],[10],[12],[14]
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%
Investment Holdings [Line Items]
Maturity Date		2027-12	[7],[17],[29]	2027-12	[8],[15],[30]	2027-12	[8],[15],[30]
Investments Maturity Month and Year		2027-12	[7],[17],[29]	2027-12	[8],[15],[30]	2027-12	[8],[15],[30]
Investment, Basis Spread, Variable Rate		7.89%	[7],[9],[17],[29]	7.89%	[8],[10],[15],[30]	7.89%	[8],[10],[15],[30]
Investment, Interest Rate, Floor		8.89%	[7],[9],[17],[29]	8.89%	[8],[10],[15],[30]	8.89%	[8],[10],[15],[30]
Principal Amount		$ 45,000	[7],[17],[29]	$ 45,000	[8],[15],[30]
Investment cost		43,844	[2],[7],[17],[29]	43,801	[4],[8],[15],[30]
Investments at Fair Value		$ 43,844	[7],[17],[29]	$ 43,801	[8],[15],[30]
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-04	[5],[6],[7],[29]	2025-04	[8],[13],[20],[30]	2025-04	[8],[13],[20],[30]
Investments Maturity Month and Year		2025-04	[5],[6],[7],[29]	2025-04	[8],[13],[20],[30]	2025-04	[8],[13],[20],[30]
Investment, Basis Spread, Variable Rate		3.70%	[5],[6],[7],[9],[29]	3.70%	[8],[10],[13],[20],[30]	3.70%	[8],[10],[13],[20],[30]
Investment, Interest Rate, Floor		6.95%	[5],[6],[7],[9],[29]	6.95%	[8],[10],[13],[20],[30]	6.95%	[8],[10],[13],[20],[30]
Investment, Interest Rate, Paid in Kind		1.00%	[5],[6],[7],[9],[29]	1.00%	[8],[10],[13],[20],[30]	1.00%	[8],[10],[13],[20],[30]
Principal Amount		$ 20,217	[5],[6],[7],[29]	$ 20,166	[8],[13],[20],[30]
Investment cost		20,366	[2],[5],[6],[7],[29]	20,242	[4],[8],[13],[20],[30]
Investments at Fair Value		$ 20,399	[5],[6],[7],[29]	$ 20,138	[8],[13],[20],[30]
Investment Exit Fee		3.95%	[5],[6],[7],[9],[29]	3.95%	[8],[10],[13],[20],[30]	3.95%	[8],[10],[13],[20],[30]
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 8.90%, Floor rate 9.90%
Investment Holdings [Line Items]
Maturity Date	[6],[11]	2025-11
Investments Maturity Month and Year	[6],[11]	2025-11
Investment, Basis Spread, Variable Rate	[6],[9],[11]	8.90%
Investment, Interest Rate, Floor	[6],[9],[11]	9.90%
Principal Amount	[6],[11]	$ 33,000
Investment cost	[2],[6],[11]	32,608
Investments at Fair Value	[6],[11]	$ 33,000
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90%
Investment Holdings [Line Items]
Maturity Date	[12],[20]			2025-11		2025-11
Investments Maturity Month and Year	[12],[20]			2025-11		2025-11
Investment, Basis Spread, Variable Rate	[10],[12],[20]			8.90%		8.90%
Investment, Interest Rate, Floor	[10],[12],[20]			9.90%		9.90%
Principal Amount	[12],[20]			$ 33,000
Investment cost	[4],[12],[20]			32,578
Investments at Fair Value	[12],[20]			$ 33,000
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76%
Investment Holdings [Line Items]
Maturity Date		2026-06	[17]	2026-06	[15]	2026-06	[15]
Investments Maturity Month and Year		2026-06	[17]	2026-06	[15]	2026-06	[15]
Investment, Basis Spread, Variable Rate		8.86%	[9],[17]	8.86%	[10],[15]	8.86%	[10],[15]
Investment, Interest Rate, Floor		9.76%	[9],[17]	9.76%	[10],[15]	9.76%	[10],[15]
Principal Amount		$ 10,149	[17]	$ 10,175	[15]
Investment cost		9,966	[2],[17]	9,980	[4],[15]
Investments at Fair Value		$ 10,028	[17]	$ 9,996	[15]
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.89%, Floor rate 9.89%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2026-09
Investments Maturity Month and Year	[7],[17]	2026-09
Investment, Basis Spread, Variable Rate	[7],[9],[17]	8.89%
Investment, Interest Rate, Floor	[7],[9],[17]	9.89%
Principal Amount	[7],[17]	$ 23,026
Investment cost	[2],[7],[17]	22,574
Investments at Fair Value	[7],[17]	$ 23,176
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2026-09		2026-09
Investments Maturity Month and Year	[8],[15]			2026-09		2026-09
Investment, Basis Spread, Variable Rate	[8],[10],[15]			9.67%		9.67%
Investment, Interest Rate, Floor	[8],[10],[15]			10.67%		10.67%
Principal Amount	[8],[15]			$ 21,445
Investment cost	[4],[8],[15]			21,003
Investments at Fair Value	[8],[15]			$ 21,050
Investment, Identifier [Axis]: Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[12],[14]			2024-10		2024-10
Investments Maturity Month and Year	[12],[14]			2024-10		2024-10
Investment, Basis Spread, Variable Rate	[10],[12],[14]			6.70%		6.70%
Investment, Interest Rate, Floor	[10],[12],[14]			9.95%		9.95%
Principal Amount	[12],[14]			$ 10,000
Investment cost	[4],[12],[14]			10,069
Investments at Fair Value	[12],[14]			$ 10,498
Investment Exit Fee	[10],[12],[14]			3.45%		3.45%
Investment, Identifier [Axis]: Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2027-07
Investments Maturity Month and Year	[7],[17]	2027-07
Investment, Basis Spread, Variable Rate	[7],[9],[17]	8.44%
Investment, Interest Rate, Floor	[7],[9],[17]	9.44%
Principal Amount	[7],[17]	$ 4,688
Investment cost	[2],[7],[17]	4,578
Investments at Fair Value	[7],[17]	$ 4,704
Investment, Identifier [Axis]: Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2027-07		2027-07
Investments Maturity Month and Year	[8],[15]			2027-07		2027-07
Investment, Basis Spread, Variable Rate	[8],[10],[15]			8.44%		8.44%
Investment, Interest Rate, Floor	[8],[10],[15]			9.44%		9.44%
Principal Amount	[8],[15]			$ 4,688
Investment cost	[4],[8],[15]			4,573
Investments at Fair Value	[8],[15]			$ 4,573
Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-03	[5],[11]	2026-03	[12],[13],[22]	2026-03	[12],[13],[22]
Investments Maturity Month and Year		2026-03	[5],[11]	2026-03	[12],[13],[22]	2026-03	[12],[13],[22]
Investment, Basis Spread, Variable Rate		3.20%	[5],[9],[11]	3.20%	[10],[12],[13],[22]	3.20%	[10],[12],[13],[22]
Investment, Interest Rate, Floor		6.45%	[5],[9],[11]	6.45%	[10],[12],[13],[22]	6.45%	[10],[12],[13],[22]
Investment, Interest Rate, Paid in Kind		1.95%	[5],[9],[11]	1.95%	[10],[12],[13],[22]	1.95%	[10],[12],[13],[22]
Principal Amount		$ 74,348	[5],[11]	$ 73,987	[12],[13],[22]
Investment cost		73,672	[2],[5],[11]	73,060	[4],[12],[13],[22]
Investments at Fair Value		$ 74,294	[5],[11]	$ 73,498	[12],[13],[22]
Investment Exit Fee		4.55%	[5],[9],[11]	4.55%	[10],[12],[13],[22]	4.55%	[10],[12],[13],[22]
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-03	[5],[16]	2025-03	[13],[14]	2025-03	[13],[14]
Investments Maturity Month and Year		2025-03	[5],[16]	2025-03	[13],[14]	2025-03	[13],[14]
Investment, Basis Spread, Variable Rate		4.50%	[5],[9],[16]	4.50%	[10],[13],[14]	4.50%	[10],[13],[14]
Investment, Interest Rate, Floor		8.25%	[5],[9],[16]	8.25%	[10],[13],[14]	8.25%	[10],[13],[14]
Investment, Interest Rate, Cap		10.25%	[5],[9],[16]	10.25%	[10],[13],[14]	10.25%	[10],[13],[14]
Investment, Interest Rate, Paid in Kind		1.95%	[5],[9],[16]	1.95%	[10],[13],[14]	1.95%	[10],[13],[14]
Principal Amount		$ 9,925	[5],[16]	$ 10,144	[13],[14]
Investment cost		9,971	[2],[5],[16]	10,150	[4],[13],[14]
Investments at Fair Value		$ 9,652	[5],[16]	$ 9,820	[13],[14]
Investment Exit Fee		4.50%	[5],[9],[16]	4.50%	[10],[13],[14]	4.50%	[10],[13],[14]
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-10	[7],[18],[23],[24]	2025-10	[8],[21],[25],[26]	2025-10	[8],[21],[25],[26]
Investments Maturity Month and Year		2025-10	[7],[18],[23],[24]	2025-10	[8],[21],[25],[26]	2025-10	[8],[21],[25],[26]
Investment, Basis Spread, Variable Rate		5.20%	[7],[9],[18],[23],[24]	5.20%	[8],[10],[21],[25],[26]	5.20%	[8],[10],[21],[25],[26]
Investment, Interest Rate, Floor		9.95%	[7],[9],[18],[23],[24]	9.95%	[8],[10],[21],[25],[26]	9.95%	[8],[10],[21],[25],[26]
Principal Amount		$ 5,500	[7],[18],[23],[24]	$ 5,000	[8],[21],[25],[26]
Investment cost		5,464	[2],[7],[18],[23],[24]	4,949	[4],[8],[21]
Investments at Fair Value		$ 5,597	[7],[18],[23],[24]	$ 4,949	[8],[21],[25],[26]
Investment Exit Fee		4.95%	[7],[9],[18],[23],[24]	4.95%	[8],[10],[21],[25],[26]	4.95%	[8],[10],[21],[25],[26]
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc.
Investment Holdings [Line Items]
Principal Amount		$ 10,528
Investment cost	[2]	10,310
Investments at Fair Value		$ 10,001
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%
Investment Holdings [Line Items]
Maturity Date	[7]	2026-08
Investments Maturity Month and Year	[7]	2026-08
Investment, Basis Spread, Variable Rate	[7],[9]	12.36%
Investment, Interest Rate, Floor	[7],[9]	13.11%
Principal Amount	[7]	$ 2,553
Investment cost	[2],[7]	2,489
Investments at Fair Value	[7]	$ 2,487
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%
Investment Holdings [Line Items]
Maturity Date	[6],[7]	2026-08
Investments Maturity Month and Year	[6],[7]	2026-08
Investment, Basis Spread, Variable Rate	[6],[7],[9]	8.63%
Investment, Interest Rate, Floor	[6],[7],[9]	9.38%
Principal Amount	[6],[7]	$ 7,975
Investment cost	[2],[6],[7]	7,821
Investments at Fair Value	[6],[7]	$ 7,514
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28%
Investment Holdings [Line Items]
Maturity Date	[8],[20]			2026-08		2026-08
Investments Maturity Month and Year	[8],[20]			2026-08		2026-08
Investment, Basis Spread, Variable Rate	[8],[10],[20]			9.53%		9.53%
Investment, Interest Rate, Floor	[8],[10],[20]			10.28%		10.28%
Principal Amount	[8],[20]			$ 10,528
Investment cost	[4],[8],[20]			10,298
Investments at Fair Value	[8],[20]			$ 10,114
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[12],[13],[14],[20]			2025-07		2025-07
Investments Maturity Month and Year	[8],[12],[13],[14],[20]			2025-07		2025-07
Investment, Basis Spread, Variable Rate	[8],[10],[12],[13],[14],[20]			3.05%		3.05%
Investment, Interest Rate, Floor	[8],[10],[12],[13],[14],[20]			7.55%		7.55%
Investment, Interest Rate, Paid in Kind	[8],[10],[12],[13],[14],[20]			1.10%		1.10%
Principal Amount	[8],[12],[13],[14],[20]			$ 31,930
Investment cost	[4],[8],[12],[13],[14],[20]			32,346
Investments at Fair Value	[8],[12],[13],[14],[20]			$ 32,012
Investment Exit Fee	[8],[10],[12],[13],[14],[20]			4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 6.29% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[5],[6],[7],[11],[16]	2025-07
Investments Maturity Month and Year	[5],[6],[7],[11],[16]	2025-07
Investment, Basis Spread, Variable Rate	[5],[6],[7],[9],[11],[16]	3.05%
Investment, Interest Rate, Floor	[5],[6],[7],[9],[11],[16]	7.55%
Investment, Interest Rate, Paid in Kind	[5],[6],[7],[9],[11],[16]	1.10%
Principal Amount	[5],[6],[7],[11],[16]	$ 34,513
Investment cost	[2],[5],[6],[7],[11],[16]	34,518
Investments at Fair Value	[5],[6],[7],[11],[16]	$ 34,413
Investment Exit Fee	[5],[6],[7],[9],[11],[16]	6.29%
Investment, Identifier [Axis]: Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[8],[12],[13],[20]			2025-08		2025-08
Investments Maturity Month and Year	[8],[12],[13],[20]			2025-08		2025-08
Investment, Basis Spread, Variable Rate	[8],[10],[12],[13],[20]			2.25%		2.25%
Investment, Interest Rate, Floor	[8],[10],[12],[13],[20]			5.50%		5.50%
Investment, Interest Rate, Paid in Kind	[8],[10],[12],[13],[20]			3.00%		3.00%
Principal Amount	[8],[12],[13],[20]			$ 28,503
Investment cost	[4],[8],[12],[13],[20]			28,442
Investments at Fair Value	[8],[12],[13],[20]			$ 28,664
Investment Exit Fee	[8],[10],[12],[13],[20]			5.00%		5.00%
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%
Investment Holdings [Line Items]
Maturity Date		2028-04	[7],[17]	2028-04	[8],[15]	2028-04	[8],[15]
Investments Maturity Month and Year		2028-04	[7],[17]	2028-04	[8],[15]	2028-04	[8],[15]
Investment, Basis Spread, Variable Rate		8.01%	[7],[9],[17]	8.01%	[8],[10],[15]	8.01%	[8],[10],[15]
Investment, Interest Rate, Floor		8.76%	[7],[9],[17]	8.76%	[8],[10],[15]	8.76%	[8],[10],[15]
Principal Amount		$ 7,500	[7],[17]	$ 7,500	[8],[15]
Investment cost		7,302	[2],[7],[17]	7,295	[4],[8],[15]
Investments at Fair Value		$ 7,325	[7],[17]	$ 7,339	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-04	[23],[24]	2025-04	[25],[26]	2025-04	[25],[26]
Investments Maturity Month and Year		2025-04	[23],[24]	2025-04	[25],[26]	2025-04	[25],[26]
Investment, Basis Spread, Variable Rate		5.10%	[9],[23],[24]	5.10%	[10],[25],[26]	5.10%	[10],[25],[26]
Investment, Interest Rate, Floor		8.35%	[9],[23],[24]	8.35%	[10],[25],[26]	8.35%	[10],[25],[26]
Principal Amount		$ 3,750	[23],[24]	$ 3,750	[25],[26]
Investment cost		3,758	[2],[23],[24]	3,744	[4],[25],[26]
Investments at Fair Value		$ 3,742	[23],[24]	$ 3,746	[25],[26]
Investment Exit Fee		2.95%	[9],[23],[24]	2.95%	[10],[25],[26]	2.95%	[10],[25],[26]
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2026-03	[5],[7],[11]	2026-03	[8],[12],[13]	2026-03	[8],[12],[13]
Investments Maturity Month and Year		2026-03	[5],[7],[11]	2026-03	[8],[12],[13]	2026-03	[8],[12],[13]
Investment, Basis Spread, Variable Rate		4.25%	[5],[7],[9],[11]	4.25%	[8],[10],[12],[13]	4.25%	[8],[10],[12],[13]
Investment, Interest Rate, Floor		9.00%	[5],[7],[9],[11]	9.00%	[8],[10],[12],[13]	9.00%	[8],[10],[12],[13]
Investment, Interest Rate, Paid in Kind		1.95%	[5],[7],[9],[11]	1.95%	[8],[10],[12],[13]	1.95%	[8],[10],[12],[13]
Principal Amount		$ 5,046	[5],[7],[11]	$ 5,021	[8],[12],[13]
Investment cost		4,886	[2],[5],[7],[11]	4,839	[4],[8],[12],[13]
Investments at Fair Value		$ 5,009	[5],[7],[11]	$ 4,839	[8],[12],[13]
Investment Exit Fee		3.95%	[5],[7],[9],[11]	3.95%	[8],[10],[12]	3.95%	[8],[10],[12]
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.76%, Floor rate 7.76%, PIK Interest 2.15%
Investment Holdings [Line Items]
Maturity Date	[5],[7],[16],[17]	2026-09
Investments Maturity Month and Year	[5],[7],[16],[17]	2026-09
Investment, Basis Spread, Variable Rate	[5],[7],[9],[16],[17]	6.76%
Investment, Interest Rate, Floor	[5],[7],[9],[16],[17]	7.76%
Investment, Interest Rate, Paid in Kind	[5],[7],[9],[16],[17]	2.15%
Principal Amount	[5],[7],[16],[17]	$ 8,268
Investment cost	[2],[5],[7],[16],[17]	8,107
Investments at Fair Value	[5],[7],[16],[17]	$ 8,184
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16%
Investment Holdings [Line Items]
Maturity Date	[8],[13],[14],[15]			2026-09		2026-09
Investments Maturity Month and Year	[8],[13],[14],[15]			2026-09		2026-09
Investment, Basis Spread, Variable Rate	[8],[10],[13],[14],[15]			6.77%		6.77%
Investment, Interest Rate, Floor	[8],[10],[13],[14],[15]			7.77%		7.77%
Investment, Interest Rate, Paid in Kind	[8],[10],[13],[14],[15]			2.16%		2.16%
Principal Amount	[8],[13],[14],[15]			$ 8,223
Investment cost	[4],[8],[13],[14],[15]			8,054
Investments at Fair Value	[8],[13],[14],[15]			$ 8,043
Investment, Identifier [Axis]: Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96%
Investment Holdings [Line Items]
Maturity Date	[14],[15],[25],[26]			2024-05		2024-05
Investments Maturity Month and Year	[14],[15],[25],[26]			2024-05		2024-05
Investment, Basis Spread, Variable Rate	[10],[14],[15],[25],[26]			9.96%		9.96%
Investment, Interest Rate, Floor	[10],[14],[15],[25],[26]			10.96%		10.96%
Principal Amount	[14],[15],[25],[26]			$ 8,436
Investment cost	[4],[14],[15],[25]			8,361
Investments at Fair Value	[14],[15],[25],[26]			$ 8,376
Investment, Identifier [Axis]: Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-02	[5],[32]	2025-02	[13],[34]	2025-02	[13],[34]
Investments Maturity Month and Year		2025-02	[5],[32]	2025-02	[13],[34]	2025-02	[13],[34]
Investment, Basis Spread, Variable Rate		5.50%	[5],[9],[32]	5.50%	[10],[13],[34]	5.50%	[10],[13],[34]
Investment, Interest Rate, Floor		8.75%	[5],[9],[32]	8.75%	[10],[13],[34]	8.75%	[10],[13],[34]
Investment, Interest Rate, Paid in Kind		1.50%	[5],[9],[32]	1.50%	[10],[13],[34]	1.50%	[10],[13],[34]
Principal Amount		$ 4,783	[5],[32]	$ 4,892	[13],[34]
Investment cost		4,628	[2],[5],[32]	4,737	[4],[13],[34]
Investments at Fair Value		$ 1,193	[5],[32]	$ 1,671	[13],[34]
Investment Exit Fee		3.00%	[5],[9],[32]	3.00%	[10],[13],[34]	3.00%	[10],[13],[34]
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2027-10		2027-10
Investments Maturity Month and Year	[8],[15]			2027-10		2027-10
Investment, Basis Spread, Variable Rate	[8],[10],[15]			7.79%		7.79%
Investment, Interest Rate, Floor	[8],[10],[15]			8.70%		8.70%
Principal Amount	[8],[15]			$ 5,948
Investment cost	[4],[8],[15]			5,771
Investments at Fair Value	[8],[15]			$ 5,771
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2027-10
Investments Maturity Month and Year	[7],[17]	2027-10
Investment, Basis Spread, Variable Rate	[7],[9],[17]	7.80%
Investment, Interest Rate, Floor	[7],[9],[17]	8.70%
Principal Amount	[7],[17]	$ 5,948
Investment cost	[2],[7],[17]	5,777
Investments at Fair Value	[7],[17]	$ 5,778
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54%
Investment Holdings [Line Items]
Maturity Date		2027-12	[7],[17]	2027-12	[8],[15]	2027-12	[8],[15]
Investments Maturity Month and Year		2027-12	[7],[17]	2027-12	[8],[15]	2027-12	[8],[15]
Investment, Basis Spread, Variable Rate		7.79%	[7],[9],[17]	7.79%	[8],[10],[15]	7.79%	[8],[10],[15]
Investment, Interest Rate, Floor		8.54%	[7],[9],[17]	8.54%	[8],[10],[15]	8.54%	[8],[10],[15]
Principal Amount		$ 7,000	[7],[17]	$ 7,000	[8],[15]
Investment cost		6,830	[2],[7],[17]	6,824	[4],[8],[15]
Investments at Fair Value		$ 6,830	[7],[17]	$ 6,824	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00%
Investment Holdings [Line Items]
Maturity Date		2024-10	[7],[17],[23],[24]	2024-10	[8],[15],[25],[26]	2024-10	[8],[15],[25],[26]
Investments Maturity Month and Year		2024-10	[7],[17],[23],[24]	2024-10	[8],[15],[25],[26]	2024-10	[8],[15],[25],[26]
Investment, Basis Spread, Variable Rate		9.00%	[7],[9],[17],[23],[24]	9.00%	[8],[10],[15],[25],[26]	9.00%	[8],[10],[15],[25],[26]
Investment, Interest Rate, Floor		10.00%	[7],[9],[17],[23],[24]	10.00%	[8],[10],[15],[25],[26]	10.00%	[8],[10],[15],[25],[26]
Principal Amount		$ 6,475	[7],[17],[23],[24]	$ 6,563	[8],[15],[25],[26]
Investment cost		6,353	[2],[7],[17],[23],[24]	6,422	[4],[8],[15],[25],[26]
Investments at Fair Value		$ 6,394	[7],[17],[23],[24]	$ 6,484	[8],[15],[25],[26]
Investment, Identifier [Axis]: Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75%
Investment Holdings [Line Items]
Maturity Date		2027-01	[11]	2027-01	[12]	2027-01	[12]
Investments Maturity Month and Year		2027-01	[11]	2027-01	[12]	2027-01	[12]
Investment, Basis Spread, Variable Rate		7.75%	[9],[11]	7.75%	[10],[12]	7.75%	[10],[12]
Investment, Interest Rate, Floor		8.75%	[9],[11]	8.75%	[10],[12]	8.75%	[10],[12]
Principal Amount		$ 20,000	[11]	$ 20,000	[12]
Investment cost		19,881	[2],[11]	19,875	[4],[12]
Investments at Fair Value		$ 20,200	[11]	$ 20,200	[12]
Investment, Identifier [Axis]: Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14%
Investment Holdings [Line Items]
Maturity Date	[15]			2023-07		2023-07
Investments Maturity Month and Year	[15]			2023-07		2023-07
Investment, Basis Spread, Variable Rate	[10],[15]			10.14%		10.14%
Investment, Interest Rate, Floor	[10],[15]			11.14%		11.14%
Principal Amount	[15]			$ 10,681
Investment cost	[4],[15]			10,593
Investments at Fair Value	[15]			$ 10,593
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00%
Investment Holdings [Line Items]
Maturity Date		2024-01	[7]	2024-01	[8]	2024-01	[8]
Investments Maturity Month and Year		2024-01	[7]	2024-01	[8]	2024-01	[8]
Investment, Basis Spread, Variable Rate		8.00%	[7],[9]	8.00%	[8],[10]	8.00%	[8],[10]
Investment, Interest Rate, Floor		9.00%	[7],[9]	9.00%	[8],[10]	9.00%	[8],[10]
Principal Amount		$ 56,208	[7]	$ 56,208	[8]
Investment cost		56,096	[2],[7]	56,062	[4],[8]
Investments at Fair Value		$ 56,096	[7]	$ 55,520	[8]
Investment, Identifier [Axis]: Debt Investments Software and Kore.ai, Inc., Senior Secured, Maturity Date April 2027, Prime + 1.50%, Floor rate 9.25%, PIK Interest 2.20%, 2.25% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-04
Investments Maturity Month and Year		2027-04
Investment, Basis Spread, Variable Rate	[9]	1.50%
Investment, Interest Rate, Floor	[9]	9.25%
Investment, Interest Rate, Paid in Kind	[9]	2.20%
Principal Amount		$ 30,000
Investment cost	[2]	29,541
Investments at Fair Value		$ 29,541
Investment Exit Fee	[9]	2.25%
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[5],[7],[23],[24]	2026-02
Investments Maturity Month and Year	[5],[7],[23],[24]	2026-02
Investment, Basis Spread, Variable Rate	[5],[7],[9],[23],[24]	0.25%
Investment, Interest Rate, Floor	[5],[7],[9],[23],[24]	7.25%
Investment, Interest Rate, Paid in Kind	[5],[7],[9],[23],[24]	1.95%
Principal Amount	[5],[7],[23],[24]	$ 3,757
Investment cost	[2],[5],[7],[23],[24]	3,723
Investments at Fair Value	[5],[7],[23],[24]	$ 3,723
Investment Exit Fee	[5],[7],[9],[23],[24]	2.70%
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2028-03
Investments Maturity Month and Year	[7],[17]	2028-03
Investment, Basis Spread, Variable Rate	[7],[9],[17]	7.88%
Investment, Interest Rate, Floor	[7],[9],[17]	8.88%
Principal Amount	[7],[17]	$ 25,900
Investment cost	[2],[7],[17]	25,255
Investments at Fair Value	[7],[17]	$ 25,255
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%
Investment Holdings [Line Items]
Maturity Date		2027-07	[7]	2027-07	[8]	2027-07	[8]
Investments Maturity Month and Year		2027-07	[7]	2027-07	[8]	2027-07	[8]
Investment, Basis Spread, Variable Rate		8.93%	[7],[9]	8.93%	[8],[10]	8.93%	[8],[10]
Investment, Interest Rate, Floor		9.93%	[7],[9]	9.93%	[8],[10]	9.93%	[8],[10]
Principal Amount		$ 13,300	[7]	$ 13,300	[8]
Investment cost		13,039	[2],[7]	13,028	[4],[8]
Investments at Fair Value		$ 13,172	[7]	$ 13,028	[8]
Investment, Identifier [Axis]: Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75%
Investment Holdings [Line Items]
Maturity Date	[21]			2024-01		2024-01
Investments Maturity Month and Year	[21]			2024-01		2024-01
Investment, Basis Spread, Variable Rate	[10],[21]			7.50%		7.50%
Investment, Interest Rate, Floor	[10],[21]			10.75%		10.75%
Principal Amount	[21]			$ 14,500
Investment cost	[4],[21]			14,398
Investments at Fair Value	[21]			$ 14,473
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06%
Investment Holdings [Line Items]
Maturity Date		2025-12	[17]	2025-12	[8],[15]	2025-12	[8],[15]
Investments Maturity Month and Year		2025-12	[17]	2025-12	[8],[15]	2025-12	[8],[15]
Investment, Basis Spread, Variable Rate		9.06%	[9],[17]	9.06%	[8],[10],[15]	9.06%	[8],[10],[15]
Investment, Interest Rate, Floor		10.06%	[9],[17]	10.06%	[8],[10],[15]	10.06%	[8],[10],[15]
Principal Amount		$ 18,366	[17]	$ 17,915	[8],[15]
Investment cost		18,033	[2],[17]	17,556	[4],[8],[15]
Investments at Fair Value		$ 17,754	[17]	$ 17,474	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2023-07	[5],[18]	2023-07	[13],[21]	2023-07	[13],[21]
Investments Maturity Month and Year		2023-07	[5],[18]	2023-07	[13],[21]	2023-07	[13],[21]
Investment, Basis Spread, Variable Rate		3.75%	[5],[9],[18]	3.75%	[10],[13],[21]	3.75%	[10],[13],[21]
Investment, Interest Rate, Floor		7.75%	[5],[9],[18]	7.75%	[10],[13],[21]	7.75%	[10],[13],[21]
Investment, Interest Rate, Paid in Kind		2.95%	[5],[9],[18]	2.95%	[10],[13],[21]	2.95%	[10],[13],[21]
Principal Amount		$ 22,375	[5],[18]	$ 22,211	[13],[21]
Investment cost		22,619	[2],[5],[18]	22,284	[4],[13],[21]
Investments at Fair Value		$ 22,619	[5],[18]	$ 22,284	[13],[21]
Investment Exit Fee		1.95%	[5],[9],[18]	1.95%	[10],[13],[21]	1.95%	[10],[13],[21]
Investment, Identifier [Axis]: Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-07	[6],[7],[11],[18]	2025-07	[8],[12],[20],[21]	2025-07	[8],[12],[20],[21]
Investments Maturity Month and Year		2025-07	[6],[7],[11],[18]	2025-07	[8],[12],[20],[21]	2025-07	[8],[12],[20],[21]
Investment, Basis Spread, Variable Rate		5.25%	[6],[7],[9],[11],[18]	5.25%	[8],[10],[12],[20],[21]	5.25%	[8],[10],[12],[20],[21]
Investment, Interest Rate, Floor		8.50%	[6],[7],[9],[11],[18]	8.50%	[8],[10],[12],[20],[21]	8.50%	[8],[10],[12],[20],[21]
Principal Amount		$ 22,500	[6],[7],[11],[18]	$ 22,500	[8],[12],[20],[21]
Investment cost		22,575	[2],[6],[7],[11],[18]	22,508	[4],[8],[12],[20],[21]
Investments at Fair Value		$ 22,929	[6],[7],[11],[18]	$ 22,817	[8],[12],[20],[21]
Investment Exit Fee		2.42%	[6],[7],[9],[11],[18]	2.42%	[8],[10],[12],[20],[21]	2.42%	[8],[10],[12],[20],[21]
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%
Investment Holdings [Line Items]
Maturity Date		2027-07	[7],[17]	2027-07	[8],[15]	2027-07	[8],[15]
Investments Maturity Month and Year		2027-07	[7],[17]	2027-07	[8],[15]	2027-07	[8],[15]
Investment, Basis Spread, Variable Rate		8.05%	[7],[9],[17]	8.05%	[8],[10],[15]	8.05%	[8],[10],[15]
Investment, Interest Rate, Floor		9.05%	[7],[9],[17]	9.05%	[8],[10],[15]	9.05%	[8],[10],[15]
Principal Amount		$ 7,500	[7],[17]	$ 7,500	[8],[15]
Investment cost		7,270	[2],[7],[17]	7,261	[4],[8],[15]
Investments at Fair Value		$ 7,295	[7],[17]	$ 7,261	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53%
Investment Holdings [Line Items]
Maturity Date		2027-04	[7],[17]	2027-04	[8],[15]	2027-04	[8],[15]
Investments Maturity Month and Year		2027-04	[7],[17]	2027-04	[8],[15]	2027-04	[8],[15]
Investment, Basis Spread, Variable Rate		7.53%	[7],[9],[17]	7.53%	[8],[10],[15]	7.53%	[8],[10],[15]
Investment, Interest Rate, Floor		8.53%	[7],[9],[17]	8.53%	[8],[10],[15]	8.53%	[8],[10],[15]
Principal Amount		$ 26,053	[7],[17]	$ 26,184	[8],[15]
Investment cost		25,516	[2],[7],[17]	25,622	[4],[8],[15]
Investments at Fair Value		$ 25,074	[7],[17]	$ 25,487	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00%
Investment Holdings [Line Items]
Maturity Date	[15]			2027-09		2027-09
Investments Maturity Month and Year	[15]			2027-09		2027-09
Investment, Basis Spread, Variable Rate	[10],[15]			8.00%		8.00%
Investment, Interest Rate, Floor	[10],[15]			9.00%		9.00%
Principal Amount	[15]			$ 18,000
Investment cost	[4],[15]			17,654
Investments at Fair Value	[15]			$ 17,654
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.25%, Floor rate 9.00%
Investment Holdings [Line Items]
Maturity Date	[17]	2027-09
Investments Maturity Month and Year	[17]	2027-09
Investment, Basis Spread, Variable Rate	[9],[17]	8.25%
Investment, Interest Rate, Floor	[9],[17]	9.00%
Principal Amount	[17]	$ 17,955
Investment cost	[2],[17]	17,622
Investments at Fair Value	[17]	$ 17,994
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 1-month LIBOR + 8.97%, Floor rate 9.97%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2026-12
Investments Maturity Month and Year	[7],[17]	2026-12
Investment, Basis Spread, Variable Rate	[7],[9],[17]	8.97%
Investment, Interest Rate, Floor	[7],[9],[17]	9.97%
Principal Amount	[7],[17]	$ 5,985
Investment cost	[2],[7],[17]	5,848
Investments at Fair Value	[7],[17]	$ 5,780
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00%
Investment Holdings [Line Items]
Maturity Date	[8],[15]			2026-12		2026-12
Investments Maturity Month and Year	[8],[15]			2026-12		2026-12
Investment, Basis Spread, Variable Rate	[8],[10],[15]			9.00%		9.00%
Investment, Interest Rate, Floor	[8],[10],[15]			10.00%		10.00%
Principal Amount	[8],[15]			$ 5,985
Investment cost	[4],[8],[15]			5,841
Investments at Fair Value	[8],[15]			$ 5,830
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2027-03
Investments Maturity Month and Year		2027-03
Investment, Basis Spread, Variable Rate	[9]	1.00%
Investment, Interest Rate, Floor	[9]	8.75%
Investment, Interest Rate, Paid in Kind	[9]	1.95%
Principal Amount		$ 15,000
Investment cost	[2]	14,892
Investments at Fair Value		$ 14,892
Investment Exit Fee	[9]	2.95%
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 6-month SOFR + 7.25%, Floor rate 8.25%
Investment Holdings [Line Items]
Maturity Date	[7],[17]	2028-03
Investments Maturity Month and Year	[7],[17]	2028-03
Investment, Basis Spread, Variable Rate	[7],[9],[17]	7.25%
Investment, Interest Rate, Floor	[7],[9],[17]	8.25%
Principal Amount	[7],[17]	$ 13,200
Investment cost	[2],[7],[17]	12,921
Investments at Fair Value	[7],[17]	$ 12,921
Investment, Identifier [Axis]: Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2024-02	[5]	2024-02	[13]	2024-02	[13]
Investments Maturity Month and Year		2024-02	[5]	2024-02	[13]	2024-02	[13]
Investment, Basis Spread, Variable Rate		4.00%	[5],[9]	4.00%	[10],[13]	4.00%	[10],[13]
Investment, Interest Rate, Floor		8.75%	[5],[9]	8.75%	[10],[13]	8.75%	[10],[13]
Investment, Interest Rate, Paid in Kind		2.00%	[5],[9]	2.00%	[10],[13]	2.00%	[10],[13]
Principal Amount		$ 3,474	[5]	$ 4,250	[13]
Investment cost		3,448	[2],[5]	4,481	[4],[13]
Investments at Fair Value		$ 3,448	[5]	$ 4,446	[13]
Investment Exit Fee		5.50%	[5],[9]	5.50%	[10],[13]	5.50%	[10],[13]
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00%
Investment Holdings [Line Items]
Maturity Date		2026-05	[7],[17]	2026-05	[8],[15]	2026-05	[8],[15]
Investments Maturity Month and Year		2026-05	[7],[17]	2026-05	[8],[15]	2026-05	[8],[15]
Investment, Basis Spread, Variable Rate		9.00%	[7],[9],[17]	9.00%	[8],[10],[15]	9.00%	[8],[10],[15]
Investment, Interest Rate, Floor		10.00%	[7],[9],[17]	10.00%	[8],[10],[15]	10.00%	[8],[10],[15]
Principal Amount		$ 11,004	[7],[17]	$ 11,032	[8],[15]
Investment cost		10,765	[2],[7],[17]	10,778	[4],[8],[15]
Investments at Fair Value		$ 10,827	[7],[17]	$ 10,793	[8],[15]
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee
Investment Holdings [Line Items]
Maturity Date	[7],[23],[24]	2027-04
Investments Maturity Month and Year	[7],[23],[24]	2027-04
Investment, Basis Spread, Variable Rate	[7],[9],[23],[24]	0.45%
Investment, Interest Rate, Floor	[7],[9],[23],[24]	7.95%
Investment, Interest Rate, Paid in Kind	[7],[9],[23],[24]	2.00%
Principal Amount	[7],[23],[24]	$ 10,500
Investment cost	[2],[7],[23],[24]	10,349
Investments at Fair Value	[7],[23],[24]	$ 10,349
Investment Exit Fee	[7],[9],[23],[24]	3.75%
Investment, Identifier [Axis]: Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-02	[5],[11],[29]	2025-02	[12],[13],[30]	2025-02	[12],[13],[30]
Investments Maturity Month and Year		2025-02	[5],[11],[29]	2025-02	[12],[13],[30]	2025-02	[12],[13],[30]
Investment, Basis Spread, Variable Rate		3.70%	[5],[9],[11],[29]	3.70%	[10],[12],[13],[30]	3.70%	[10],[12],[13],[30]
Investment, Interest Rate, Floor		6.95%	[5],[9],[11],[29]	6.95%	[10],[12],[13],[30]	6.95%	[10],[12],[13],[30]
Investment, Interest Rate, Paid in Kind		1.25%	[5],[9],[11],[29]	1.25%	[10],[12],[13],[30]	1.25%	[10],[12],[13],[30]
Principal Amount		$ 63,384	[5],[11],[29]	$ 63,187	[12],[13],[30]
Investment cost		63,224	[2],[5],[11],[29]	62,640	[4],[12],[30]
Investments at Fair Value		$ 64,281	[5],[11],[29]	$ 63,429	[12],[13],[30]
Investment Exit Fee		5.25%	[5],[9],[11],[29]	5.25%	[10],[12],[13],[30]	5.25%	[10],[12],[13],[30]
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%
Investment Holdings [Line Items]
Maturity Date		2027-12	[7],[17],[23],[24]	2027-12	[8],[15],[25],[26]	2027-12	[8],[15],[25],[26]
Investments Maturity Month and Year		2027-12	[7],[17],[23],[24]	2027-12	[8],[15],[25],[26]	2027-12	[8],[15],[25],[26]
Investment, Basis Spread, Variable Rate		8.03%	[7],[9],[17],[23],[24]	8.03%	[8],[10],[15],[25],[26]	8.03%	[8],[10],[15],[25],[26]
Investment, Interest Rate, Floor		9.03%	[7],[9],[17],[23],[24]	9.03%	[8],[10],[15],[25],[26]	9.03%	[8],[10],[15],[25],[26]
Principal Amount		$ 9,213	[7],[17],[23],[24]	$ 9,000	[8],[15],[25],[26]
Investment cost		9,001	[2],[7],[17],[23],[24]	8,779	[4],[8],[15],[25],[26]
Investments at Fair Value		$ 9,001	[7],[17],[23],[24]	$ 8,779	[8],[15],[25],[26]
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%
Investment Holdings [Line Items]
Maturity Date		2027-05	[7],[17]	2027-05	[8],[15]	2027-05	[8],[15]
Investments Maturity Month and Year		2027-05	[7],[17]	2027-05	[8],[15]	2027-05	[8],[15]
Investment, Basis Spread, Variable Rate		8.31%	[7],[9],[17]	8.31%	[8],[10],[15]	8.31%	[8],[10],[15]
Investment, Interest Rate, Floor		9.31%	[7],[9],[17]	9.31%	[8],[10],[15]	9.31%	[8],[10],[15]
Principal Amount		$ 16,313	[7],[17]	$ 16,313	[8],[15]
Investment cost		16,014	[2],[7],[17]	16,000	[4],[8],[15]
Investments at Fair Value		$ 16,251	[7],[17]	$ 16,072	[8],[15]
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.48%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.48%
Investment cost	[2]	$ 7,336
Investments at Fair Value		$ 7,156
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.50%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.50%		0.50%
Investment cost	[4]			$ 7,222
Investments at Fair Value				$ 7,014
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee
Investment Holdings [Line Items]
Maturity Date		2025-05	[5],[6]	2025-05	[13],[20]	2025-05	[13],[20]
Investments Maturity Month and Year		2025-05	[5],[6]	2025-05	[13],[20]	2025-05	[13],[20]
Investment, Basis Spread, Variable Rate		4.70%	[5],[6],[9]	4.70%	[10],[13],[20]	4.70%	[10],[13],[20]
Investment, Interest Rate, Floor		7.95%	[5],[6],[9]	7.95%	[10],[13],[20]	7.95%	[10],[13],[20]
Investment, Interest Rate, Paid in Kind		1.45%	[5],[6],[9]	1.45%	[10],[13],[20]	1.45%	[10],[13],[20]
Principal Amount		$ 4,052	[5],[6]	$ 4,037	[13],[20]
Investment cost		4,018	[2],[5],[6]	3,985	[4],[13],[20]
Investments at Fair Value		$ 4,048	[5],[6]	$ 4,008	[13],[20]
Investment Exit Fee		3.95%	[5],[6],[9]	3.95%	[10],[13],[20]	3.95%	[10],[13],[20]
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00%
Investment Holdings [Line Items]
Maturity Date		2024-12	[5]	2024-12	[13]	2024-12	[13]
Investments Maturity Month and Year		2024-12	[5]	2024-12	[13]	2024-12	[13]
Investment, Interest Rate, Paid in Kind		10.00%	[5],[9]	10.00%	[10],[13]	10.00%	[10],[13]
Principal Amount		$ 3,318	[5]	$ 3,237	[13]
Investment cost		3,318	[2],[5]	3,237	[4],[13]
Investments at Fair Value		$ 3,108	[5]	$ 3,006	[13]
Investment, Identifier [Axis]: Equity Investments (8.30%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(8.30%)
Investment cost	[2]	$ 143,818
Investments at Fair Value		$ 124,417
Investment, Identifier [Axis]: Equity Investments (9.56%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			9.56%		9.56%
Investment cost	[4]			$ 153,173
Investments at Fair Value				$ 133,972
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.03%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.03%
Investment cost	[2]	$ 663
Investments at Fair Value		473
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.04%		0.04%
Investment cost	[4]			$ 663
Investments at Fair Value				498
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock
Investment Holdings [Line Items]
Investment cost		433	[2],[37]	433	[4],[38]
Investments at Fair Value		$ 27	[37]	$ 24	[38]
Shares | shares		61,300	[37]	61,300	[38]	61,300	[38]
Investments Owned Acquisition Date		Apr. 30, 2021	[37]	Apr. 30, 2021	[38]	Apr. 30, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Investment Holdings [Line Items]
Investment cost		$ 13	[2]	$ 13	[4]
Investments at Fair Value		$ 210		$ 226
Shares | shares		42,137		42,137		42,137
Investments Owned Acquisition Date		Apr. 30, 2010	[37]	Apr. 30, 2010	[38]	Apr. 30, 2010	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 89	[2]	$ 89	[4]
Investments at Fair Value		$ 101		$ 116
Shares | shares		42,989		42,989		42,989
Investments Owned Acquisition Date		Apr. 30, 2010	[37]	Apr. 30, 2010	[38]	Apr. 30, 2010	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 128	[2]	$ 128	[4]
Investments at Fair Value		$ 135		$ 132
Shares | shares		42,989		42,989		42,989
Investments Owned Acquisition Date		Apr. 30, 2010	[37]	Apr. 30, 2010	[38]	Apr. 30, 2010	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.56%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.56%
Investment cost	[2]	$ 13,170
Investments at Fair Value		8,385
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.57%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.57%		0.57%
Investment cost	[4]			$ 13,488
Investments at Fair Value				7,995
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4
Investment Holdings [Line Items]
Investment cost		1,151	[2],[23],[24]	1,151	[4],[25],[26]
Investments at Fair Value		$ 354	[23],[24]	$ 257	[25],[26]
Shares | shares		199,742	[23],[24]	199,742	[25],[26]	199,742	[25],[26]
Investments Owned Acquisition Date		Dec. 15, 2021	[23],[24],[37]	Dec. 15, 2021	[25],[26],[38]	Dec. 15, 2021	[25],[26],[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 945	[2],[37]	$ 945	[4],[38]
Investments at Fair Value		$ 5,211	[37]	$ 4,003	[38]
Shares | shares		81,996	[37]	81,996	[38]	81,996	[38]
Investments Owned Acquisition Date		Dec. 20, 2018	[37]	Dec. 20, 2018	[38]	Dec. 20, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 5,263	[2],[37]	$ 5,263	[4],[38]
Investments at Fair Value		$ 934	[37]	$ 1,110	[38]
Shares | shares		100,738	[37]	100,738	[38]	100,738	[38]
Investments Owned Acquisition Date		Dec. 26, 2018	[37]	Dec. 26, 2018	[38]	Dec. 26, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2],[37]	$ 1,000	[4],[38]
Investments at Fair Value		$ 418	[37]	$ 225	[38]
Shares | shares		100,000	[37]	100,000	[38]	100,000	[38]
Investments Owned Acquisition Date		Sep. 17, 2021	[37]	Sep. 17, 2021	[38]	Sep. 17, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A
Investment Holdings [Line Items]
Investment cost		$ 1,663	[2]	$ 1,663	[4]
Investments at Fair Value		$ 383		$ 372
Shares | shares		286,080		286,080		286,080
Investments Owned Acquisition Date		Oct. 25, 2016	[37]	Oct. 25, 2016	[38]	Oct. 25, 2016	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Investment Holdings [Line Items]
Investment cost		$ 632	[2]	$ 632	[4]
Investments at Fair Value		$ 146		$ 141
Shares | shares		108,710		108,710		108,710
Investments Owned Acquisition Date		Oct. 25, 2016	[37]	Oct. 25, 2016	[38]	Oct. 25, 2016	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 577	[2],[37]	$ 577	[4],[38]
Investments at Fair Value		$ 187	[37]	$ 266	[38]
Shares | shares		48,365	[37]	48,365	[38]	48,365	[38]
Investments Owned Acquisition Date		Jun. 28, 2013	[37]	Jun. 28, 2013	[38]	Jun. 28, 2013	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Acquisition Date 7/31/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 39	[2]	$ 39	[4]
Investments at Fair Value		$ 0
Shares | shares		3,095		3,095		3,095
Investments Owned Acquisition Date		Jul. 31, 2020	[37]	Jul. 31, 2020	[38]	Jul. 31, 2020	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-2
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2]	$ 1,000	[4]
Investments at Fair Value		$ 752		$ 805
Shares | shares		7,063		7,063		7,063
Investments Owned Acquisition Date		Jan. 24, 2022	[37]	Jan. 24, 2022	[38]	Jan. 24, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Acquisition Date 5/23/2018, Series Common Stock
Investment Holdings [Line Items]
Investments at Fair Value
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 900	[2],[31]	$ 900	[4],[33]
Investments at Fair Value	[31]	$ 0
Shares | shares		414,994,863	[31]	414,994,863	[33]	414,994,863	[33]
Investments Owned Acquisition Date		May 23, 2018	[31],[37]	May 23, 2018	[33],[38]	May 23, 2018	[33],[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB
Investment Holdings [Line Items]
Investment cost		$ 0	[2],[31]	$ 0	[4],[33]
Investments at Fair Value
Shares | shares		1,000,000	[31]	1,000,000	[33]	1,000,000	[33]
Investments Owned Acquisition Date		Jun. 06, 2016	[31],[37]	Jun. 06, 2016	[33],[38]	Jun. 06, 2016	[33],[38]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc.
Investment Holdings [Line Items]
Investment cost		$ 2,295	[2]	$ 2,295	[4]
Investments at Fair Value		$ 529		$ 513
Shares | shares		394,790		394,790		394,790
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation
Investment Holdings [Line Items]
Investment cost		$ 900	[2]	$ 900	[4]
Investments at Fair Value		$ 0
Shares | shares		415,994,863		415,994,863		415,994,863
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Uber Technologies, Inc., Acquisition Date 12/1/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 318
Investments at Fair Value	[38]			$ 816
Shares | shares	[38]			32,991		32,991
Investments Owned Acquisition Date	[38]			Dec. 01, 2020		Dec. 01, 2020
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.49%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.49%		2.49%
Investment cost	[4]			$ 28,444
Investments at Fair Value				34,869
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.75%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	2.75%
Investment cost	[2]	$ 28,444
Investments at Fair Value		41,191
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		1,884	[2],[31]	1,884	[4],[33]
Investments at Fair Value		$ 1,170	[31]	$ 1,107	[33]
Shares | shares		830,000	[31]	830,000	[33]	830,000	[33]
Investments Owned Acquisition Date		Mar. 01, 2018	[31],[37]	Mar. 01, 2018	[33],[38]	Mar. 01, 2018	[33],[38]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A
Investment Holdings [Line Items]
Investment cost		$ 26,122	[2],[31]	$ 26,122	[4],[33]
Investments at Fair Value		$ 14,942	[31]	$ 14,137	[33]
Shares | shares		10,602,752	[31]	10,602,752	[33]	10,602,752	[33]
Investments Owned Acquisition Date		Mar. 01, 2018	[31],[37]	Mar. 01, 2018	[33],[38]	Mar. 01, 2018	[33],[38]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units
Investment Holdings [Line Items]
Investment cost		$ 35	[2],[31]	$ 35	[4],[33]
Investments at Fair Value		$ 24,595	[31]	$ 19,153	[33]
Shares | shares		1	[31]	1	[33]	1	[33]
Investments Owned Acquisition Date		Mar. 26, 2021	[31],[37]	Mar. 26, 2021	[33],[38]	Mar. 26, 2021	[33],[38]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Investment Holdings [Line Items]
Investment cost		$ 403	[2]	$ 403	[4]
Investments at Fair Value		$ 484		$ 472
Shares | shares		210,282		210,282		210,282
Investments Owned Acquisition Date		Sep. 30, 2021	[37]	Sep. 30, 2021	[38]	Sep. 30, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC
Investment Holdings [Line Items]
Investment cost		$ 28,006	[2]	$ 28,006	[4]
Investments at Fair Value		$ 16,112		$ 15,244
Shares | shares		11,432,752		11,432,752		11,432,752
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.00%
Investment cost	[2]	$ 3,638
Investments at Fair Value		23
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.01%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.01%		0.01%
Investment cost	[4]			$ 3,638
Investments at Fair Value				89
Investment, Identifier [Axis]: Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		1,329	[2],[37]	1,329	[4],[38]
Investments at Fair Value		$ 6	[37]	$ 20	[38]
Shares | shares		8,836	[37]	8,836	[38]	8,836	[38]
Investments Owned Acquisition Date		Dec. 10, 2018	[37]	Dec. 10, 2018	[38]	Dec. 10, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,500	[2],[37]	$ 1,500	[4],[38]
Investments at Fair Value		$ 2	[37]	$ 3	[38]
Shares | shares		680	[37]	13,600	[38]	13,600	[38]
Investments Owned Acquisition Date		Mar. 28, 2014	[37]	Mar. 28, 2014	[38]	Mar. 28, 2014	[38]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 500	[2]	$ 500	[4]
Investments at Fair Value				$ 33
Shares | shares		165,000		165,000		165,000
Investments Owned Acquisition Date		Dec. 08, 2015	[37]	Dec. 08, 2015	[38]	Dec. 08, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 309	[2],[37]	$ 309	[4],[38]
Investments at Fair Value		$ 15	[37]	$ 33	[38]
Shares | shares		2,498	[37]	2,498	[38]	2,498	[38]
Investments Owned Acquisition Date		Apr. 06, 2015	[37]	Apr. 06, 2015	[38]	Apr. 06, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (1.96%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	1.96%
Investment cost	[2]	$ 38,889
Investments at Fair Value		29,396
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.66%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.66%		2.66%
Investment cost	[4]			$ 43,971
Investments at Fair Value				37,315
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[25],[38]			1,000
Investments at Fair Value	[25],[38]			$ 2,108
Shares | shares	[25],[38]			38,461		38,461
Investments Owned Acquisition Date	[25],[38]			Sep. 19, 2022		Sep. 19, 2022
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[25],[38]			$ 1,000
Investments at Fair Value	[25],[38]			$ 540
Shares | shares	[25],[38]			25,000		25,000
Investments Owned Acquisition Date	[25],[38]			Sep. 14, 2020		Sep. 14, 2020
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 42	[2],[23],[37]	$ 42	[4],[25],[38]
Investments at Fair Value	[25],[38]			$ 0
Shares | shares		1,000	[23],[37]	1,000	[25],[38]	1,000	[25],[38]
Investments Owned Acquisition Date		Apr. 06, 2021	[23],[37]	Apr. 06, 2021	[25],[38]	Apr. 06, 2021	[25],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2],[37]	$ 1,000	[4],[38]
Investments at Fair Value		$ 17	[37]	$ 50	[38]
Shares | shares		9,923	[37]	9,924	[38]	9,924	[38]
Investments Owned Acquisition Date		Aug. 19, 2014	[37]	Aug. 19, 2014	[38]	Aug. 19, 2014	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 1,715
Investments at Fair Value	[38]			$ 2,843
Shares | shares	[38]			190,179		190,179
Investments Owned Acquisition Date	[38]			Jul. 31, 2011		Jul. 31, 2011
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 4,165	[2],[19],[23],[37]	$ 4,165	[4],[22],[25],[38]
Investments at Fair Value		$ 7,835	[19],[23],[37]	$ 9,797	[22],[25],[38]
Shares | shares		127,021	[19],[23],[37]	127,021	[22],[25],[38]	127,021	[22],[25],[38]
Investments Owned Acquisition Date		May 09, 2022	[19],[23],[37]	May 09, 2022	[22],[25],[38]	May 09, 2022	[22],[25],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,871	[2],[23],[24],[37]	$ 1,871	[4],[25],[26],[38]
Investments at Fair Value		$ 2,087	[23],[24],[37]	$ 2,904	[25],[26],[38]
Shares | shares		98,100	[23],[24],[37]	98,100	[25],[26],[38]	98,100	[25],[26],[38]
Investments Owned Acquisition Date		Oct. 05, 2020	[23],[24],[37]	Oct. 05, 2020	[26],[38]	Oct. 05, 2020	[26],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[2],[37]	$ 2,255
Investments at Fair Value	[37]	$ 3,836
Shares | shares	[37]	231,329
Investments Owned Acquisition Date	[37]	Jun. 21, 2018
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[25],[38]			$ 1,367
Investments at Fair Value	[25],[38]			$ 413
Shares | shares	[25],[38]			70,796		70,796
Investments Owned Acquisition Date	[25],[38]			Feb. 13, 2019		Feb. 13, 2019
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 1,000
Investments at Fair Value	[38]			$ 11
Shares | shares	[38]			13,550		13,550
Investments Owned Acquisition Date	[38]			Jan. 08, 2015		Jan. 08, 2015
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 550	[2],[23],[37]	$ 550	[4],[25],[38]
Investments at Fair Value		$ 196	[23],[37]	$ 213	[25],[38]
Shares | shares		20,000	[23],[37]	20,000	[25],[38]	20,000	[25],[38]
Investments Owned Acquisition Date		Jul. 22, 2015	[23],[37]	Jul. 22, 2015	[25],[38]	Jul. 22, 2015	[25],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2],[37]	$ 1,000	[4],[38]
Investments at Fair Value		$ 1,230	[37]	$ 1,527	[38]
Shares | shares		442,477	[37]	442,477	[38]	442,477	[38]
Investments Owned Acquisition Date		Oct. 26, 2022	[37]	Oct. 26, 2022	[38]	Oct. 26, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 4,250	[2],[29]	$ 4,250	[4],[30]
Investments at Fair Value		$ 1,979	[29]	$ 2,233	[30]
Shares | shares		3,466,840	[29]	3,466,840	[30]	3,466,840	[30]
Investments Owned Acquisition Date		May 07, 2021	[29],[37]	May 07, 2021	[30],[38]	May 07, 2021	[30],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 4,000	[2],[37]	$ 4,000	[4],[38]
Investments at Fair Value		$ 3,889	[37]	$ 3,937	[38]
Shares | shares		235,295	[37]	235,295	[38]	235,295	[38]
Investments Owned Acquisition Date		May 03, 2022	[37]	May 03, 2022	[38]	May 03, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 800	[2],[23],[37]	$ 800	[4],[25],[38]
Investments at Fair Value		$ 6	[23],[37]	$ 5	[25],[38]
Shares | shares		43,243	[23],[37]	43,243	[25],[38]	43,243	[25],[38]
Investments Owned Acquisition Date		Mar. 31, 2021	[23],[37]	Mar. 31, 2021	[25],[38]	Mar. 31, 2021	[25],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 2,000	[2],[23],[24]	$ 2,000	[4],[25],[26]
Investments at Fair Value		$ 1,476	[23],[24]	$ 1,476	[25],[26]
Shares | shares		983	[23],[24]	983	[25],[26]	983	[25],[26]
Investments Owned Acquisition Date		Dec. 15, 2021	[23],[24],[37]	Dec. 15, 2021	[25],[26],[38]	Dec. 15, 2021	[25],[26],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 2,744	[2],[37]	$ 2,744	[4],[38]
Investments at Fair Value		$ 194	[37]	$ 143	[38]
Shares | shares		76,362	[37]	76,362	[38]	76,362	[38]
Investments Owned Acquisition Date		Feb. 26, 2007	[37]	Feb. 26, 2007	[38]	Feb. 26, 2007	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,500	[2],[37]	$ 1,500	[4],[38]
Investments at Fair Value		$ 16	[37]	$ 18	[38]
Shares | shares		944	[37]	944	[38]	944	[38]
Investments Owned Acquisition Date		Aug. 22, 2007	[37]	Aug. 22, 2007	[38]	Aug. 22, 2007	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 203	[2],[37]	$ 203	[4],[38]
Investments at Fair Value		$ 22	[37]	$ 17	[38]
Shares | shares		11,119	[37]	11,119	[38]	11,119	[38]
Investments Owned Acquisition Date		Aug. 11, 2015	[37]	Aug. 11, 2015	[38]	Aug. 11, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,269	[2],[37]	$ 1,269	[4],[38]
Investments at Fair Value		$ 7	[37]	$ 7	[38]
Shares | shares		16,228	[37]	16,228	[38]	16,228	[38]
Investments Owned Acquisition Date		Feb. 02, 2017	[37]	Feb. 02, 2017	[38]	Feb. 02, 2017	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 2,100	[2],[23],[37]	$ 2,100	[4],[25],[38]
Investments at Fair Value		$ 1,955	[23],[37]	$ 2,280	[25],[38]
Shares | shares		155,555	[23],[37]	155,555	[25],[38]	155,555	[25],[38]
Investments Owned Acquisition Date		May 05, 2022	[23],[37]	May 05, 2022	[25],[38]	May 05, 2022	[25],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 863	[2]	$ 863	[4],[38]
Investments at Fair Value	[38]			$ 11
Shares | shares		68,816		68,816	[38]	68,816	[38]
Investments Owned Acquisition Date		Feb. 28, 2018	[37]	Feb. 28, 2018	[38]	Feb. 28, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2]	$ 1,000	[4]
Investments at Fair Value		$ 985		$ 1,012
Shares | shares		170,102		170,102		170,102
Investments Owned Acquisition Date		Oct. 31, 2022	[37]	Oct. 31, 2022	[38]	Oct. 31, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 3,000	[2]	$ 3,000	[4]
Investments at Fair Value		$ 1,944		$ 2,063
Shares | shares		510,308		510,308		510,308
Investments Owned Acquisition Date		Dec. 11, 2020	[37]	Dec. 11, 2020	[38]	Dec. 11, 2020	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 2,945	[2],[37]	$ 2,945	[4],[38]
Investments at Fair Value		$ 1,362	[37]	$ 1,555	[38]
Shares | shares		1,566,064	[37]	1,566,064	[38]	1,566,064	[38]
Investments Owned Acquisition Date		Nov. 26, 2019	[37]	Nov. 26, 2019	[38]	Nov. 26, 2019	[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 332	[2],[23],[24],[37]	$ 332	[4],[22],[25],[26],[38]
Investments at Fair Value		$ 346	[23],[24],[37]	$ 389	[22],[25],[26],[38]
Shares | shares		17,175	[23],[24],[37]	17,175	[22],[25],[26],[38]	17,175	[22],[25],[26],[38]
Investments Owned Acquisition Date		Jan. 31, 2019	[23],[24],[37]	Jan. 31, 2019	[22],[25],[26],[38]	Jan. 31, 2019	[22],[25],[26],[38]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Valo Health LLC
Investment Holdings [Line Items]
Investment cost		$ 4,000	[2]	$ 4,000	[4]
Investments at Fair Value		$ 2,929		$ 3,075
Shares | shares		680,410		680,410		680,410
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.09%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.09%
Investment cost	[2]	$ 2,150
Investments at Fair Value		1,347
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.11%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.11%		0.11%
Investment cost	[4]			$ 2,150
Investments at Fair Value				1,521
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F
Investment Holdings [Line Items]
Investment cost		650	[2]	650	[4]
Investments at Fair Value		$ 564		$ 606
Shares | shares		15,116		15,116		15,116
Investments Owned Acquisition Date		Nov. 17, 2022	[37]	Nov. 17, 2022	[38]	Nov. 17, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 1,500	[2]	$ 1,500	[4]
Investments at Fair Value		$ 783		$ 915
Shares | shares		248,900		248,900		248,900
Investments Owned Acquisition Date		Mar. 08, 2022	[37]	Mar. 08, 2022	[38]	Mar. 08, 2022	[38]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.19%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.19%
Investment cost	[2]	$ 6,782
Investments at Fair Value		2,868
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.21%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.21%		0.21%
Investment cost	[4]			$ 6,781
Investments at Fair Value				2,894
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock
Investment Holdings [Line Items]
Investment cost		5,094	[2],[37]	5,094	[4],[38]
Investments at Fair Value		$ 1,883	[37]	$ 1,784	[38]
Shares | shares		825,732	[37]	825,732	[38]	825,732	[38]
Investments Owned Acquisition Date		Mar. 11, 2019	[37]	Mar. 11, 2019	[38]	Mar. 11, 2019	[38]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 1,688	[2]	$ 1,687	[4]
Investments at Fair Value		$ 985		$ 1,110
Shares | shares		217,880		217,880		217,880
Investments Owned Acquisition Date		Mar. 30, 2021	[37]	Mar. 30, 2021	[38]	Mar. 30, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Information Services (0.40%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.40%
Investment cost	[2]	$ 4,440
Investments at Fair Value		6,012
Investment, Identifier [Axis]: Equity Investments Information Services (0.58%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.58%		0.58%
Investment cost	[4]			$ 4,440
Investments at Fair Value				8,175
Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock
Investment Holdings [Line Items]
Investment cost		615	[2],[37]	615	[4],[38]
Investments at Fair Value		$ 2,153	[37]	$ 2,383	[38]
Shares | shares		547,880	[37]	547,880	[38]	547,880	[38]
Investments Owned Acquisition Date		Jun. 21, 2019	[37]	Jun. 21, 2019	[38]	Jun. 21, 2019	[38]
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 3,825	[2]	$ 3,825	[4]
Investments at Fair Value		$ 3,859		$ 3,375
Shares | shares		41,021		41,021		41,021
Investments Owned Acquisition Date		Dec. 30, 2021	[37]	Dec. 30, 2021	[38]	Dec. 30, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 0
Investments at Fair Value	[38]			$ 2,417
Shares | shares	[38]			295,861		295,861
Investments Owned Acquisition Date	[38]			Nov. 20, 2007		Nov. 20, 2007
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.04%
Investment cost	[2]	$ 2,953
Investments at Fair Value		625
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.07%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.07%		0.07%
Investment cost	[4]			$ 2,953
Investments at Fair Value				915
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units
Investment Holdings [Line Items]
Investment cost	[4],[33]			0
Investments at Fair Value		$ 3	[31]	$ 6	[33]
Shares | shares		180,000	[31]	180,000	[33]	180,000	[33]
Investments Owned Acquisition Date		Oct. 15, 2021	[31],[37]	Oct. 15, 2021	[33],[38]	Oct. 15, 2021	[33],[38]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Investment Holdings [Line Items]
Investment cost	[2],[31]	$ 250
Investments at Fair Value	[31]	$ 253
Shares | shares	[31]	5,000,000
Investments Owned Acquisition Date	[31],[37]	Oct. 15, 2021
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA
Investment Holdings [Line Items]
Investment cost		$ 1,500	[2]	$ 1,499	[4]
Investments at Fair Value
Shares | shares		221,893		221,893		221,893
Investments Owned Acquisition Date		Nov. 03, 2014	[37]	Nov. 03, 2014	[38]	Nov. 03, 2014	[38]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 871	[2],[37]	$ 871	[4],[38]
Investments at Fair Value		$ 243	[37]	$ 433	[38]
Shares | shares		1,490,700	[37]	1,490,700	[38]	1,490,700	[38]
Investments Owned Acquisition Date		Nov. 30, 2009	[37]	Nov. 30, 2009	[38]	Nov. 30, 2009	[38]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 332	[2],[37]	$ 333	[4],[38]
Investments at Fair Value		$ 126	[37]	$ 163	[38]
Shares | shares		36,457	[37]	36,457	[38]	36,457	[38]
Investments Owned Acquisition Date		Dec. 16, 2013	[37]	Dec. 16, 2013	[38]	Dec. 16, 2013	[38]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC
Investment Holdings [Line Items]
Investment cost		$ 250	[2]	$ 250	[4]
Investments at Fair Value		$ 256		$ 319
Shares | shares		5,180,000		5,180,000		5,180,000
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.01%		0.01%
Investment cost	[4]			$ 160
Investments at Fair Value				205
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	0.02%
Investment cost	[2]	$ 160
Investments at Fair Value		296
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		160	[2]	160	[4]
Investments at Fair Value		$ 296		$ 205
Shares | shares		277,995		277,995		277,995
Investments Owned Acquisition Date		Jul. 01, 2011	[37]	Jul. 01, 2011	[38]	Jul. 01, 2011	[38]
Investment, Identifier [Axis]: Equity Investments Software (1.66%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(1.66%)
Investment cost	[2]	$ 28,542
Investments at Fair Value		24,838
Investment, Identifier [Axis]: Equity Investments Software (2.07%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.07%		2.07%
Investment cost	[4]			$ 32,498
Investments at Fair Value				28,966
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock
Investment Holdings [Line Items]
Investment cost		1,000	[2]	1,000	[4]
Investments at Fair Value		$ 911		$ 793
Shares | shares		1,000,000		1,000,000		1,000,000
Investments Owned Acquisition Date		Aug. 09, 2021	[37]	Aug. 09, 2021	[38]	Aug. 09, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note
Investment Holdings [Line Items]
Investment cost		$ 2,792	[2],[39]	$ 3,000	[4],[40]
Investments at Fair Value		$ 2,793	[39]	$ 3,000	[40]
Shares | shares		3	[39]	3	[40]	3	[40]
Investments Owned Acquisition Date		Mar. 24, 2021	[37],[39]	Mar. 24, 2021	[38],[40]	Mar. 24, 2021	[38],[40]
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3
Investment Holdings [Line Items]
Investment cost		$ 51	[2]	$ 51	[4]
Investments at Fair Value		$ 0		$ 6
Shares | shares		53,614		53,614		53,614
Investments Owned Acquisition Date		Oct. 26, 2012	[37]	Oct. 26, 2012	[38]	Oct. 26, 2012	[38]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 500	[2],[23],[24]	$ 500	[4],[25],[26]
Investments at Fair Value		$ 660	[23],[24]	$ 732	[25],[26]
Shares | shares		108,500	[23],[24]	108,500	[25],[26]	108,500	[25],[26]
Investments Owned Acquisition Date		Nov. 20, 2018	[23],[24],[37]	Nov. 20, 2018	[25],[26],[38]	Nov. 20, 2018	[25],[26],[38]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 138	[2],[23],[24]	$ 138	[4],[25],[26]
Investments at Fair Value		$ 233	[23],[24]	$ 258	[25],[26]
Shares | shares		41,000	[23],[24]	41,000	[25],[26]	41,000	[25],[26]
Investments Owned Acquisition Date		Dec. 22, 2020	[23],[24],[37]	Dec. 22, 2020	[25],[26],[38]	Dec. 22, 2020	[25],[26],[38]
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 4,284	[2]	$ 4,284	[4]
Investments at Fair Value		$ 545		$ 503
Shares | shares		20,000		20,000		20,000
Investments Owned Acquisition Date		Nov. 29, 2018	[37]	Nov. 29, 2018	[38]	Nov. 29, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2
Investment Holdings [Line Items]
Investment cost		$ 1,000	[2]	$ 1,000	[4]
Investments at Fair Value		$ 1,639		$ 1,764
Shares | shares		458,841		458,841		458,841
Investments Owned Acquisition Date		Oct. 22, 2015	[37]	Oct. 22, 2015	[38]	Oct. 22, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3
Investment Holdings [Line Items]
Investment cost		$ 300	[2]	$ 300	[4]
Investments at Fair Value		$ 365		$ 395
Shares | shares		93,620		93,620		93,620
Investments Owned Acquisition Date		Aug. 24, 2017	[37]	Aug. 24, 2017	[38]	Aug. 24, 2017	[38]
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 307	[2]	$ 307	[4]
Investments at Fair Value
Shares | shares		190		190		190
Investments Owned Acquisition Date		Jan. 18, 2013	[37]	Jan. 18, 2013	[38]	Jan. 18, 2013	[38]
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 265	[2]	$ 265	[4]
Investments at Fair Value		$ 21		$ 24
Shares | shares		38,461		38,461		38,461
Investments Owned Acquisition Date		Dec. 04, 2020	[37]	Dec. 04, 2020	[38]	Dec. 04, 2020	[38]
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 4,854	[2],[37]	$ 4,854	[4],[38]
Investments at Fair Value		$ 2,191	[37]	$ 2,100	[38]
Shares | shares		1,019,255	[37]	1,019,255	[38]	1,019,255	[38]
Investments Owned Acquisition Date		Aug. 01, 2018	[37]	Aug. 01, 2018	[38]	Aug. 01, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 8,670	[2],[37]	$ 8,670	[4],[38]
Investments at Fair Value		$ 11,985	[37]	$ 9,106	[38]
Shares | shares		1,418,337	[37]	1,418,337	[38]	1,418,337	[38]
Investments Owned Acquisition Date		Sep. 23, 2020	[37]	Sep. 23, 2020	[38]	Sep. 23, 2020	[38]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 2,000	[2]	$ 2,000	[4]
Investments at Fair Value		$ 2,039		$ 1,940
Shares | shares		580,983		580,983		580,983
Investments Owned Acquisition Date		Nov. 25, 2020	[37]	Nov. 25, 2020	[38]	Nov. 25, 2020	[38]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F
Investment Holdings [Line Items]
Investment cost		$ 280	[2]	$ 280	[4]
Investments at Fair Value		$ 225		$ 221
Shares | shares		52,956		52,956		52,956
Investments Owned Acquisition Date		Aug. 12, 2021	[37]	Aug. 12, 2021	[38]	Aug. 12, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 3,748
Investments at Fair Value	[38]			$ 5,719
Shares | shares	[38]			700,000		700,000
Investments Owned Acquisition Date	[38]			Mar. 22, 2017		Mar. 22, 2017
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 2,000	[2]	$ 2,000	[4]
Investments at Fair Value		$ 808		$ 1,023
Shares | shares		952,562		952,562		952,562
Investments Owned Acquisition Date		Jul. 08, 2021	[37]	Jul. 08, 2021	[38]	Jul. 08, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 101	[2],[37]	$ 101	[4],[38],[41]
Investments at Fair Value		$ 423	[37]	$ 1,382	[38],[41]
Shares | shares		289,992	[37]	289,992	[38],[41]	289,992	[38],[41]
Investments Owned Acquisition Date		May 07, 2020	[37]	May 07, 2020	[38],[41]	May 07, 2020	[38],[41]
Investment, Identifier [Axis]: Equity Investments Software, Contentful Global, Inc.
Investment Holdings [Line Items]
Investment cost		$ 638	[2]	$ 638	[4]
Investments at Fair Value		$ 893		$ 990
Shares | shares		149,500		149,500		149,500
Investment, Identifier [Axis]: Equity Investments Software, Druva Holdings, Inc.
Investment Holdings [Line Items]
Investment cost		$ 1,300	[2]	$ 1,300	[4]
Investments at Fair Value		$ 2,004		$ 2,159
Shares | shares		552,461		552,461		552,461
Investment, Identifier [Axis]: Equity Investments Software, SingleStore, Inc.
Investment Holdings [Line Items]
Investment cost		$ 2,280	[2]	$ 2,280	[4]
Investments at Fair Value		$ 2,264		$ 2,161
Shares | shares		633,939		633,939		633,939
Investment, Identifier [Axis]: Equity Investments Surgical Devices (0.18%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.18%		0.18%
Investment cost	[4]			$ 2,479
Investments at Fair Value				2,546
Investment, Identifier [Axis]: Equity Investments Surgical Devices (0.24%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.24%)
Investment cost	[2]	$ 2,479
Investments at Fair Value		3,592
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B
Investment Holdings [Line Items]
Investment cost		250	[2]	250	[4]
Investments at Fair Value		$ 0
Shares | shares		219,298		219,298		219,298
Investments Owned Acquisition Date		Jan. 18, 2007	[37]	Jan. 18, 2007	[38]	Jan. 18, 2007	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F
Investment Holdings [Line Items]
Investment cost		$ 118	[2]	$ 118	[4]
Investments at Fair Value		$ 0
Shares | shares		1,523,693		1,523,693		1,523,693
Investments Owned Acquisition Date		Dec. 18, 2018	[37]	Dec. 18, 2018	[38]	Dec. 18, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-1
Investment Holdings [Line Items]
Investment cost		$ 150	[2]	$ 150	[4]
Investments at Fair Value		$ 0
Shares | shares		2,418,125		2,418,125		2,418,125
Investments Owned Acquisition Date		Dec. 18, 2018	[37]	Dec. 18, 2018	[38]	Dec. 18, 2018	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 712	[2]	$ 712	[4]
Investments at Fair Value		$ 0
Shares | shares		1,991,157		1,991,157		1,991,157
Investments Owned Acquisition Date		Feb. 08, 2013	[37]	Feb. 08, 2013	[38]	Feb. 08, 2013	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 282	[2]	$ 282	[4]
Investments at Fair Value		$ 0
Shares | shares		656,538		656,538		656,538
Investments Owned Acquisition Date		Jun. 16, 2010	[37]	Jun. 16, 2010	[38]	Jun. 16, 2010	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 429	[2]	$ 429	[4]
Investments at Fair Value		$ 0
Shares | shares		2,786,367		2,786,367		2,786,367
Investments Owned Acquisition Date		Jul. 14, 2015	[37]	Jul. 14, 2015	[38]	Jul. 14, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 538	[2],[37],[42]	$ 538	[4],[38]
Investments at Fair Value		$ 3,592	[37],[42]	$ 2,546	[38]
Shares | shares		50,000	[37],[42]	50,000	[38]	50,000	[38]
Investments Owned Acquisition Date		Nov. 07, 2012	[37],[42]	Nov. 07, 2012	[38]	Nov. 07, 2012	[38]
Investment, Identifier [Axis]: Equity Investments Surgical Devices, Gynesonics, Inc.
Investment Holdings [Line Items]
Investment cost		$ 1,941	[2]	$ 1,941	[4]
Investments at Fair Value		$ 0
Shares | shares		9,595,178		9,595,178		9,595,178
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.36%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.36%)
Investment cost	[2]	$ 11,508
Investments at Fair Value		5,371
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.57%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.57%		0.57%
Investment cost	[4]			$ 11,508
Investments at Fair Value				7,984
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1
Investment Holdings [Line Items]
Investment cost		711	[2]	711	[4]
Investments at Fair Value		$ 985		$ 995
Shares | shares		187,265		187,265		187,265
Investments Owned Acquisition Date		Sep. 13, 2012	[37]	Sep. 13, 2012	[38]	Sep. 13, 2012	[38]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1
Investment Holdings [Line Items]
Investment cost		$ 2,000	[2]	$ 2,000	[4]
Investments at Fair Value		$ 865		$ 2,173
Shares | shares		188,611		188,611		188,611
Investments Owned Acquisition Date		May 10, 2019	[37]	May 10, 2019	[38]	May 10, 2019	[38]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 500	[2]	$ 500	[4]
Investments at Fair Value
Shares | shares		1,035		1,035		1,035
Investments Owned Acquisition Date		Jun. 01, 2015	[37]	Jun. 01, 2015	[38]	Jun. 01, 2015	[38]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units
Investment Holdings [Line Items]
Investment cost		$ 102	[2]	$ 102	[4]
Investments at Fair Value
Shares | shares		59,665		59,665		59,665
Investments Owned Acquisition Date		Aug. 31, 2013	[37]	Aug. 31, 2013	[38]	Aug. 31, 2013	[38]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 3,153	[2],[37]	$ 3,153	[4],[38],[41]
Investments at Fair Value		$ 484	[37]	$ 634	[38],[41]
Shares | shares		304,487	[37]	304,486	[38],[41]	304,486	[38],[41]
Investments Owned Acquisition Date		Dec. 10, 2020	[37]	Dec. 10, 2020	[38],[41]	Dec. 10, 2020	[38],[41]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 4,500	[2]	$ 4,500	[4]
Investments at Fair Value		$ 2,341		$ 2,456
Shares | shares		593,080		593,080		593,080
Investments Owned Acquisition Date		Jun. 28, 2021	[37]	Jun. 28, 2021	[38]	Jun. 28, 2021	[38]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost		$ 542	[2],[37]	$ 542	[4],[38]
Investments at Fair Value		$ 696	[37]	$ 1,726	[38]
Shares | shares		457,841	[37]	457,841	[38]	457,841	[38]
Investments Owned Acquisition Date		May 28, 2015	[37]	May 28, 2015	[38]	May 28, 2015	[38]
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 2,255
Investments at Fair Value	[38]			$ 1,763
Shares | shares	[38]			231,329		231,329
Investments Owned Acquisition Date	[38]			Jun. 21, 2018		Jun. 21, 2018
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Investment Holdings [Line Items]
Investment cost	[2],[37]	$ 1,000
Investments at Fair Value	[37]	$ 14
Shares | shares	[37]	13,550
Investments Owned Acquisition Date	[37]	Jan. 08, 2015
Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Investment Holdings [Line Items]
Investment cost	[4],[33]			$ 250
Investments at Fair Value	[33]			$ 313
Shares | shares	[33]			5,000,000		5,000,000
Investments Owned Acquisition Date	[33],[38]			Oct. 15, 2021		Oct. 15, 2021
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.26%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.26%)
Investment cost	[2]	$ 3,807
Investments at Fair Value		$ 3,900
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.28%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.28%		0.28%
Investment cost	[4]			$ 3,499
Investments at Fair Value				$ 3,893
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.24%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.24%)
Investment cost	[2]	$ 3,426
Investments at Fair Value		3,550
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.25%		0.25%
Investment cost	[4]			$ 3,118
Investments at Fair Value				3,518
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020
Investment Holdings [Line Items]
Investment cost		3,007	[2],[7],[23],[24]	2,699	[4],[8],[25],[26]
Investments at Fair Value		$ 3,103	[7],[23],[24]	$ 3,080	[8],[25],[26]
Investments Owned Acquisition Date		Nov. 16, 2020	[7],[23],[24],[37]	Nov. 16, 2020	[8],[25],[26],[38]	Nov. 16, 2020	[8],[25],[26],[38]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022
Investment Holdings [Line Items]
Investment cost		$ 419	[2],[7],[23],[24]	$ 419	[4],[8],[25],[26]
Investments at Fair Value		$ 447	[7],[23],[24]	$ 438	[8],[25],[26]
Investments Owned Acquisition Date		Jun. 23, 2022	[7],[23],[24],[37]	Jun. 23, 2022	[8],[25],[26],[38]	Jun. 23, 2022	[8],[25],[26],[38]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.02%)
Investment cost	[2]	$ 381
Investments at Fair Value		350
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.03%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.03%		0.03%
Investment cost	[4]			$ 381
Investments at Fair Value				$ 375
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Investment Holdings [Line Items]
Investment cost	[2],[23],[24]	381
Investments at Fair Value	[23],[24]	$ 350
Investments Owned Acquisition Date	[23],[24],[37]	Jul. 21, 2022
Investment, Identifier [Axis]: Investments (208.82%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(208.82%)
Investment cost	[2]	$ 3,150,846
Investments at Fair Value		$ 3,130,178
Investment, Identifier [Axis]: Investments (211.49%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			211.49%		211.49%
Investment cost	[4]			$ 3,005,696
Investments at Fair Value				$ 2,963,955
Investment, Identifier [Axis]: Investments after Cash and Cash Equivalents (209.82%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(209.82%)
Investment cost	[2]	$ 3,165,846
Investments at Fair Value		$ 3,145,178
Investment, Identifier [Axis]: Investments in Securities (208.56%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(208.56%)
Investment cost	[2]	$ 3,147,039
Investments at Fair Value		$ 3,126,278
Investment, Identifier [Axis]: Investments in Securities (211.21%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			211.21%		211.21%
Investment cost	[4]			$ 3,002,197
Investments at Fair Value				$ 2,960,062
Investment, Identifier [Axis]: Warrant Investments (2.19%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			2.19%		2.19%
Investment cost	[4]			$ 30,964
Investments at Fair Value				$ 30,646
Investment, Identifier [Axis]: Warrant Investments (2.22%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(2.22%)
Investment cost	[2]	$ 31,723
Investments at Fair Value		$ 33,210
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.03%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.03%)	[1]	0.03%	[3]	0.03%	[3]
Investment cost		$ 485	[2]	$ 485	[4]
Investments at Fair Value		505		486
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B
Investment Holdings [Line Items]
Investment cost		24	[2]	24	[4]
Investments at Fair Value		$ 23		$ 23
Shares | shares		15,399		15,399		15,399
Investments Owned Acquisition Date		Jun. 21, 2022	[37]	Jun. 21, 2022	[38]	Jun. 21, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 461	[2]	$ 461	[4]
Investments at Fair Value		$ 482		$ 463
Shares | shares		53,418		53,418		53,418
Investments Owned Acquisition Date		Dec. 23, 2022	[37]	Dec. 23, 2022	[38]	Dec. 23, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.01%)	[1]	0.01%	[3]	0.01%	[3]
Investment cost		$ 541	[2]	$ 541	[4]
Investments at Fair Value		118		99
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		123	[2]	123	[4]
Investments at Fair Value		$ 118		$ 99
Shares | shares		229,611		229,611		229,611
Investments Owned Acquisition Date		Jun. 28, 2022	[37]	Jun. 28, 2022	[38]	Jun. 28, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 418	[2]	$ 418	[4]
Investments at Fair Value
Shares | shares		2,834,375		2,834,375		2,834,375
Investments Owned Acquisition Date		Apr. 19, 2013	[37]	Apr. 19, 2013	[38]	Apr. 19, 2013	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.14%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.14%)
Investment cost	[2]	$ 1,712
Investments at Fair Value		2,120
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.17%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.17%		0.17%
Investment cost	[4]			$ 1,712
Investments at Fair Value				2,323
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 228	[2]	228	[4]
Investments at Fair Value
Shares | shares		1,662,441		1,662,441		1,662,441
Investments Owned Acquisition Date		Jun. 03, 2014	[37]	Jun. 03, 2014	[38]	Jun. 03, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units
Investment Holdings [Line Items]
Investment cost	[4]			$ 0
Investments at Fair Value		$ 1,025		$ 1,103
Shares | shares		206,185		206,185		206,185
Investments Owned Acquisition Date		Jun. 27, 2014	[37]	Jun. 27, 2014	[38]	Jun. 27, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock
Investment Holdings [Line Items]
Investment cost	[4]			$ 0
Investments at Fair Value
Shares | shares		206,185		206,185		206,185
Investments Owned Acquisition Date		Jun. 27, 2014	[37]	Jun. 27, 2014	[38]	Jun. 27, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 1,101	[2]	$ 1,101	[4]
Investments at Fair Value		$ 720		$ 745
Shares | shares		206,185		206,185		206,185
Investments Owned Acquisition Date		Jul. 16, 2013	[37]	Jul. 16, 2013	[38]	Jul. 16, 2013	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 365	[2]	$ 365	[4]
Investments at Fair Value
Shares | shares		54,054		54,054		54,054
Investments Owned Acquisition Date		Aug. 13, 2014	[37]	Aug. 13, 2014	[38]	Aug. 13, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 18	[2]	$ 18	[4]
Investments at Fair Value		$ 375		$ 475
Shares | shares		686,270		686,270		686,270
Investments Owned Acquisition Date		Jun. 27, 2018	[37]	Jun. 27, 2018	[38]	Jun. 27, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.19%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.19%		0.19%
Investment cost	[4]			$ 4,248
Investments at Fair Value				2,639
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.23%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.23%)
Investment cost	[2]	$ 4,581
Investments at Fair Value		3,414
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		164	[2],[23],[24]	164	[4],[25],[26]
Investments at Fair Value		$ 40	[23],[24]	$ 34	[25],[26]
Shares | shares		174,163	[23],[24]	174,163	[25],[26]	174,163	[25],[26]
Investments Owned Acquisition Date		Dec. 14, 2021	[23],[24],[37]	Dec. 14, 2021	[25],[26],[38]	Dec. 14, 2021	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 20	[2]	$ 20	[4]
Investments at Fair Value
Shares | shares		529,661		529,661		529,661
Investments Owned Acquisition Date		Oct. 29, 2019	[37]	Oct. 29, 2019	[38]	Oct. 29, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 116	[2],[29]	$ 116	[4],[30]
Investments at Fair Value		$ 201	[29]	$ 127	[30]
Shares | shares		11,806	[29]	11,806	[30]	11,806	[30]
Investments Owned Acquisition Date		Mar. 12, 2021	[29],[37]	Mar. 12, 2021	[30],[38]	Mar. 12, 2021	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 39	[2]	$ 39	[4]
Investments at Fair Value		$ 43		$ 19
Shares | shares		127,032		127,032		127,032
Investments Owned Acquisition Date		Mar. 29, 2019	[37]	Mar. 29, 2019	[38]	Mar. 29, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Modern Life, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock
Investment Holdings [Line Items]
Investment cost	[2]	$ 214
Investments at Fair Value		$ 218
Shares | shares		49,192
Investments Owned Acquisition Date	[37]	Mar. 30, 2023
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 166	[2],[29]	$ 166	[4],[30]
Investments at Fair Value		$ 138	[29]	$ 155	[30]
Shares | shares		117,042	[29]	117,042	[30]	117,042	[30]
Investments Owned Acquisition Date		Dec. 22, 2022	[29],[37]	Dec. 22, 2022	[30],[38]	Dec. 22, 2022	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 470	[2],[29]	$ 470	[4],[30]
Investments at Fair Value		$ 219	[29]	$ 308	[30]
Shares | shares		13,106	[29]	13,106	[30]	13,106	[30]
Investments Owned Acquisition Date		Mar. 12, 2021	[29],[37]	Mar. 12, 2021	[30],[38]	Mar. 12, 2021	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 88	[2],[37]	$ 88	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 0	[38]
Shares | shares		5,139	[37]	5,139	[38]	5,139	[38]
Investments Owned Acquisition Date		Apr. 30, 2018	[37]	Apr. 30, 2018	[38]	Apr. 30, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 842	[2],[18],[19]	$ 842	[4],[21],[22]
Investments at Fair Value		$ 2,027	[18],[19]	$ 1,332	[21],[22]
Shares | shares		1,379,761	[18],[19]	1,379,761	[21],[22]	1,379,761	[21],[22]
Investments Owned Acquisition Date		Jun. 12, 2019	[18],[19],[37]	Jun. 12, 2019	[21],[22],[38]	Jun. 12, 2019	[21],[22],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc.
Investment Holdings [Line Items]
Investment cost		$ 140	[2]	$ 140	[4]
Investments at Fair Value		$ 27		$ 43
Shares | shares		2,051,587		2,051,587		2,051,587
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 57	[2]	$ 57	[4]
Investments at Fair Value		$ 26	[18]	$ 43
Shares | shares		1,607,143		1,607,143		1,607,143
Investments Owned Acquisition Date		Nov. 14, 2022	[37]	Nov. 14, 2022	[38]	Nov. 14, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 83	[2]	$ 83	[4]
Investments at Fair Value		$ 1
Shares | shares		444,444		444,444		444,444
Investments Owned Acquisition Date		Aug. 23, 2019	[37]	Aug. 23, 2019	[38]	Aug. 23, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc.
Investment Holdings [Line Items]
Investment cost		$ 860	[2]	$ 860	[4]
Investments at Fair Value		$ 66		$ 118
Shares | shares		3,611,537		3,611,537		3,611,537
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 16	[2]	$ 16	[4]
Investments at Fair Value		$ 22		$ 43
Shares | shares		600,000		600,000		600,000
Investments Owned Acquisition Date		Apr. 20, 2020	[37]	Apr. 20, 2020	[38]	Apr. 20, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A
Investment Holdings [Line Items]
Investment cost		$ 782	[2]	$ 782	[4]
Investments at Fair Value		$ 29		$ 50
Shares | shares		1,800,000		1,800,000		1,800,000
Investments Owned Acquisition Date		Jun. 30, 2016	[37]	Jun. 30, 2016	[38]	Jun. 30, 2016	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 62	[2]	$ 62	[4]
Investments at Fair Value		$ 15		$ 25
Shares | shares		1,211,537		1,211,537		1,211,537
Investments Owned Acquisition Date		Aug. 01, 2018	[37]	Aug. 01, 2018	[38]	Aug. 01, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 844	[2],[18]	$ 844	[4],[21]
Investments at Fair Value		$ 384	[18]	$ 280	[21]
Shares | shares		267,225	[18]	267,225	[21]	267,225	[21]
Investments Owned Acquisition Date		May 01, 2018	[18],[37]	May 01, 2018	[21],[38]	May 01, 2018	[21],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 218	[2],[18]	$ 218	[4],[21]
Investments at Fair Value	[21]			$ 4
Shares | shares		486,359	[18]	486,359	[21]	486,359	[21]
Investments Owned Acquisition Date		Sep. 25, 2020	[18],[37]	Sep. 25, 2020	[21],[38]	Sep. 25, 2020	[21],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 126	[2]	$ 126	[4]
Investments at Fair Value		$ 24		$ 25
Shares | shares		98,428		98,428		98,428
Investments Owned Acquisition Date		Mar. 31, 2022	[37]	Mar. 31, 2022	[38]	Mar. 31, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock
Investment Holdings [Line Items]
Investment cost	[2]	$ 119
Investments at Fair Value		$ 14
Shares | shares		130,355
Investments Owned Acquisition Date	[37]	Mar. 28, 2022
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited
Investment Holdings [Line Items]
Investment cost		$ 155	[2]	$ 155	[4]
Investments at Fair Value		$ 13		$ 194
Shares | shares		79,083		79,083		79,083
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 129	[2],[18],[19],[23],[24]	$ 129	[4],[21],[22],[25],[26]
Investments at Fair Value		$ 13	[18],[19],[23],[24]	$ 192	[21],[22],[25],[26]
Shares | shares		77,215	[18],[19],[23],[24]	77,215	[21],[22],[25],[26]	77,215	[21],[22],[25],[26]
Investments Owned Acquisition Date		Feb. 11, 2021	[18],[19],[23],[24],[37]	Feb. 11, 2021	[21],[22],[25],[26],[38]	Feb. 11, 2021	[21],[22],[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 26	[2],[19],[23],[24]	$ 26	[4],[22],[25],[26]
Investments at Fair Value	[22],[25],[26]			$ 2
Shares | shares		1,868	[19],[23],[24]	1,868	[22],[25],[26]	1,868	[22],[25],[26]
Investments Owned Acquisition Date		Aug. 27, 2021	[19],[23],[24],[37]	Aug. 27, 2021	[22],[25],[26],[38]	Aug. 27, 2021	[22],[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.01%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.01%)
Investment cost	[2]	$ 214
Investments at Fair Value		189
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2022, Common Stock
Investment Holdings [Line Items]
Investment cost	[2]	214
Investments at Fair Value		$ 189
Shares | shares		522,930
Investments Owned Acquisition Date	[37]	Feb. 03, 2023
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.00%)	[1]	0.00%	[3]	0.00%	[3]
Investment cost		$ 465	[2]	$ 465	[4]
Investments at Fair Value		0		1
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock
Investment Holdings [Line Items]
Investment cost		74	[2]	74	[4]
Investments at Fair Value		$ 0
Shares | shares		110,882		110,882		110,882
Investments Owned Acquisition Date		Sep. 30, 2015	[37]	Sep. 30, 2015	[38]	Sep. 30, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1	[2]	$ 1	[4]
Investments at Fair Value		$ 0
Shares | shares		459,183		459,183		459,183
Investments Owned Acquisition Date		Oct. 27, 2014	[37]	Oct. 27, 2014	[38]	Oct. 27, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 390	[2],[37]	$ 390	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 1	[38]
Shares | shares		3,929	[37]	3,929	[38]	3,929	[38]
Investments Owned Acquisition Date		Aug. 28, 2014	[37]	Aug. 28, 2014	[38]	Aug. 28, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.60%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.60%		0.60%
Investment cost	[4]			$ 7,466
Investments at Fair Value				8,444
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.70%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.70%)
Investment cost	[2]	$ 8,142
Investments at Fair Value		10,484
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		166	[2],[37]	166	[4],[38]
Investments at Fair Value		$ 4	[37]	$ 10	[38]
Shares | shares		58,000	[37]	58,000	[38]	58,000	[38]
Investments Owned Acquisition Date		Feb. 24, 2014	[37]	Feb. 24, 2014	[38]	Feb. 24, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 304	[2],[23],[24]	$ 304	[4],[25],[26]
Investments at Fair Value		$ 0	[23],[24]	$ 0	[25],[26]
Shares | shares		201,330	[23],[24]	201,330	[25],[26]	201,330	[25],[26]
Investments Owned Acquisition Date		Jun. 29, 2018	[23],[24],[37]	Jun. 29, 2018	[25],[26],[38]	Jun. 29, 2018	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 175	[2],[23],[37]	$ 56	[4],[25],[38]
Investments at Fair Value		$ 562	[23],[37]	$ 674	[25],[38]
Shares | shares		22,949	[23],[37]	18,360	[25],[38]	18,360	[25],[38]
Investments Owned Acquisition Date		Jun. 15, 2022	[23],[37]	Jun. 15, 2022	[25],[38]	Jun. 15, 2022	[25],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[25],[38]			$ 61
Investments at Fair Value	[25],[38]			$ 31
Shares | shares	[25],[38]			5,311		5,311
Investments Owned Acquisition Date	[25],[38]			Jun. 08, 2020		Jun. 08, 2020
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Investment Holdings [Line Items]
Investment cost		$ 237	[2],[29]	$ 238	[4],[30]
Investments at Fair Value		$ 236	[29]	$ 256	[30]
Shares | shares		69,239	[29]	69,239	[30]	69,239	[30]
Investments Owned Acquisition Date		Dec. 27, 2022	[29],[37]	Dec. 27, 2022	[30],[38]	Dec. 27, 2022	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,101	[2],[18],[19],[23],[37]	$ 880	[4],[21],[22],[25],[38]
Investments at Fair Value		$ 1,289	[18],[19],[23],[37]	$ 1,590	[21],[22],[25],[38]
Shares | shares		53,971	[18],[19],[23],[37]	40,396	[21],[22],[25],[38]	40,396	[21],[22],[25],[38]
Investments Owned Acquisition Date		Sep. 25, 2020	[18],[19],[23],[37]	Sep. 25, 2020	[21],[22],[25],[38]	Sep. 25, 2020	[21],[22],[25],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 287	[2],[29]	$ 287	[4],[30]
Investments at Fair Value		$ 253	[29]	$ 318	[30]
Shares | shares		100,000	[29]	100,000	[30]	100,000	[30]
Investments Owned Acquisition Date		Dec. 08, 2021	[29],[37]	Dec. 08, 2021	[30],[38]	Dec. 08, 2021	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 37	[2],[37]	$ 37	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 3	[38]
Shares | shares		16,112	[37]	16,112	[38]	16,112	[38]
Investments Owned Acquisition Date		Sep. 14, 2020	[37]	Sep. 14, 2020	[38]	Sep. 14, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 101	[2],[23],[24]	$ 101	[4],[25],[26]
Investments at Fair Value		$ 129	[23],[24]	$ 199	[25],[26]
Shares | shares		223,642	[23],[24]	223,642	[25],[26]	223,642	[25],[26]
Investments Owned Acquisition Date		May 31, 2019	[23],[24],[37]	May 31, 2019	[25],[26],[38]	May 31, 2019	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 266	[2],[37]	$ 266	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 0	[38]
Shares | shares		520	[37]	520	[38]	520	[38]
Investments Owned Acquisition Date		Jun. 11, 2014	[37]	Jun. 11, 2014	[38]	Jun. 11, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 119	[2],[37]	$ 119	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 0	[38]
Shares | shares		201	[37]	200	[38]	200	[38]
Investments Owned Acquisition Date		Feb. 18, 2016	[37]	Feb. 18, 2016	[38]	Feb. 18, 2016	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 110	[2],[37]	$ 110	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 0	[38]
Shares | shares		2,202	[37]	2,202	[38]	2,202	[38]
Investments Owned Acquisition Date		Dec. 20, 2019	[37]	Dec. 20, 2019	[38]	Dec. 20, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 88	[2],[23],[29],[37]	$ 88	[4],[25],[30],[38]
Investments at Fair Value		$ 52	[23],[29],[37]	$ 59	[25],[30],[38]
Shares | shares		14,342	[23],[29],[37]	14,342	[25],[30],[38]	14,342	[25],[30],[38]
Investments Owned Acquisition Date		Nov. 02, 2022	[23],[29],[37]	Nov. 02, 2022	[25],[30],[38]	Nov. 02, 2022	[25],[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 425	[2],[23],[37]	$ 177	[4],[25],[38]
Investments at Fair Value		$ 1,829	[23],[37]	$ 1,977	[25],[38]
Shares | shares		11,799	[23],[37]	10,131	[25],[38]	10,131	[25],[38]
Investments Owned Acquisition Date		May 09, 2022	[23],[37]	May 09, 2022	[25],[38]	May 09, 2022	[25],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[25],[26],[38]			$ 460
Investments at Fair Value	[25],[26],[38]			$ 958
Shares | shares	[25],[26],[38]			73,710		73,710
Investments Owned Acquisition Date	[25],[26],[38]			Oct. 16, 2017		Oct. 16, 2017
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 520	[2],[37]	$ 520	[4],[38]
Investments at Fair Value		$ 113	[37]	$ 34	[38]
Shares | shares		426,866	[37]	426,866	[38]	426,866	[38]
Investments Owned Acquisition Date		Aug. 01, 2018	[37]	Aug. 01, 2018	[38]	Aug. 01, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 848	[2],[18],[19],[23],[29],[37]	$ 848	[4],[21],[22],[25],[30],[38]
Investments at Fair Value		$ 60	[18],[19],[23],[29],[37]	$ 101	[21],[22],[25],[30],[38]
Shares | shares		64,687	[18],[19],[23],[29],[37]	64,687	[21],[22],[25],[30],[38]	64,687	[21],[22],[25],[30],[38]
Investments Owned Acquisition Date		Sep. 17, 2021	[18],[19],[23],[29],[37]	Sep. 17, 2021	[21],[22],[25],[30],[38]	Sep. 17, 2021	[21],[22],[25],[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 640	[2],[37]	$ 281	[4],[38]
Investments at Fair Value		$ 3,312	[37]	$ 677	[38]
Shares | shares		205,391	[37]	111,934	[38]	111,934	[38]
Investments Owned Acquisition Date		Sep. 15, 2022	[37]	Sep. 15, 2022	[38]	Sep. 15, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E
Investment Holdings [Line Items]
Investment cost		$ 20	[2],[29]	$ 20	[4],[30]
Investments at Fair Value		$ 13	[29]	$ 21	[30]
Shares | shares		475,510	[29]	475,510	[30]	475,510	[30]
Investments Owned Acquisition Date		Mar. 23, 2022	[29],[37]	Mar. 23, 2022	[30],[38]	Mar. 23, 2022	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 296	[2],[18],[37]	$ 296	[4],[21],[38]
Investments at Fair Value		$ 76	[18],[37]	$ 15	[21],[38]
Shares | shares		106,035	[18],[37]	106,035	[21],[38]	106,035	[21],[38]
Investments Owned Acquisition Date		May 14, 2021	[18],[37]	May 14, 2021	[21],[38]	May 14, 2021	[21],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,284	[2],[18],[23],[37]	$ 1,033	[4],[21],[25],[38]
Investments at Fair Value		$ 2,236	[18],[23],[37]	$ 1,084	[21],[25],[38]
Shares | shares		264,226	[18],[23],[37]	231,613	[21],[25],[38]	231,613	[21],[25],[38]
Investments Owned Acquisition Date		Feb. 28, 2019	[18],[23],[37]	Feb. 28, 2019	[21],[25],[38]	Feb. 28, 2019	[21],[25],[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 280	[2]	$ 280	[4],[38]
Investments at Fair Value				$ 1	[38]
Shares | shares		31,352		31,352	[38]	31,352	[38]
Investments Owned Acquisition Date		Mar. 27, 2019	[37]	Mar. 27, 2019	[38]	Mar. 27, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units
Investment Holdings [Line Items]
Investment cost		$ 256	[2]	$ 256	[4]
Investments at Fair Value		$ 91		$ 127
Shares | shares		102,216		102,216		102,216
Investments Owned Acquisition Date		Jun. 15, 2020	[37]	Jun. 15, 2020	[38]	Jun. 15, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[38]			$ 510
Investments at Fair Value	[38]			$ 281
Shares | shares	[38]			1,392,787		1,392,787
Investments Owned Acquisition Date	[38]			Dec. 09, 2022		Dec. 09, 2022
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/28/2019, Common Stock
Investment Holdings [Line Items]
Investment cost	[2],[37]	$ 510
Investments at Fair Value	[37]	$ 212
Shares | shares	[37]	1,392,787
Investments Owned Acquisition Date	[37]	Mar. 18, 2019
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 3
Investment Holdings [Line Items]
Investment cost		$ 72	[2],[18],[23],[24]	$ 72	[4],[21],[25],[26]
Investments at Fair Value		$ 17	[18],[23],[24]	$ 28	[21],[25],[26]
Shares | shares		133,692	[18],[23],[24]	133,692	[21],[25],[26]	133,692	[21],[25],[26]
Investments Owned Acquisition Date		Dec. 30, 2021	[18],[23],[24],[37]	Dec. 30, 2021	[21],[25],[26],[38]	Dec. 30, 2021	[21],[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.07%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.07%)
Investment cost	[2]	$ 692
Investments at Fair Value		1,048
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.09%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.09%		0.09%
Investment cost	[4]			$ 692
Investments at Fair Value				1,273
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock
Investment Holdings [Line Items]
Investment cost		101	[2],[37]	101	[4],[38]
Investments at Fair Value		$ 101	[37]	$ 86	[38]
Shares | shares		49,078	[37]	49,078	[38]	49,078	[38]
Investments Owned Acquisition Date		Mar. 15, 2017	[37]	Mar. 15, 2017	[38]	Mar. 15, 2017	[38]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 34	[2]	$ 34	[4]
Investments at Fair Value		$ 195		$ 212
Shares | shares		8,503		8,511		8,511
Investments Owned Acquisition Date		Jun. 21, 2022	[37]	Jun. 21, 2022	[38]	Jun. 21, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 557	[2]	$ 557	[4]
Investments at Fair Value		$ 752		$ 975
Shares | shares		622,255		622,255		622,255
Investments Owned Acquisition Date		Nov. 08, 2021	[37]	Nov. 08, 2021	[38]	Nov. 08, 2021	[38]
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.00%		0.00%
Investment cost	[4]			$ 114
Investments at Fair Value				14
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock
Investment Holdings [Line Items]
Investment cost	[4]			114
Investments at Fair Value				$ 14
Shares | shares				100,618		100,618
Investments Owned Acquisition Date	[38]			Mar. 28, 2022		Mar. 28, 2022
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.03%)
Investment cost	[2]	$ 680
Investments at Fair Value		444
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.04%		0.04%
Investment cost	[4]			$ 680
Investments at Fair Value				509
Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		207	[2],[29]	207	[4],[30]
Investments at Fair Value		$ 106	[29]	$ 114	[30]
Shares | shares		176,200	[29]	176,200	[30]	176,200	[30]
Investments Owned Acquisition Date		Oct. 21, 2021	[29],[37]	Oct. 21, 2021	[30],[38]	Oct. 21, 2021	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 82	[2],[23],[24]	$ 82	[4],[25],[26]
Investments at Fair Value		$ 0	[23],[24]	$ 0	[25],[26]
Shares | shares		65,587	[23],[24]	65,587	[25],[26]	65,587	[25],[26]
Investments Owned Acquisition Date		Nov. 19, 2014	[23],[24],[37]	Nov. 19, 2014	[25],[26],[38]	Nov. 19, 2014	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 1
Investment Holdings [Line Items]
Investment cost		$ 356	[2]	$ 356	[4]
Investments at Fair Value		$ 318		$ 380
Shares | shares		60,000		60,000		60,000
Investments Owned Acquisition Date		Aug. 22, 2017	[37]	Aug. 22, 2017	[38]	Aug. 22, 2017	[38]
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 35	[2],[23],[24]	$ 35	[4],[25],[26]
Investments at Fair Value		$ 20	[23],[24]	$ 15	[25],[26]
Shares | shares		94,857	[23],[24]	94,857	[25],[26]	94,857	[25],[26]
Investments Owned Acquisition Date		Jun. 29, 2022	[23],[24],[37]	Jun. 29, 2022	[25],[26],[38]	Jun. 29, 2022	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.21%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.21%)
Investment cost	[2]	$ 1,112
Investments at Fair Value		3,109
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.30%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.30%		0.30%
Investment cost	[4]			$ 1,112
Investments at Fair Value				4,156
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		537	[2]	537	[4]
Investments at Fair Value		$ 1,092		$ 1,154
Shares | shares		392,308		392,308		392,308
Investments Owned Acquisition Date		Mar. 31, 2022	[37]	Mar. 31, 2022	[38]	Mar. 31, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 528	[2]	$ 528	[4]
Investments at Fair Value		$ 1,352		$ 1,202
Shares | shares		1,111,111		1,111,111		1,111,111
Investments Owned Acquisition Date		Mar. 23, 2022	[37]	Mar. 23, 2022	[38]	Mar. 23, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 47	[2],[37]	$ 47	[4],[38]
Investments at Fair Value		$ 665	[37]	$ 1,800	[38]
Shares | shares		87,784	[37]	87,784	[38]	87,784	[38]
Investments Owned Acquisition Date		May 09, 2018	[37]	May 09, 2018	[38]	May 09, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.00%)	[1]	0.00%	[3]	0.00%	[3]
Investment cost		$ 54	[2]	$ 35	[4]
Investments at Fair Value		64		35
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-1
Investment Holdings [Line Items]
Investment cost		54	[2]	35	[4]
Investments at Fair Value		$ 64		$ 35
Shares | shares		332,433		221,622		221,622
Investments Owned Acquisition Date		Dec. 30, 2022	[37]	Dec. 30, 2022	[38]	Dec. 30, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.04%)
Investment cost	[2]	$ 2,034
Investments at Fair Value		530
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.07%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.07%		0.07%
Investment cost	[4]			$ 2,034
Investments at Fair Value				919
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock
Investment Holdings [Line Items]
Investment cost		455	[2]	455	[4]
Investments at Fair Value
Shares | shares		22,572		22,572		22,572
Investments Owned Acquisition Date		Jan. 28, 2015	[37]	Jan. 28, 2015	[38]	Jan. 28, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated
Investment Holdings [Line Items]
Investment cost		$ 713	[2]	$ 713	[4]
Investments at Fair Value
Shares | shares		836,752		836,752		836,752
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Investment Holdings [Line Items]
Investment cost		$ 362	[2]	$ 362	[4]
Investments at Fair Value
Shares | shares		110,946		110,946		110,946
Investments Owned Acquisition Date		Nov. 03, 2014	[37]	Nov. 03, 2014	[38]	Nov. 03, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB
Investment Holdings [Line Items]
Investment cost		$ 351	[2]	$ 351	[4]
Investments at Fair Value
Shares | shares		725,806		725,806		725,806
Investments Owned Acquisition Date		Sep. 21, 2018	[37]	Sep. 21, 2018	[38]	Sep. 21, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-1
Investment Holdings [Line Items]
Investment cost		$ 294	[2]	$ 294	[4]
Investments at Fair Value				$ 54
Shares | shares		3,076,323		3,076,323		3,076,323
Investments Owned Acquisition Date		Dec. 29, 2017	[37]	Dec. 29, 2017	[38]	Dec. 29, 2017	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 110	[2],[37]	$ 110	[4],[38]
Investments at Fair Value		$ 4	[37]	$ 0	[38]
Shares | shares		59,642	[37]	59,642	[38]	59,642	[38]
Investments Owned Acquisition Date		Feb. 04, 2022	[37]	Feb. 04, 2022	[38]	Feb. 04, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 401	[2],[37]	$ 401	[4],[38]
Investments at Fair Value		$ 526	[37]	$ 864	[38]
Shares | shares		62,794	[37]	62,794	[38]	62,794	[38]
Investments Owned Acquisition Date		Sep. 27, 2013	[37]	Sep. 27, 2013	[38]	Sep. 27, 2013	[38]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 61	[2],[37]	$ 61	[4],[38]
Investments at Fair Value		$ 0	[37]	$ 1	[38]
Shares | shares		15,712	[37]	15,712	[38]	15,712	[38]
Investments Owned Acquisition Date		Mar. 31, 2017	[37]	Mar. 31, 2017	[38]	Mar. 31, 2017	[38]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.04%)	[1]	0.04%	[3]	0.04%	[3]
Investment cost		$ 99	[2]	$ 850	[4]
Investments at Fair Value		670		524
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-2
Investment Holdings [Line Items]
Investment cost		99	[2]	99	[4]
Investments at Fair Value		$ 670		$ 524
Shares | shares		750,000		750,000		750,000
Investments Owned Acquisition Date		Jun. 26, 2015	[37]	Jun. 26, 2015	[38]	Jun. 26, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock
Investment Holdings [Line Items]
Investment cost	[4],[30]			$ 751
Investments at Fair Value	[30]			$ 0
Shares | shares	[30]			800,000		800,000
Investments Owned Acquisition Date	[30],[38]			Dec. 16, 2021		Dec. 16, 2021
Investment, Identifier [Axis]: Warrant Investments and Software (0.59%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.59%		0.59%
Investment cost	[4]			$ 9,761
Investments at Fair Value				8,244
Investment, Identifier [Axis]: Warrant Investments and Software (0.64%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.64%)
Investment cost	[2]	$ 10,150
Investments at Fair Value		9,546
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G
Investment Holdings [Line Items]
Investment cost		74	[2]	74	[4]
Investments at Fair Value
Shares | shares		231,535		231,535		231,535
Investments Owned Acquisition Date		May 22, 2015	[37]	May 22, 2015	[38]	May 22, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 449	[2]	$ 448	[4]
Investments at Fair Value		$ 525		$ 365
Shares | shares		254,778		254,778		254,778
Investments Owned Acquisition Date		Sep. 23, 2022	[37]	Sep. 23, 2022	[38]	Sep. 23, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 284	[2]	$ 284	[4]
Investments at Fair Value		$ 511		$ 398
Shares | shares		29,691		29,691		29,691
Investments Owned Acquisition Date		Nov. 18, 2020	[37]	Nov. 18, 2020	[38]	Nov. 18, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 165	[2],[29]	$ 165	[4],[30]
Investments at Fair Value		$ 97	[29]	$ 61	[30]
Shares | shares		194,629	[29]	194,629	[30]	194,629	[30]
Investments Owned Acquisition Date		Oct. 04, 2021	[29],[37]	Oct. 04, 2021	[30],[38]	Oct. 04, 2021	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 117	[2]	$ 117	[4]
Investments at Fair Value		$ 8		$ 1
Shares | shares		211,342		211,342		211,342
Investments Owned Acquisition Date		Sep. 30, 2020	[37]	Sep. 30, 2020	[38]	Sep. 30, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 71	[2]	$ 71	[4]
Investments at Fair Value		$ 21		$ 14
Shares | shares		477,454		477,454		477,454
Investments Owned Acquisition Date		Nov. 06, 2018	[37]	Nov. 06, 2018	[38]	Nov. 06, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 54	[2],[23],[24]	$ 54	[4],[25],[26]
Investments at Fair Value		$ 531	[23],[24]	$ 400	[25],[26]
Shares | shares		6,763	[23],[24]	6,763	[25],[26]	6,763	[25],[26]
Investments Owned Acquisition Date		Apr. 10, 2018	[23],[24],[37]	Apr. 10, 2018	[25],[26],[38]	Apr. 10, 2018	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 974	[2]	$ 974	[4],[22]
Investments at Fair Value		$ 346		$ 364	[22]
Shares | shares		165,456		165,456	[22]	165,456	[22]
Investments Owned Acquisition Date		Mar. 30, 2022	[37]	Mar. 30, 2022	[22],[38]	Mar. 30, 2022	[22],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 462	[2],[37]	$ 462	[4],[38]
Investments at Fair Value		$ 563	[37]	$ 488	[38]
Shares | shares		105,350	[37]	105,350	[38]	105,350	[38]
Investments Owned Acquisition Date		Apr. 25, 2019	[37]	Apr. 25, 2019	[38]	Apr. 25, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 26	[2],[18],[23],[24]	$ 26	[4],[21],[25],[26]
Investments at Fair Value		$ 24	[18],[23],[24]	$ 19	[21],[25],[26]
Shares | shares		102,898	[18],[23],[24]	102,898	[21],[25],[26]	102,898	[21],[25],[26]
Investments Owned Acquisition Date		Sep. 21, 2022	[18],[23],[24],[37]	Sep. 21, 2022	[21],[25],[26],[38]	Sep. 21, 2022	[21],[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 97	[2]	$ 97	[4]
Investments at Fair Value		$ 188		$ 131
Shares | shares		909,091		909,091		909,091
Investments Owned Acquisition Date		Mar. 21, 2014	[37]	Mar. 21, 2014	[38]	Mar. 21, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 353	[2]	$ 353	[4]
Investments at Fair Value		$ 196		$ 168
Shares | shares		453,641		453,641		453,641
Investments Owned Acquisition Date		Mar. 11, 2019	[37]	Mar. 11, 2019	[38]	Mar. 11, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,594	[2]	$ 1,594	[4]
Investments at Fair Value		$ 2,292		$ 2,657
Shares | shares		718,898		718,898		718,898
Investments Owned Acquisition Date		Oct. 08, 2019	[37]	Oct. 08, 2019	[38]	Oct. 08, 2019	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 545	[2]	$ 545	[4]
Investments at Fair Value		$ 463		$ 180
Shares | shares		727,047		727,047		727,047
Investments Owned Acquisition Date		Aug. 02, 2021	[37]	Aug. 02, 2021	[38]	Aug. 02, 2021	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 278	[2]	$ 278	[4]
Investments at Fair Value		$ 353		$ 300
Shares | shares		95,911		95,911		95,911
Investments Owned Acquisition Date		Jun. 30, 2022	[37]	Jun. 30, 2022	[38]	Jun. 30, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 8	[2],[23],[24]	$ 8	[4],[25],[26]
Investments at Fair Value		$ 5	[23],[24]	$ 6	[25],[26]
Shares | shares		522	[23],[24]	522	[25],[26]	522	[25],[26]
Investments Owned Acquisition Date		Apr. 13, 2022	[23],[24],[37]	Apr. 13, 2022	[25],[26],[38]	Apr. 13, 2022	[25],[26],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 584	[2]	$ 583	[4]
Investments at Fair Value		$ 347		$ 382
Shares | shares		362,837		362,837		362,837
Investments Owned Acquisition Date		Sep. 12, 2022	[37]	Sep. 12, 2022	[38]	Sep. 12, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 198	[2]	$ 198	[4]
Investments at Fair Value
Shares | shares		56,765		56,765		56,765
Investments Owned Acquisition Date		Jan. 27, 2022	[37]	Jan. 27, 2022	[38]	Jan. 27, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock
Investment Holdings [Line Items]
Investment cost	[4]			$ 107
Investments at Fair Value				$ 6
Shares | shares				62,500		62,500
Investments Owned Acquisition Date	[38]			Sep. 30, 2016		Sep. 30, 2016
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 96	[2]	$ 96	[4]
Investments at Fair Value		$ 47		$ 39
Shares | shares		75,917		75,917		75,917
Investments Owned Acquisition Date		May 10, 2018	[37]	May 10, 2018	[38]	May 10, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 325	[2]	$ 325	[4]
Investments at Fair Value		$ 396		$ 314
Shares | shares		84,995		84,995		84,995
Investments Owned Acquisition Date		Jul. 29, 2022	[37]	Jul. 29, 2022	[38]	Jul. 29, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C
Investment Holdings [Line Items]
Investment cost	[2]	$ 208
Investments at Fair Value		$ 221
Shares | shares		64,293
Investments Owned Acquisition Date	[37]	Mar. 31, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock
Investment Holdings [Line Items]
Investment cost	[2],[23],[24]	$ 16
Investments at Fair Value	[23],[24]	$ 17
Shares | shares	[23],[24]	39,948
Investments Owned Acquisition Date	[23],[24],[37]	Jan. 23, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 131	[2]	$ 131	[4]
Investments at Fair Value		$ 3		$ 1
Shares | shares		89,685		89,685		89,685
Investments Owned Acquisition Date		Feb. 14, 2018	[37]	Feb. 14, 2018	[38]	Feb. 14, 2018	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 252	[2]	$ 252	[4]
Investments at Fair Value		$ 252		$ 225
Shares | shares		82,362		82,362		82,362
Investments Owned Acquisition Date		Sep. 30, 2020	[37]	Sep. 30, 2020	[38]	Sep. 30, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 172	[2],[18]	$ 172	[4],[21]
Investments at Fair Value		$ 198	[18]	$ 175	[21]
Shares | shares		70,000	[18]	70,000	[21]	70,000	[21]
Investments Owned Acquisition Date		Mar. 29, 2019	[18],[37]	Mar. 29, 2019	[21],[38]	Mar. 29, 2019	[21],[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 0	[2]	$ 0	[4]
Investments at Fair Value
Shares | shares		132,168		132,168		132,168
Investments Owned Acquisition Date		May 28, 2014	[37]	May 28, 2014	[38]	May 28, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 215	[2]	$ 215	[4]
Investments at Fair Value		$ 346		$ 298
Shares | shares		69,120		69,120		69,120
Investments Owned Acquisition Date		Jun. 30, 2020	[37]	Jun. 30, 2020	[38]	Jun. 30, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred
Investment Holdings [Line Items]
Investment cost		$ 314	[2]	$ 314	[4]
Investments at Fair Value
Shares | shares		474,019		474,019		474,019
Investments Owned Acquisition Date		Jan. 13, 2016	[37]	Jan. 13, 2016	[38]	Jan. 13, 2016	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock
Investment Holdings [Line Items]
Investment cost	[2]	$ 96
Investments at Fair Value		$ 100
Shares | shares		77,934
Investments Owned Acquisition Date	[37]	Mar. 22, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 103	[2]	$ 103	[4]
Investments at Fair Value		$ 533		$ 426
Shares | shares		312,596		312,596		312,596
Investments Owned Acquisition Date		Apr. 28, 2020	[37]	Apr. 28, 2020	[38]	Apr. 28, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 206	[2]	$ 206	[4]
Investments at Fair Value		$ 85		$ 69
Shares | shares		1,041,667		1,041,667		1,041,667
Investments Owned Acquisition Date		Feb. 13, 2020	[37]	Feb. 13, 2020	[38]	Feb. 13, 2020	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Investment Holdings [Line Items]
Investment cost		$ 234	[2]	$ 234	[4]
Investments at Fair Value		$ 337		$ 436
Shares | shares		8,076		8,076		8,076
Investments Owned Acquisition Date		Nov. 03, 2014	[37]	Nov. 03, 2014	[38]	Nov. 03, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares
Investment Holdings [Line Items]
Investment cost	[2],[23],[24]	$ 174
Investments at Fair Value	[23],[24]	$ 179
Shares | shares	[23],[24]	254,877
Investments Owned Acquisition Date	[23],[24],[37]	Mar. 22, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		$ 1,275	[2],[29]	$ 1,275	[4],[30]
Investments at Fair Value		$ 362	[29]	$ 321	[30]
Shares | shares		152,048	[29]	152,048	[30]	152,048	[30]
Investments Owned Acquisition Date		Jan. 21, 2022	[29],[37]	Jan. 21, 2022	[30],[38]	Jan. 21, 2022	[30],[38]
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%)
Investment Holdings [Line Items]
Investment owned, percent of net assets		(0.04%)	[1]	0.04%	[3]	0.04%	[3]
Investment cost		$ 39	[2]	$ 46	[4]
Investments at Fair Value		597		492
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C
Investment Holdings [Line Items]
Investment cost	[4]			7
Investments at Fair Value
Shares | shares				16,835		16,835
Investments Owned Acquisition Date	[38]			Jan. 16, 2013		Jan. 16, 2013
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock
Investment Holdings [Line Items]
Investment cost		39	[2],[37],[42]	$ 39	[4],[38]
Investments at Fair Value		$ 597	[37],[42]	$ 492	[38]
Shares | shares		14,440	[37],[42]	14,440	[38]	14,440	[38]
Investments Owned Acquisition Date		Sep. 11, 2015	[37],[42]	Sep. 11, 2015	[38]	Sep. 11, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.00%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[1]	(0.00%)
Investment cost	[2]	$ 723
Investments at Fair Value		372
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.03%)
Investment Holdings [Line Items]
Investment owned, percent of net assets	[3]			0.03%		0.03%
Investment cost	[4]			$ 723
Investments at Fair Value				488
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock
Investment Holdings [Line Items]
Investment cost		52	[2]	52	[4]
Investments at Fair Value		$ 37		$ 44
Shares | shares		18,472		18,472		18,472
Investments Owned Acquisition Date		Apr. 15, 2022	[37]	Apr. 15, 2022	[38]	Apr. 15, 2022	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-1
Investment Holdings [Line Items]
Investment cost		$ 64	[2]	$ 64	[4]
Investments at Fair Value		$ 272		$ 275
Shares | shares		93,632		93,632		93,632
Investments Owned Acquisition Date		Apr. 30, 2013	[37]	Apr. 30, 2013	[38]	Apr. 30, 2013	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc.
Investment Holdings [Line Items]
Investment cost		$ 218	[2]	$ 218	[4]
Investments at Fair Value		$ 63		$ 169
Shares | shares		456,883		456,883		456,883
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A
Investment Holdings [Line Items]
Investment cost		$ 155	[2]	$ 155	[4]
Investments at Fair Value		$ 48		$ 126
Shares | shares		325,000		325,000		325,000
Investments Owned Acquisition Date		Apr. 22, 2014	[37]	Apr. 22, 2014	[38]	Apr. 22, 2014	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B
Investment Holdings [Line Items]
Investment cost		$ 63	[2]	$ 63	[4]
Investments at Fair Value		$ 15		$ 43
Shares | shares		131,883		131,883		131,883
Investments Owned Acquisition Date		Apr. 07, 2015	[37]	Apr. 07, 2015	[38]	Apr. 07, 2015	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D
Investment Holdings [Line Items]
Investment cost		$ 120	[2]	$ 120	[4]
Investments at Fair Value
Shares | shares		471,327		471,327		471,327
Investments Owned Acquisition Date		Jun. 20, 2013	[37]	Jun. 20, 2013	[38]	Jun. 20, 2013	[38]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C
Investment Holdings [Line Items]
Investment cost		$ 269	[2]	$ 269	[4]
Investments at Fair Value
Shares | shares		150,036		150,036		150,036
Investments Owned Acquisition Date		Mar. 24, 2015	[37]	Mar. 24, 2015	[38]	Mar. 24, 2015	[38]
Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Investment Holdings [Line Items]
Investment cost	[4],[25],[26]			$ 381
Investments at Fair Value	[25],[26]			$ 375
Investments Owned Acquisition Date	[25],[26],[38]			Jul. 21, 2022		Jul. 21, 2022
[1] Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [2] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $87.9 million, $106.6 million and $18.7 million, respectively. The tax cost of investments is $3.1 billion. [3] Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [4] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion. [5] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [6] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [7] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of March 31, 2023 (Refer to “Note 11 - Commitments and Contingencies”). [8] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022 (Refer to “Note 11 — Commitments and Contingencies”). [9] Interest rate PRIME represents 8.00% as of March 31, 2023. 1-month LIBOR, 3-month LIBOR and 6-month LIBOR represent 4.86%, 5.19%, and 5.31%, respectively, as of March 31, 2023. [10] Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent 4.40%, 4.77%, and 5.14%, respectively, as of December 31, 2022. [11] Denotes second lien senior secured debt. [12] Denotes second lien senior secured debt. [13] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [14] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [15] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [16] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [17] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [18] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [19] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of March 31, 2023. [20] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [21] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [22] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022. [23] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [24] Non-U.S. company or the company’s principal place of business is outside the United States. [25] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [26] Non-U.S. company or the company’s principal place of business is outside the United States. [27] Denotes that all or a portion of the debt investment is convertible debt. [28] Denotes that all or a portion of the debt investment is convertible debt. [29] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [30] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [31] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [32] Debt is on non-accrual status as of March 31, 2023, and is therefore considered non-income producing. Note that as of March 31, 2023, only the PIK, or payment-in-kind, portion is on non-accrual for the Company’s debt investment in Tectura Corporation. [33] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [34] Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that as of December 31, 2022, only the PIK, or payment-in-kind, portion is on non-accrual for the Company’s debt investment in Tectura Corporation. [35] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.3 million, respectively. [36] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively. [37] Except for warrants in 24 publicly traded companies and common stock in 35 publicly traded companies, all investments are restricted as of March 31, 2023 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”). [38] Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”). [39] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of March 31, 2023, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.8 million. [40] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million. [41] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act. [42] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.